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Abstract 
The aim of this work was to synthesise novel strontium containing glass-ceramics 
based on the apatite-wollastonite system.  Parent glasses were formed via the melt 
quench route with strontium being substituted for calcium according to: 
35.4SiO2•7.1P2O5•0.4CaF2•7.1MgO• (49.9-X)CaO•XSrO, where X = 6.2, 12.5, 18.7 
or 24.9.  Glass frits were ground and sieved and size distribution shown to be 
constant.  Successful substitution of strontium into the parent glass was confirmed 
with energy dispersive x-ray (EDX) analysis, x-ray diffraction (XRD) and density 
measurements  Glass rods were successfully cast for all the compositions tested.  
The x-ray attenuation of the material increased with increasing strontium 
substitution in line with theoretical values. 
Differential scanning calorimetry (DSC) revealed two major exotherms, TP1 and TP2.  
TP1 moved to lower temperatures with increasing strontium substitution while TP2 
moved to higher temperatures.  XRD and Rietveld refinement identified TP1 as 
corresponding to fluorapatite and TP2 as to wollastonite, both phases took in 
strontium following substitution.  Pseudowollastonite formed at higher strontium 
contents.  The weight percentage of wollastonite decreased with increasing 
strontium substitution.  Scanning electron microscopy (SEM) and EDX revealed the 
bulk morphology and composition of the material’s phases. 
Porous scaffolds were formed by sintering the parent glasses in carbon moulds.  
Increasing strontium substitution shifted sintering from a solid state mechanism 
towards liquid phase resulting in a loss of porosity.  In all but the highest 
substitution, the flexural strength decreased with increasing strontium. 
Simulated body fluid (SBF) testing indicated an increase in solution pH with 
increasing strontium substitution and a shift in the ability of the material to form a 
surface apatite layer.  Human bone mesenchymal stem cells (hMSCs) were able to 
attach, expand and differentiate on the materials.  Strontium doping was shown to 
significantly affect the osteogenic capacity of apatite-wollastonite glass-ceramic. 
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Chapter 1 
Introduction 
Bone has a remarkable ability to heal but in cases where a defect may be too large or 
disease prevents healing, a surgical intervention is required.  Bone 
transplantation/grafting is a recognised treatment for non-union fractures, bone loss 
due to tumours, congenital skeletal growth disorders and other bone defects that will 
not heal by themselves.  In 2001, there were roughly 500,000 bone grafts in the US 
alone [1].  This value is set to rise due to advances in technology and healthcare 
along with an aging population [2].  The ideal graft material must be biocompatible, 
osteoinductive, osteoconductive, easy to use and cost effective [1].  Allogeneic bone 
grafts, collected from tissue donors, are a common source of transplanted bone.  
Banks of allogeneic donor tissue can be built up, though storage methods such as 
freezing can alter the materials properties.  Allogeneic grafts also carry a risk of 
immunorejection or disease transferral [3].   Xenogeneic scaffolds, such as Bio-Oss, 
are utilised in dentistry to increases bone mass for implants.  Autogenic bone grafts 
are the current gold standard.  However, availability and donor site morbidity limit 
the technique [3].  This is emphasised by a Cochrane Collaboration systematic 
review following which it was determined that autografts were more successful in 
healing bone defects than allografts; but the method was over complicated due to 
graft harvesting [4].  Tissue engineering offers an alternative source of autologous 
bone and as well as novel methods of promoting bone formation and regeneration.   
Tissue engineering is defined by Langer and Vacanti as: 
“An interdisciplinary filed that applies the principles of engineering and life sciences 
toward the development of biological substitutes that restore, maintain, or improve 
tissue function or a whole organ” [5]. 
Tissue engineers utilise a combination of cells, scaffolds, growth factors and 
mechanical stimulation to promote tissue formation in vitro and in vivo.  In order to 
tissue engineer bone, its anatomy and physiology must first be understood. 
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1.1 Bone 
1.1.1 Anatomy 
Bone is a composite, designed to support the body structurally, whilst acting as a 
calcium store and “factory” for the production of blood cells.  There are two forms 
of skeletal bone: dense cortical and spongy cancellous.  Their structure is highly 
hierarchical [6].  Cortical bone is composed of cylindrical oseteons where-as 
cancellous bone is formed from trabecular struts, figure 1.  The bone matrix of the 
two structural organisations is composed of mineral and organic phases as well as 
water.  The organic phase is 90% collagen I by weight [7], other collagen forms may 
be present, for example, collagens II and X in the metaphysis during growth [8].  
Also contained in the organic phase are non-collagenous proteins such as 
osteopontin, osteocalcin and osteonectin [9], as well as various other glycoproteins.  
The mineral phase is composed of hydroxyapatite, Ca10(PO4)6(OH)2, a calcium 
phosphate.  The mineral hydroxyapatite forms crystals of varying size [10] that lie 
inside and outside collagenous phases [11], thus forming a strong, interwoven, 
composite. 
 
Figure 1: The structure of cancellous and cortical components of a human long bone, 
reproduced with permission [12]. 
The bone matrix is maintained and remodelled by four main cell types: osteoclasts, 
osteoprogenitors, osteoblasts and osteocytes.  Osteoclasts are multinuclear cells 
formed form the fusion of multiple monocytes; phagocytic white blood cells derived 
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from hematopoietic stem cells (HSCs) [13].  Osteoclasts are involved in the 
dissolution of bone: osteolysis, via the secretion of acids and proteolytic enzymes 
[13].  Ostoeprogenitor cells, differentiated from multipotent mesenchymal stem cells 
(MSCs), are adult stem cells that divide and mature into osteoblasts [14].  
Osteoblasts are responsible for new bone formation, osteogenesis, via the 
calcification of collagen osteoids.  Osteoclast and osteoblasts together form a basic 
multicellular unit (BMU).  The balance of activity of the two cell types is essential 
for bone mass maintenance.  When osteoblasts become fully surrounded by new 
bone, most undergo apoptosis, the remaining become quiescent and differentiate into 
ostocytes or bone lining cells.  Osteocytes are found in lacunae between lamellae 
(calcified matrix) sheets, linked via cytoplasmic extensions within canaliculi 
channels [15].  Their role is to detect damage to the bone matrix, then stimulate 
osteoblasts and osteoclasts to respond accordingly [16]. 
1.1.2 Mechanical Properties 
The mechanical properties of bone lay between that of its mineral and collagenous 
components.  This however produces highly anisotropic mechanical properties.  
Bone is much stronger in compression than tension due to the formation of micro-
cracks during tension.  The strength (yield stress) of cortical bone in compression is 
117-216MPa compared to 78.8-151MPa under tension [17].  Also, due to the 
longitudinal alignment of the osteons, bone is much stronger when tested along its 
long axis, see figure 2.  This is in part due to the trapping of cracks by lamella and 
osteon cement lines [18].  The strength in compression  and tension decreases to 
106-133MPa and 51-56MPa [17], respectively, when bone samples are tested in the 
transverse direction.  The bend strength of bone varies with sample and test method 
choice but is given with the range of 30-90MPa [19].  The modulus and strength of 
bone increases with mineral content and apparent density [18, 20].  The modulus of 
cortical bone has been given as 17.2GPa compared to 6.13GPa for cancellous bone 
[17].  The modulus of cancellous bone can be directly related to apparent density via 
a power law [17].  The trabeculae of cancellous bone are arranged in a fashion that 
best distributes applied forces, contributing to bone’s anisotropic properties. 
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Figure 2: The effect of bone orientation on its modulus and flexural strength, as 
calculated via a 3-point bend test.  All angles are given with respect to the long 
axis of the bone samples, reproduced with permission [21]. 
1.1.3 Bone Growth 
1.1.3.1 Development 
Bone matrix formation occurs in two forms during development: intramembranous 
ossification, whereby bone develops from mesenchymal or dermal tissue, and 
endochondral ossification, bone replacing an existing cartilage model [22].  
Intramembranous ossification involves an initial condensation of the mesenchyme 
and is the mechanism by which the flat bones of the skull form [23].  Bone 
signalling factors, predominantly bone morphogenic proteins (BMPs), initiate the 
transformation of bone marrow stem cells into differentiated osteoblasts then secrete 
the organic collagen bone matrix.  This mineral is then subsequently mineralised and 
the bone growth proceeds with the recruitment of more cells and the deposition of 
more bone.  Endochondral formation takes place primarily in long bones and is 
responsible for both their formation and growth.  Unlike in intramembranous 
ossification, the condensed mesenchymal cells differentiate into chondroblasts, 
which deposit a cartilage matrix.  Chondroblasts embedded in cartilage are known as 
chondrocytes.  Mesenchymal cells around the periphery form the perichondrium and 
differentiate into osteoblasts.  The cartilage matrix is then calcified and bone is 
formed [22]. 
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1.1.3.2 Increasing Length 
Throughout childhood, bones elongate via the migration of osteoblasts to the 
epiphyses (the end of the bone).  Ossification of a cartilaginous plate, the epiphyseal 
plate, between the epiphyses and diaphysis (shaft) then occurs.  The bone continues 
to extend due to growth of the cartilaginous plate exceeding the rate of 
ossification [24].  Growth stops during puberty when accelerated ossification 
exceeds cartilage expansion. 
1.1.3.3 Increasing Diameter 
Bone diameter increases via formation without resorption, this is known as bone 
modelling and occurs on the outer/periosteal surface of the bone.  On the inner 
surface of the bone, the endosteal surface, bone modelling proceeds as the removal 
of bone without replacement.  In this manner, the marrow cavity grows as the bone 
increases in width [25]. Bone removal of the marrow cavity occurs at a reduced rate 
compared to radial growth [26], thus increasing the thickness of the cortical and 
cancellous bone walls. 
1.1.4 Bone Remodelling 
Bone remodelling is controlled by endocrine signalling, such as oestrogen, 
parathyroid hormone (PTH) and calcitonin; as well as auto- and paracrine signalling, 
for example: sclerostin [16], Wnt and RANK pathways [27].  Microcracks due to 
loading may also disrupt osteocyte extensions, leading to their death and triggering 
the formation of osteoclasts and osteoblasts [27].  Remodelling occurs differently in 
trabecular and cancellous bone, though both processes involve the removal and 
subsequent deposition of matrix by an active BMU.  Cortical remodelling involves 
the formation of a cutting cone by osteoclasts, creating a tunnel roughly 2,000μm 
long and 150-200μm wide [27].  This is followed by osteoblastic bone deposition, 
replacing the bone removed by osteoclasts with concentric, new layers.  Via this 
process, the BMU forms a new osteon with Haversian canal [28], as observed in 
cortical bone.  In cancellous remodelling, the BMU moves across the surface of a 
trabeculae, cutting a trench 40-60μm in depth [27], before filling it in with fresh 
bone.  This results in the formation of a “hemi-osteon” [29]. 
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1.1.5 Bone Healing 
Bone fractures heal via two methods - primary or secondary healing: 
Primary bone healing occurs when two faces of a fracture remain in contact.  
Oscteocytes form cutting cones through the fracture, these are then remodelled and 
the fracture is secured.  Any gaps between the fracture surfaces are quickly filled 
with hematoma containing osteoblasts that deposit new bone in the defect [30]. 
Secondary bone healing occurs when there is a fragmented fracture and progresses 
along the following sequence [30]: 
Inflammation  Granulation  Callus mineralisation  Callus remodelling  
Concurrent remodelling 
1.2 Mesenchymal Stem Cells (MSCs) 
“Mesenchymal stem cell” (MSC) is a broad term that covers multipotent stem cells 
that have the capacity to divide asymmetrically and give rise to multiple cell 
phenotypes of the mesoderm.  This includes osteoblasts, chondrocytes, 
adipocytes [31], tenocytes [32] and cardio- and skeletal- myocytes [33].  They have 
been isolated from various tissues in the body, but most commonly from the bone 
marrow stromal stem cell niche.  Other locations that MSCs have been isolated 
include dental pulp [34], adipose tissue [35], dermis [36], skeletal muscle [37] and 
prenatal tissues such as amniotic fluid [38] and umbilical cord blood [39]. 
It is due to their osteogenic potential and occurrence throughout the body that MSCs 
are the most commonly utilised cells for bone tissue engineering.  Though 
osteogenically differentiated MSCs, osteoblasts, can be isolated directly from the 
body, they have been shown to undergo a massive reduction in deoxyribonucleic 
acid (DNA), ribonucleic acid (RNA) and protein synthesis with age, dropping to 
bellow half maximum activity after 15 doublings [40], reducing their long term bone 
forming capacity.  Also, their somatic, differentiated, phenotype prevents prolonged 
expansion in vivo due to progressive shorting of telomeres [41]. 
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1.2.1 Identification of Mesenchymal Stem Cells 
1.2.1.1 Flow Cytometry 
One of the major problems encountered in the use of MSCs has been the 
development of specific cell markers.  MSCs in culture express many markers, such 
as CD105 (SH2), CD 73 (SH3 and SH4), CD166, CD29, CD44, CD90,  and 
STRO-1 [42].  They also test negative for antigens to the CD14, CD34, CD45 and 
HLA-DR antibodies; of which the epitopes are enriched on the surface of 
hematopoietic stem cells [42].  The markers listed are however non-specific and 
different groups utilise different markers [33], adding to the confusing general 
terminology of “mesenchymal stem cell”.  The surface markers can be detected by 
staining with specific antibodies containing fluorochromes or target sites for 
secondary, labelled antibodies.  The labelled cells can then be counted or sorted into 
purified populations using flow cytometry or fluorescence activated cell 
sorting (FACS). 
1.2.1.2 In vitro Differentiation 
MSCs can be identified in culture via their potency (capability to differentiate into 
different cell phenotypes).  Cells are placed in a variety of media in order to 
differentiate them into the lineages of choice.  Table 1 displays examples of 
supplements utilised to initiate differentiation.  Different laboratories may follow 
different protocols, as can be seen in the variation in concentrations between the two 
osteogenic supplements, contributing to the difficulties in defining mesenchymal 
stem cells.  Dexamethasone is a catabolic steroid and its use in varying 
concentrations will alter the metabolism of the cells. 
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Table 1: Examples of MSC differentiation supplements. 
Differentiation 
Supplement 
Content Author 
Osteogenic 
1x10
-5 
M dexamethalone 
(dex), 0.2 M β-
glycerophosphate, 
5x01
-3 
M ascorbic acid 
Lennon, 2006 [43] 
Osteogenic 
1x10
-7 M dex, 0.01 M β-
glycerophosphate, 
5x01
-5 
M ascorbic acid 
Roura, 2006 [44] 
Adipogenic 
1x10-6M aex, 5x10-4M 
misobutylmethylxanthine, 
10μg/ml insulin, 1x10-
4M indomethacin 
Roura, 2006 [44] 
Myogenic 
1x10-5M 5-azacytidine 
(5-AZ) 
Roura, 2006 [44] 
 
The ability of the cells to differentiate in the presence of the supplements is 
measured via a variety of assays.  Successful osteogenic differentiation can be 
observed via the production of alkaline phosphatase (easily detected via an ALP 
assay), increased mineralisation (via von Kassa and Alizarin red staining and a 
calcium assay) and also visually as the cells become more rounded and mineralised 
nodules may be present [43].  The formation of adipogenic cells is observed with the 
use of a Nile/oil red stain.  Myogenic cells can be identified by the formation of 
inter-cellular gap junctions (measured by observing the movement of marked 
particles between neighbouring cells), Ca
2+
 oscillations (associated with muscle 
contraction) and the presence of sarcomeric proteins.  Fluorescent histochemical 
stains can also be used.  Examples of differentiated and un-differentiated MSCs are 
shown in figure 3. 
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Figure 3: MSCs (left) and differentiation induced MSCs (right) labelled with 
fluorescent histochemical stains.  Adipocytes: Blue = Hoechst nuclear stain, 
Red = AdipoRed.  Osteoblasts: Blue = Hoechst nuclear stain, Red = Alkaline 
Phosphatase, Chondrocytes: Blue = mucins, Red = nuclei, reproduced with 
permission [45]. 
1.2.2 MSC Immunoregulation 
Allogenic MSCs can be utilised in vivo due to their ability to constrict T-cell 
proliferation [46].  This is done by complex interactions, both cell-cell and via 
soluble factors, that hold T-cells in G0 phase.  This helps reduce rejection of 
allogenically implanted MSCs.  It must be noted, however, that this characteristic 
may favour tumour growth in vivo [47].  It is suggested that MSC’s 
immunoprivileged  ability decreases as the stem cells become further 
differentiated [47]. 
1.2.3 MSC Aging 
MSCs osteogenic potential decreases with age [44].  MSCs from older patients have 
the same length telomeres and lipofuscin biomarker build up as those from younger 
subjects [44], thus the reduction in potential may be due to oxidative damage or 
senescence of supporting cells [33]. 
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1.3 Bone Tissue Engineering Scaffolds 
Scaffolds are utilised to provide support and direction for new bone formation.  
Bioactive biomaterials that are used for bone scaffolds vary depending on the site in 
which the material is to be used.  Polymers may be used in low load applications, 
such as the calvarium and pallet whereas inorganic ceramics are favoured for load 
bearing applications.  The rate of resorption of the material must be considered and 
balanced with the rate of bone formation to ensure that structural integrity of the 
scaffold is not lost once it is implanted.  For some materials this can be done by 
varying the base composition or a composite of two or more phases may be used.  
The modulus of the material should be matched to that of the native tissue, this has 
been shown to help induce MSC differentiation down the osteogenic 
lineage [48, 49].  The porosity of the scaffold must be considered.  Macroporosity 
(>50µm) is important to allow the penetration of cells into a scaffold.  1000µm is 
considered the minimum pore size for cortical bone ingrowth, pore sizes smaller 
than this fail to support osteoid formation and result in the deposition of fibrous 
tissue [50].  However, non-load bearing bone has been shown to form equally well 
in porosities smaller than 100µm than those greater [51].  A larger porosity 
facilitates cell proliferation and migration compared to smaller porosities as oxygen 
and nutrients can more readily diffuse in [52].  Microporosity (<10µm) plays a key 
role in osteoinduction.  The increased surface roughness associated with high levels 
of microporosity provide a large surface area for new bone formation [53, 54]. 
1.3.1 Polymers 
As mentioned, polymers may be used for bone tissue engineering in low-load 
applications.  Natural polymers such as collagen and hyaluronic acid [55] provide 
binding sites for cells and are highly biocompatible.  However, the use of natural 
materials, primarily sourced from animals, introduces a risk of disease transmission.  
Synthetic polymers such as polylactic acid (PLA) and polyglycolide (PGA) have 
been utilised.  PLA and PGA degrade at different rate is the body and the 
composition of the two in a composite, copoly lactic acid/glycolic acid (PLGA), 
allows for tailored degradation rates.  Synthetic polymers lack the binding sites 
required for cell attachment [56].  Hydrogels and peptides that gel in inside the body 
have attracted interest as injectable scaffolds [57]. 
- 11 - 
1.3.2 Bioactive Glasses And Ceramics 
Bioceramics and glasses are an attractive material for use in load bearing bone tissue 
engineering.  The most common bioceramics are the calcium phosphates.  These 
include hydroxyapatite (HA) [58], β-tricalcium phosphate (β-TCP), and α-tricalcium 
phosphate (α-TCP).  HA is very stable however and will not readily absorb in the 
body.  β-TCP and α-TCP are less stable and can be combined with HA to control 
degradation rates and allow for the formation of a bone bonding apatite layer on its 
surface.  Bioactive glasses, such 45S5 [59], based around Ca and P containing silica 
glasses are also popular as they rapidly form apatite layers on their surface when 
implanted into the body.  They are however relatively weak.  Glass ceramics, 
consisting of a crystal phase within a glass, allow for enhanced mechanical 
properties while maintaining the bioactivity of the bioactive glasses.  Examples of 
bioactive glass ceramics are apatite-wollastonite (Ca5(PO4)3F and CaSiO3 in a 
CaO·MgO·2SiO2·P2O5 glass) [60-64] and apatite-mullite [65].  Apatite-wollastonite 
gets its strength from the apatite phase lying within a fibrous wollastonite phase that 
helps block crack propagation [66]. 
1.3.2.1 Strontium Containing Bioactive Glasses and Glass Ceramics 
Strontium, like calcium, is a divalent cation.  As strontium and calcium have the 
same charge and similar sizes they can often be substituted for each other in 
crystalline and amorphous structures.  In recent years interest has grown in the 
substitution of strontium for calcium in bioactive calcium phosphate ceramics, 
glasses and glass-ceramics such as Bioglass 45S5 [67-70], hydroxyapatite [71, 72] 
and wollastonite [73].  The inclusion of strontium into bioactive calcium phosphates 
is of interest due to both its biological role and its contribution towards the materials 
chemistry, structure and physical properties. 
Strontium is the active component of anti-osteoporotic drug strontium ranelate, two 
strontium ions bound to ranelic acid.  Orally administered strontuim ranelate has 
been shown to increase bone mineral density and reduce fracture risk in osteoporotic 
women [74].  It does this by both up-regulating osteoblastic new bone formation and 
down-regulating osteoclastic bone resorption [75], a feature unique among other 
osteoporosis treatments such as anti-catabolic and pro-anabolic drugs.  Suggested 
modes of action for the effect of strontium on osteoblast and osteoclast activity will 
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now briefly be examined.  For bone mass to increase, the activity of osteoblasts must 
exceed that of osteoclasts.  This can either be achieved by increasing the number of 
osteoblasts, increasing the rate of osteoblast activity, decreasing the number of 
osteoclasts or decreasing the rate of osteoclast activity.  Strontium has been shown 
to work by a combination of all four routes. 
Osteoblast are capable of inducing osteoclast differentiation by the expression of 
receptor activator of nuclear factor κ-B lignad (RANKL) which bind to receptor 
activator of nuclear factor κ-B (RANK) on osteoclast precursor cells, activating 
intracellular signalling that leads to differentiation into osteoclasts [76].  Osteoblasts 
may also express osteoprotegrin (OPG), a decoy protein that is capable of blocking 
the interaction of RANKL with the RANK receptor, thus inhibiting osteoclast 
differentiation.  Strontium has been shown to increase osteoblast OPG expression 
and decrease RANKL expression, therefore reducing osteoclast differentiation.  The 
result is decoupling of the relationship between osteoblast and osteoclast numbers, 
leading a relative reduction in osteoclast population. 
Strontium has also been shown to interact with the calcium sensing receptor (CaSR) 
on both osteoblasts and osteoclasts.  In the case of osteoclasts, the interaction effects 
both osteoclast activity and lifespan.  Both calcium and strontium act as full agonists 
for the CaSR, with strontium having a lower affinity [77].  CaSR stimulation in 
osteoclast activates phospholipase C (PLC) activity which, via a signalling cascade, 
triggers the nuclear translation of nuclear factor κB (NFκB), resulting in apoptosis of 
the osteoclast and a reduction in osteoclast numbers [78].  Strontium interaction with 
the CaSR, compared to that of calcium, has been shown to alter the PLC activated 
signalling cascade [78], indication that strontium’s effect on osteoclast bone 
resorption is also as a result of cellular activity and apoptosis control. 
Strontium has been shown to enhance replication of pre-osteoblasts, reduce 
osteoblast apoptosis and increase in vitro nodule formation (an indication of 
osteoegenesis) [74].  Activation of the CaSR receptor by strontium in osteoblasts has 
been shown to increase osteoblast replication via up-regulation of mitogen activated 
protein kinase (MAPK) leading to increased osteoblast replication [79].  Another 
signally pathway that is key to the osteoblast response to strontium is the 
calcineurin/nuclear factor of activated Tc (NFATc) [80].  This pathway has been 
shown to be activated by strontium, resulting in increased osteoblast replication. 
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While it is clear that strontium plays a crucial role in bone metabolism, its role in the 
material properties of bioactive calcium phosphates should not be downplayed.  The 
substitution of strontium into calcium phosphates has been shown to expand the 
crystal unit cells [71, 72] or glass networks [81, 82] due to the increase in ionic radii 
(1.00 to 1.18 Å [83]) between the two .  This in turn alters the degradation of the 
material and subsequent ion release [67, 73, 84, 85], the ability of a glass to sinter 
and crystallise [86, 87], the ability of the material to form a surface apatite layer [73, 
88, 89] and also the ability of the material to direct cell attachment and fate [71, 90, 
91]. 
Strontium has been successfully substituted into glasses in the 
CaO•P2O5•CaF2•SiO2•MgO system [86].  The glasses however had a higher 
magnesium content than A-W and when heated crystallised to form diopside and 
apatite containing glass-ceramics.  To the writers knowledge, strontium has yet to be 
incorporated into the A-W parent glass. 
1.4 Glass-Ceramic Theory 
In order to be understand the processing of glass ceramics, the theory behind the 
material must first be understood, staring with the structure and formation of the 
glass. 
1.4.1 Glass Formation 
As a liquid is cooled slowly through its melting point, Tm, it may crystallise as 
constituent atoms, ions or molecules arrange into their equilibrium lattices. 
However, some materials are capable of forming glasses if the liquid is cooled at a 
high enough rate.  The composition of these glass-forming materials are usually 
based around a simple oxide, most commonly silica (SiO2), for reasons that will be 
discussed later.  As the rate of cooling increase, the time required for the liquid 
elements to establish their equilibrium configuration increases [92] as viscosity of 
the melt increases.  This prevents the formation of crystal phases and the liquid 
becomes supercooled.  The difference between the temperature of the supercooled 
liquid and Tm is dubbed undercooling.  At sufficiently high levels of undercooling, 
there is insufficient time for elements to form the long-range structure indicative of 
crystal lattices.  At the glass-transition point, Tg, the viscosity of the melt approaches 
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1014 poise [93] and  ions become fixed, forming an X-ray  amorphous glass 
showing only a short range ordered network [94]. 
Unlike slowly passing through Tm to form crystals, passage of a supercooled liquid 
through Tg does not result in a massive change in specific volume, see figure 4.  This 
exemplifies a significant difference between the structure of the glass and crystal 
and shows similarities between the liquid and glass packing. 
 
Figure 4: The change in specific volume as a function of temperature for theoretical 
glass, ceramic and crystal phases, reproduced with permission [94]. 
The conformational changes that occur during crystal and glass formation can also 
be observed via differential thermal analysis (DTA), figure 5.  As crystals form at 
point Tm, a large exothermic peak is observed as elements settle into low energy 
configurations, this coincides with the drop in specific volume observed in figure 4.  
However, the supercooled liquid shows no latent heat evolution and no specific 
volume change as it passes through Tm, indicating elements are still in their liquid 
arrangement.  At Tg, only a small peak is observed in the DTA trace, thus supporting 
the small gradient change observed in the figure 4 and indicating that the glass 
formed has a structure similar to that of a liquid [95]. 
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Figure 5: Theoretical DTA plot of (a) a crystal and (b) a glass  as they undergo 
melting (Tm) and glass transition (Tg), reproduced with permission [94]. 
Though glasses formed from a supercooled melt lack the long-range, repeating 
structure of their crystal forms, they retain similar interatomic forces, and co-
ordinations [96].  This is most clearly observed in vitreous silica, where, in both its 
crystalline and amorphous states, each silicon ion is surrounded by four oxygen ions 
and each oxygen ion is surrounded by two silicon ions [93], forming a polyhedron.  
In the crystalline state, this polyhedron repeats in a regular manner, providing long-
range order to the structure.  However, in the amorphous state a continuous network 
of these polyhedra exist, but only short-range order is shown, see figure 6. 
 
Figure 6: Silica in its a) crystalline state b) glassy state c) with non-bridging oxygen 
ions.  Open circles indicate oxygen ions, black dots silicon ions and large 
circles are network modifiers, reproduced with permission [94]. 
In 1932, Zachariasen utilised studies of silica glass to establish a theory of glass 
structure [97].  The foundation of his work was a previous theory proposed by 
Goldschmidt (1926).  Goldschmidt identified that for simple oxides there was a 
relationship between their glass forming capacity and the relative size of their cation 
in respect to the size of oxygen (anion) [96], in that only certain structures allow for 
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cations to be spaced in such a manner that they do not impose too great a repulsive 
charge on each other.  Thus he determined that any oxide that conformed to 
equation 1 should theoretically be termed a glass former. 
  
  
     
Equation 1 
Where Rc = the radius of the cation and Ra= the radius of the anion.  Zachariasen 
expanded on Goldschmidt’s work to develop four rules which predict if a single 
oxide is capable of forming a glass: 
 Each oxygen must be linked to not more than two cations. 
 The number of oxygen atoms that surround a cation must be low, ie. the 
coordination number must be 3 (triangular) or 4 (tetrahedral). 
 The oxygen polyhedra are bonded to each other at their vertices and not at 
their edges or sides. 
 At least three of the polyhedron vertices must be bonded to other polyhedral. 
These rules predicted the following glass-forming oxides: SiO2, GeO2, B2O3, and 
P2O5, all of which are known as network formers.  Other normally non-glass formers 
may substitute for network formers, such as Al2O3 substituting for silica, to form 
glass, these are referred to as intermediate glass components [98]. 
Network modifiers are glass components that occupy positions outside of the 
coordination polyhedra.  As their name suggests, they modify the structure and 
properties of the network.  Network modifiers are often alkalis and alkaline earth 
metals, such as CaO and Na2O.  Most network modifiers act as fluxes, lowering the 
liquidus temperature of the network while simultaneously reducing the viscosity 
[93].  Network modifiers work by depolymerising the network via the reduction of 
“bridging oxygens” that connect the tetrahedra at their vertices.  The resultant “non-
bridging oxygens” depolymerise the network to a degree by no longer contributing 
to cation-oxygen-cation bonds [98] and form the vertex of a tetrahedron, to which 
the network modifier is attached [96].  They also act as centres for chemical 
attack [93]. 
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So why is the low energy crystalline state not always achieved in glass formers, 
even though the bonding patterns of the vitreous and crystalline states are so 
similar?  The answer lies in the ability of the bonds of a glass former to be distorted 
by small amounts from their preferred orientations without the expenditure of large 
amounts of energy.  This results in deformed bond angles and lengths that disrupt 
the long-range order of the crystal and thus it may be denoted as amorphous.  The 
distributed bond lengths and angles require different energies to break, thus glasses 
do not have a well-defined melting point, unlike crystals where an equal amount of 
energy is required for breakage of all bonds [93].  Quenched glasses contain high 
concentrations of vacancies, dislocations, broken bonds and electron imperfection as 
a result of the disrupted lattice. 
1.4.2 Crystallisation 
The controlled crystallisation of a glass can be utilised to impart enhanced properties 
on the material, such as: increased machinabillity and toughness, high temperature 
stability, controlled expansion and biocompatibility [99].  A partial transformation 
of the glass to a crystal leads to the formation of a glass-ceramic, a material that 
shares the properties of the base glass and the crystal phases formed. 
Crystallisation results in a drastic change in the atomic arrangement of small, 
localised volumes that form an interface between the parent glass and crystallised 
fraction.  Crystallisation occurs in two stages: nucleation and growth. 
Crystal nucleation is the formation of small, stable crystal phases within the parent 
glass.  This may occur either randomly throughout the bulk of the parent glass 
(homogenous nucleation) or preferred sites (heterogenous nucleation).  The 
formation of nuclei is best understood by examining the balance of the negative free 
energy transformation that occurs when a metastable glass rearranges to a stable 
crystal and the positive free energy that is required for the formation of a new 
interface. 
The largest free energy change, ΔG* occurs at a nuclei radius of r*.  This is known 
as the critical radius, any nuclei smaller than r* will have to reduce in size to reduce 
the free energy change, however any nuclei larger than r* will increase in size with a 
reduction in free energy and is thus thermodynamically stable. 
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Thus the rate of steady state nucleation per unit volume per unit time, Ic, equation 2, 
depends on the thermodynamic barrier ΔG* that must be first overcome to form a 
nuclei with radius greater than r*.  It also depends on the free energy required for the 
transport of molecules from the base glass, across the interface to the growing nuclei 
(the kinetic barrier), ΔGa.  ΔG* can be defined with respects to the interfacial 
energy, σ, the bulk free energy of the liquid-to-crystal transformation, ΔG (per mol), 
the molar volume of the crystal phase, Vm, and assuming that all nuclei are spherical 
and the crystal phase formed has the same composition as the parent glass [100], 
equation 3. 
        [
        
  
  
] 
Equation 2 
    
       
 
    
 
Equation 3 
AN is a constant while ΔG* decreases with decreasing temperature while ΔGa is 
considered to be temperature independent.  Equations 2 and 3 dictate that optimum 
homogenous nucleation occurs at a specific temperature. 
Though equations 2 and 3 are useful in the description of a system who’s crystal and 
glass phases share the same composition, the case of crystallisation of two phases 
from a single glass is more complicated.  Consider the two phase system which 
precipitates crystal phases α and β.  The precipitation of a phase will result in a 
reduction in free energy that acts as a driving force for crystallisation, ΔG.  During 
crystallisation from a liquid, ΔG is greatest when the composition of the precipitate 
is the same as the liquid [100].  However, for a solid state transformation the free-
energy-composition relationship is broadened and ΔG will now be influenced by the 
interfacial energy and kinetic barrier and thus ΔG may not be a maximum when the 
two compositions are the same [101], dictating the first phase that will crystallise. 
Nucleation may occur preferentially at specific sites within the glass; this is known 
as heterogeneous nucleation.  Interfaces in the parent material, ie. the material’s free 
surface (surface nucleation) or the surface of precipitates (bulk nucleation), are 
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favoured for heterogeneous nucleation as they reduce the thermodynamic barrier 
which must be overcome [95]. 
The principle behind this reduction in energy can be seen by examining the 
wettability of a nucleation site, ie. how easily the crystal may spread over the site, 
figure 7.  Resolving the interface energies, γNC and γCL in figure 7 gives γNL, where 
N, L and C represent the nucleating site, liquid and crystal, respectively, equation 4  
Thus the contact angle, θ, determines wettability and can be utilised to determine the 
thermodynamic barrier of heterogeneous nucleation, ΔGhet*, equation 5 [95]. 
 
Figure 7: Heterogeneous nucleation wetting/contact angle and interface vectors, 
modified with permission [94]. 
                
Equation 4 
     
     (
                 
 
) 
Equation 5 
1.4.3 Nucleating Agents 
Nucleating agents work by either precipitating out of the parent glass during a heat 
treatment (as is the case with many metallic nucleating agents, eg. Au, Ag, Pt and 
Pd) or by the induction of amorphous phase separation (APS), if multiple phases are 
more stable than one [102],  leading to the formation of an interface between the two 
glasses [95] and skewed concentration distributions [101].  Phase separation 
occurring above the liquidus produces two stable phases that remain after cooling; if 
the two phases exist bellow the liquidus then metastable states will occur that will 
form a single phase upon rapid cooling but that can be recovered with the 
appropriate heat treatment [102].  Nucleating agents may also alter homogenous 
nucleation by increasing ΔG, reducing σ or by increasing the diffusion rate [101].  
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Many non-metallic nucleating agents exist and are mainly oxides such as TiO2 and 
ZrO2.  The process by which non-metallic nucleating agents promote crystallisation 
is poorly understood, but it is known that agents are specific to certain glasses  
[100].  Apatite containing glass-ceramics utilise P2O5 and fluorides as a nucleating 
agents where they reduce ΔG* and promote APS [101]. 
The formation of critical nuclei leads to crystal growth.  The controlling factor in 
crystal growth is the free energy required for the movement of elements from either 
the glass to the crystal or vice versa.  It has already been stated that the arrangement 
of the crystal phase possesses a lower free energy than the glass phase.  Figure 8 
symbolises the activation energies that must be overcome for the movement of an 
element between the glass and crystal phases.  vΔGv refers to the volume free 
energy, ΔGa the activation free energy and λ the size of  the glass and crystal 
interface over which elements must diffuse. 
 
Figure 8: a) schematic free energy diagram for the growth of a crystal across an 
interface b) schematic of the arrangement of atoms during the phase 
transformation, modified with permission [103]. 
It is clear that ΔGa+vΔGv is greater than vΔGv and thus there is more restriction to 
the flux  of elements to the glass than to the crystal, leading to crystal growth [95].  
The rate of growth, the difference between the flux of elements from the glass-to-
crystal and crystal-to-glass, U, is defined in equation 6, where v0 is the attempted 
jump frequency of the elements [95].  
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Equation 6 
1.4.4 Heat Treatments 
Heat treatments can be used to tightly control the final grain structure of a glass 
ceramic.  As seen, both the formation of nuclei and the growth of crystal are highly 
dependent on temperature.  The temperature ranges at which nucleation and growth 
occur vary dependent on the system.  In some systems, there may be a broad overlap 
between the two, in this case a single heat treatment may be appropriate to maximise 
both the number of nuclei and the rate of crystal growth.  In other systems the 
nucleation and growth temperature ranges may be spaced apart and in this case a 
two stage heat treatment is required: an initial dwell stage for nucleation and a 
second higher temperature dwell to ensure rapid crystal growth, figure 9. 
 
Figure 9: Nucleation and growth regions and appropriate heat treatment regimes for 
(a) overlapping curves (b) sparsely overlapping, modified with 
permission [94]. 
The effect of different nucleation processes must also be considered when designing 
a heat treatment.  Bulk or surface nucleation may be favoured dependent on the heat 
treatment, as seen in figure 10.  The two processes can be differentiated utilising 
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differential thermal analysis.  Bulk nucleation produces a sharp peak where-as 
surface nucleation produces a much boarder one [104]. 
 
Figure 10: Bulk (a) and surface (b) nucleation in an Li2O-Al2O3-SiO2 glass 
following different heat treatments, modified with permission [104]. 
The size of the particles being heat treated will also determine the type of nucleation 
present.  Surface nucleation favours smaller particles.  In the case of apatite-
wollastonite, the crystallisation of the surface nucleating wollastonite phase is 
shifted to a higher temperature when larger particles are used, figure 11 
. 
Figure 11: DTA showing the shift in the wollastonite peak (W) between different 
particle sizes for a 5K.min
-1
 heating rate, reproduced with permission [60]. 
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When more than one phase is to be crystallised the phenomenon of amorphous 
phase separation and the preference for either surface or bulk nucleation can be 
utilised to ensure the crystallisation of both phases [105].  The combined optimum 
nucleation temperature for the two crystallising phases can be determined via DTA 
by plotting the variation between the crystallisation temperature during constant 
heating with the crystallisation temperature following a holding period at an 
assumed nucleation temperature, figure 12.  The largest temperature shift observed 
is taken as the optimum nucleation temperature [62]. 
 
Figure 12: Optimum nucleation temperature calculation for apatite and mullite 
containing glass-ceramics calculated from DTA data, reproduced with 
permission [106]. 
Crystallisation heat treatments can be combined with a sintering heat treatment to 
allow for a single stage treatment in the formation of porous glass-ceramics from a 
glass powder. 
1.5 Sintering 
Heat treatment of the powders not only triggers crystallisation but also fusion of the 
particulates and densification of the final material.  Sintering not only determines the 
strength of the bonds between the sintered particles (and thus the bulk material) but 
also the size of the pores of the material. 
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Sintering is performed at temperatures well below the melting point of the material 
at a temperature determined by the material composition and particle size.  The 
driving force for sintering is the reduction in interfaces and contact angles in the 
material as well as the secondary elimination of grain boundary area, thus sintering 
is faster when smaller particles are used since diffusion distances are smaller and 
curvature induced stresses are greater [107].  Two main types of sintering can occur: 
solid state sintering and liquid phase sintering. 
1.5.1 Solid State Sintering 
A simple model to display solid state sintering is that of two spheres, diameter D, 
contacting at a single point, figure 13.  Following initial contact, sintering progresses 
in three stages: early stage neck growth, late stage neck growth and finally a fully 
coalesced particle with diameter 1.26D [108].  During the early stage, pores between 
the particles remain interconnected but as necking progresses pores become smaller 
and smoother.  The final stage results in the closure of pores.  Any gasses that may 
have been evolved during the sintering process may be trapped, preserving the pore 
and impeding densification. 
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Figure 13: Sintering necking of two theoretical spherical particles, modified with 
permission [107]. 
The transport mechanism by which necking occurs can be visualised by considering 
pores as large accumulations of vacancies.  Vacancy and mass transport occurs via 
two main mechanisms: surface transport and bulk transport. 
Surface transport occurs at lower temperatures and results in necking with minimal 
densification due to mass transport occurring at the particle surface.  It involves 
surface diffusion and evaporation-condensation.  Bulk transport occurs at higher 
temperatures than surface transport [108].  It results in the transport of mass from 
within the particles to the necking region, causing densification.  Bulk transport 
mechanisms include volume diffusion, grain boundary diffusion, plastic flow and 
viscous flow.  Viscous flow is the favoured mechanism in glasses where-as 
crystalline materials favour grain boundary diffusion, volume diffusion and stress-
induced plastic flow (though the role of the latter decreases with sintering time as 
stresses and dislocations are removed) [108]. 
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1.5.2 Liquid Phase Sintering 
Liquid phase sintering (LPS) utilises the formation of a liquid phase during sintering 
of alloys that melt over a large temperature range or composite [108].  LPS is 
associated with faster diffusion rates than solid state sintering.  During LPS, the 
solid phase is usually soluble in the liquid phase formed, this allows for high levels 
of wetting and good contact between the two components.  This also leads to 
enhanced densification as capillary action draws the solid phase particles 
together [107].  In a single component system, solid state sintering precedes LPS.  
But as temperatures increase, LPS takes over.  A low melting point component can 
be added to a powder mix to form a composite to enhance LPS and further promote 
densification. 
Liquid phase sintering can be used for the binding a solid particles using free-form 
fabrication methods such as selective laser sintering.  This method has successfully 
been used to create porous apatite-wollastonite scaffolds [62]. 
1.5.3 Sintering Assessment 
The level of sintering can be observed by looking at the shrinkage and deformation 
of the sample during or after heating.  Hot stage microscopy allows for analysis of 
the structure of the sample as a function of temperature and is useful in relating 
shrinkages to thermodynamic events such as glass transitions and 
crystallisation [109].  Linear shrinkage can be measured by comparing the 
dimensions of the material pre- and post-sintering [110].  Further visual analysis can 
be performed using scanning electron microscopy (SEM), which is useful for 
observing the final structure of the material, with changes in particle morphology 
and the formation of necks being easily assessed visually [61, 110].  This can be 
performed on either the material surface or on cross-sections to map the pore sizes 
and distributions.  In glasses, the phase that may form during sintering can also be 
observed using SEM [110] and their composition mapped using energy dispersive x-
ray analysis (EDX) [111].  Crystalline phases that form in the material can be 
identified and quantified using XRD. 
Incomplete sintering leaves behind residual porosity.  The post sintering porosity is 
often reported as a density and is calculated from a direct measurement of the 
material mass and volume.  The volume can be determined by filling the open pores 
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with paraffin oil and submerging the material in water to record to the volume 
increase [108].  The pores of the material can either be open, those that are 
connected to the surface, or closed pores, those that are sealed within the material.  
The Archimedes method can be used to measure open porosity and subsequently 
combined with the density to calculate the actually porosity that incorporates closed 
pores [112].  The material is weighed dried, weighed after fluid impregnation then 
weighed in water and the resulting value used to calculate the porosity.  The 
Archimedes method is most suited to large geometries and so alternative methods 
are often used for smaller samples.  Other impregnation techniques include mercury 
or liquid extrusion porosimetry and nitrogen pycnometry which can provide micro-
porosity distributions and material densities, respectively, by loading and unloading 
the selected medium into the material and measuring the difference is forces 
required to do so [113]. 
Micro computed tomography x-ray imaging allows for the construction of 3D 
models that represent the porous material.  The technique is non-invasive and can be 
combined with custom algorithms to provide values for the different pore features 
such as size distribution and interconnectivity [113]. 
The level of sintering of a material can also be determined using mechanical 
measurements.  The more sintered a material, the stronger it will be.  Pores reduce 
the effective cross-section of the material and thus its strength [108, 114].  The 
compressive strength and flexural strength are most commonly recorded for porous 
ceramics and glasses with the BS ISO 6872-2008, testing of dental ceramics 
specifying a 3- or 4-point bend test should be used [115].  The mechanical strength 
is also influenced by many other factors including crystallite composition, grain 
size, impurity levels, flaws and pore characteristics.  The heat treatment applied to 
induce sintering will affect all these factors and so measurement of the mechanical 
strength of the material remains a successfully technique to determine the success of 
a sintering process [108]. 
1.6 Thesis Aims and Objectives 
It is well known that the substitution of strontium into calcium phosphate systems 
has been shown to up-regulate osteoblast activity and down-regulate osteoclast 
activity, increasing the rate of neo-bone formation while also influencing the 
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material’s processing and physical properties.  While strontium substitution into the 
Bioglass 45S family of glasses is well documented, its substitution into the more 
mechanically and biologically stable apatite-wollastonite glass-ceramic is as of yet 
un-reported. 
1.6.1 Overall Aim 
The overall aim of this piece of work was to form a bioactive glass-ceramic based 
on the substitution of strontium into apatite-wollastonite glass-ceramic. 
To achieve this a range of glasses were formed based on the molar substitution of 
strontium for calcium into the apatite-wollastonite parent glass.  Their subsequent 
devitrification was investigated and utilised to form semi-crystalline glass-ceramics.  
The physical and biological properties of the developed materials was then 
investigated with respect to their application as bone replacement materials. 
1.6.2 Objectives 
The work can be broken down into four main objectives, presented as single 
chapters and subsequently discussed as a whole: 
Chapter 2: The ability of the novel compositions to form an amorphous glass was 
investigated and control of the processing assessed. 
Chapter 3: The thermodynamic and physical characterisation of the materials’ 
devitrification was performed and utilised to produce a controlled heat treatment for 
the formation of strontium containing glass-ceramics. 
Chapter 4: The ability of the strontium containing materials to be sinter was then 
assessed and the combined processing knowledge subsequently applied to form 
porous glass-ceramics who’s mechanical and physical properties was characterised. 
Chapter 5: In vitro testing assessed the capacity of the materials to form a surface 
apatite layer in a biologically relevant solution and also their ability to direct human 
mesenchymal stem cell attachment, growth and differentiation. 
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Chapter 2: Glass Powder Production 
2.1 Introduction 
Apatite-wollastonite glass-ceramic is formed from the controlled devitrification of 
an amorphous parent glass.  In this work, the parent glass was produced via the melt 
quench route.  Heating of the mixed oxide precursors to above their melting points 
followed by rapid quenching into a water bath allows for the solidification of the 
metastable glass without the formation of crystal nuclei.  Strontium was substituted 
for calcium at molar ratios into the apatite-wollastonite composition reported by 
Kokubo [116] and Xiao [62] and the glass forming ability of the compositions was 
tested prior to devitrification studies. 
The aim of this work was to determine if strontium had successfully been substituted 
into the glass network, retaining its amorphous structure, and to ensure that 
processing had produced powders with a regular morphology and size distribution.  
The subsequent devitrification studies were performed via differential scanning 
calorimetry (DSC).  The DSC output is strongly influenced by particle size and thus 
consistent particle size distributions were essential.  A scanning electron microscope 
(SEM) and dynamic light scattering were used to observe the morphology and size 
of the particles.  The incorporation of strontium into the material was observed via 
the energy dispersive x-ray analysis (EDX) probe of an SEM and the amorphous 
nature observed via powder x-ray diffraction. 
2.2 Experimental Methodologies 
2.2.1 Glass Production 
2.2.1.1 Glass Melt Quench 
The apatite-wollastonite parent glass composition was that used by Xiao 2008 [62] 
and first reported by Kokubo in 1991 [116] to which gradual substitutions of 
strontium for calcium were made.  Relative molar and weight ratios of the glass 
components are shown in table 2.  
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Table 2: Molar composition of the 0 Mol % strontium feedstock. 
Reagent MgO CaO SiO2 P2O5 CaF2 
Mr 40.304 56.079 60.084 141.943 78.076 
Molar% 7.1 49.9 35.4 7.1 0.4 
Weight% 4.6 44.7 34.0 16.2 0.5 
 
The mass of reagents required for a 200g batch were calculated.  Whilst most of the 
reagents are available in the forms stated above, calcium oxide (CaO) is not stable in 
air and will spontaneously react with carbon dioxide (CO2) to form calcium 
carbonate (CaCO3).  During production of the glass, calcium carbonate is used as a 
precursor reagent to calcium oxide as it is stable at room temperature in an air 
atmosphere and undergoes thermal decomposition at temperatures above 825°C, 
releasing one molecule of carbon dioxide and one molecule of calcium oxide per 
molecule of calcium carbonate, a process known as calcination, equation 7. 
     
    
→          
Equation 7 
Thus, one mole of calcium carbonate is required to produce one mole of calcium 
oxide.  The mass required for a 200g batch of glass can be easily calculated from the 
relative atomic masses of the two reagents. 
                                            
                
    
  
 
    
      
           
                                                          
The final reagent composition of a 200g batch of 0 Mol % strontium glass is shown 
in table  3. 
Table 3: Final composition of the 0 Mol % strontium feedstock. 
Reagent MgO CaCO2 SiO2 P2O5 CaF2 
Supplier 
VWR 
International 
VWR 
International 
Tilcon 
Sands 
Sigma-
Aldrich 
VWR 
International 
Mass (g) 9.2 159.6 68.0 32.5 1.0 
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The reagents were weighed to the nearest 0.1g (Sartorius Roughing Balance, 
PT3100) into a mixing container.  A steel agitation bar was added and the reagents 
were mixed for 1 hour.  The powder mix was then transferred to a slip cast alumina 
crucible (Elite Thermal Systems) and agitated to promote powder densification and 
release trapped air.  The crucible and powder were subsequently placed in a larger 
mullite crucible (Dyson Thermo), half filled with calcined alumina powder (VWR) 
and covered with a lid.  The mullite crucible was included to contain any molten 
flux should the alumina crucible fail.  The crucibles containing the powder mix were 
then pre-heated at 10K.min
-1
 to 500°C and held at this temperature for 15 minutes 
(Elite BCF 13/12-2416 furnace).  They were then transferred to a second furnace 
(Pyrotherm 1600°C), pre-heated to 1400°C.  The temperature of the furnace was 
then immediately increased to 1450°C and the powders were left to melt for two 
hours.  The addition of alumina to the mullite crucible and an initial low temperature 
heat soak were used to minimise the thermal shock experienced by the crucible thus 
increasing the batch yield. 
Following melting, the liquid flux was shock quenched into a cold water bath.  The 
formed glass cracked into small frits soon after solidification due to stresses induced 
from the bulk cooling slower than the surface.  The solidified glass was then sucked 
from the base of the bath using a pump (Clarke CPE 110) and passed through a 
36µm sieve pan (Fisher Scientific).  The glass frits were then placed in a drying 
cabinet for 24 hours to dry and allow for any residual stresses to be resolved. 
2.2.1.2 Novel Compositions 
Strontium (Sr
2+
) was substituted in to the glass feedstock in place of calcium (Ca
2+
).  
Strontium oxide (SrO) was chosen as the source of Sr
2+
 ions, replacing calcium 
oxide (CaO).  Substitutions were calculated on a molar basis to produce glasses with 
compositions 35.4SiO2•7.1P2O5•0.4CaF2•7.1MgO• (49.9-X)CaO•XSrO, where X = 
6.2, 12.5, 18.7 or 24.9. Strontium carbonate (SrCO3) was used as a precursor and 
was reduced, as with CaCO3, in a calcination reaction, equation 8. 
     
    
→          
Equation 8 
- 32 - 
The mass of each reagent required, Wt, can be calculated utilising the relative 
molecular mass, Mr, equation 9. 
     (
    
   
) 
Equation 9 
And the mass percentage of each reagent, Wt%, calculated from the total mass, 
equation10. 
           
         
∑  
 
Equation 10 
The molar ratio was varied as opposed to the weight ratio to ensure that the 
composition of the glass did not vary with respects to the remaining elements.  Four 
novel Sr containing compositions were proposed, the formulations of which are 
shown in tables 4 to 7. 
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Table 4: 3.12 Mol % strontium composition. 
Reagent MgO CaCO3 SrCO3 SiO2 P2O5 CaF2 
Mr 40.304 100.086 147.628 60.084 141.943 78.076 
Molar% 7.1 43.7 6.2 35.4 7.1 0.4 
Weight% 4.4 37.3 9.9 32.5 15.5 0.5 
Table 5: 6.24 Mol % strontium composition. 
Reagent MgO CaCO3 SrCO3 SiO2 P2O5 CaF2 
Mr 40.304 100.086 147.628 60.084 141.943 78.076 
Molar% 7.1 37.4 12.5 35.4 7.1 0.4 
Weight% 4.2 30.6 18.9 31.1 14.8 0.5 
Table 6: 9.35 Mol % strontium composition. 
Reagent MgO CaCO3 SrCO3 SiO2 P2O5 CaF2 
Mr 40.304 100.086 147.628 60.084 141.943 78.076 
Molar% 7.1 31.2 18.7 35.4 7.1 0.4 
Weight% 4.0 24.5 27.1 29.8 14.2 0.4 
Table 7: 12.47 Mol % strontium composition. 
Reagent MgO CaCO3 SrCO3 SiO2 P2O5 CaF2 
Mr 40.304 100.086 147.628 60.084 141.943 78.076 
Molar% 7.1 24.9 24.9 35.4 7.1 0.4 
Weight% 3.9 18.8 34.7 28.6 13.6 0.4 
 
2.2.1.3 Powder Formation 
After drying, glass frits were ground.  Though reagents were calculated to produce 
200g of glass, some flux remained in the crucibles following pouring.  Roughly 
165±5g of frit were ground each time to ensure particle size distributions remained 
constant between batches.  Though the addition of strontium to the glasses should 
increase the density of the frits and thus using the same volume would have been 
more appropriate, this was not possible at this stage of processing.  Powders were 
ground in a puck mill (Gy-Ro Mill) for 2 minutes.  The resulting powders were then 
sorted according to size using a sieve stack (Octagon Digital).  An amplitude of 6 
was used for 90 minutes to ensure thorough sorting of the size fractions.  
BSI410/1986 certified sieves in sizes 45µm, 90µm, 125µm, 1mm and 2mm were 
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used (Fisher Scientific) sorting particles into <45µm, 45-90µm, 90-125µm, 
125µm-1mm, 1-2mm and >2mm size fractions. 
2.2.2 Glass Powder Characterisation 
Powder characterisation was performed on the 45-90µm particle size fraction.  This 
fraction was used due to its successful use previously in the formation of apatite-
wollastonite porous bone scaffolds [62, 117]. 
2.2.2.1 Scanning Electron Microscopy / Energy Dispersive X-Ray Analysis 
In this work, all SEM images were taken on a Hitachi S3400N variable pressure 
SEM with either the secondary electron or back scattered detectors using the native 
software.  Glass powders were attached to an aluminium stub via a conducting 
carbon patch.  All samples were gold sputtered (Agar Auto Sputter Coater) to 
provide a conducting surface layer 6nm thick.  Images were taken at an accelerating 
voltage of 10keV and 50µA probe current.  Particle size analysis of the SEM images 
was done using ImageJ software.  Energy dispersive x-ray analysis was performed 
using a Bruker XFlash detector and analysed with Quantax analysis software.  An 
accelerating voltage of 10keV was used for all EDX measurements.  The 
accelerating voltage used must be greater than twice the highest excitation energy, 
Ec, of any element present in order to obtain adequate intensities.  Calcium was the 
element with the highest excitation energy, with an Ec of 3.692keV (for theKα1 
electron), and so an accelerating voltage of 10keV was suitable.  Quantifications 
were taken from three different shards for each composition and an average taken.  
A peak-to-background ZAF evaluation (P/B-ZAF) algorithm was used for the 
elemental quantification.  Elemental identification was done utilising a preset list of 
expected elements (Ca, Sr, Mg, Si, P, O and F) plus automatic identification.  The 
Bremsstrahlung background was automatically calculated.  A Bayes deconvolution 
was used for line overlap separation.  Standard samples, provided by MAC mciro 
analysis consultants, of CaSiO3, CaMg(CO3)2 and CaPO were analysed to determine 
the accuracy of the semi-quantitative analysis. 
2.2.2.2 Laser Scattering Particle Size Analysis 
Particle size analysis was also performed via laser light scattering using a Malvern 
Mastersizer 2000.  The system was first cleaned before a background reading was 
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taken.  A slurry of roughly 1wt% glass particles in water was first made up.  An 
additional dispersing agent was not required.  The slurry was then passed through 
the light scattering laser and optics using a Hydro S (Malvern) small volume sample 
dispersion unit.  A generic glass bead refractive index of 1.520 was assigned to the 
particles while the dispersant, water, had a refractive index of 1.330.  A constant 
stirring rate of 1800rpm was used.  10 readings were taken per material and the 
average calculated and reported. 
2.2.2.3 X-Ray Diffraction 
X-ray powder diffraction was performed on the 45-90µm glass particles using a 
Philips X’Pert diffractometer with a spinning disc attachment and recorded using the 
X’Pert Data Collector software.  A CuKα x-ray source was used.  A 15x15mm fixed 
incident beam mask was used.  Roughly 0.5g of glass powder was placed in the 
sample holders per scan.  A step size of 0.0334225°, dwell of 3.18 seconds and disc 
rotation speed of 4 seconds were used to scan between the range of 10-70°2θ. 
2.2.3 Radio Density 
Radio density refers to the attenuation of electromagnetic radiation as it passes 
through a material.  The attenuation of x-rays through a material is the underlying 
principle behind clinical x-ray radiography and computed tomography (CT) imaging 
techniques.  An increase in the attenuation and thus radio density of an implant will 
aid in the postoperative identification of the device and monitoring of 
degradation/absorption.  The replacement of calcium with strontium will have an 
effect on the radio density of the material.  The x-ray intensity (I) decays 
exponentially when transmitted through a dense material and can be related to the 
incident x-ray intensity, I0, the material linear absorption coefficient, A (cm
-1
), and 
the material thickness, d (cm) by the Beer-Lambert law, equation 11 [118]. 
     
    
Equation 11 
The linear absorption coefficient is derived from the mass absorption coefficient, 
µ (cm
2
/g), and density of the material, ρ (g/cm3), equation 12 [118]. 
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Equation 12 
Thus the density of the material also plays a crucial role in the attenuation of x-rays 
through a material, equation 13 [118]. 
     
     
Equation 13 
Equation 13 can be re-arranged to calculate the mass absorption co-efficient, 
equation 14. 
   
  (
 
  
)
   
 
Equation 14 
Thus, the mass absorption coefficient of a material can calculated by measuring the 
intensity of an x-ray beam before (I0) and after (I) passing through the material if the 
density (ρ) and thickness (d) of the material are known.   
The density of the glasses was measured using a helium pycnometer and a clinical x-
ray device, digital film and image reconstruction system were used to take x-ray 
radiographs of 100% dense samples of Sr substituted glasses.  100% dense samples 
were utilised to ensure that thickness measurements of the samples were a true 
measure of the amount of material with which the x-rays had interacted. 
2.2.3.1 Density Determination 
The density of the glass was first measured using a Micromeritics Accupyc 1330 
helium pycnometer.  The pycnometer was calibrated using standard steel spheres.  
1±0.25g of glass was analysed per composition.  The pycnometer automatically 
repeats the density measurement until 5 results with a standard deviation of less than 
0.02 are recorded and reports the average.  The mass attenuation coefficient could 
then be calculated using equation 12. 
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2.2.3.2 Glass Rod Formation 
To produce 100% dense samples 65g of glass 125µm-1mm particle size fractions 
were ground for 10s in a puck mill (Gy-Ro-Mill) and then packed into a slip cast 
alumina crucible (Elite Thermal Systems) and agitated.  Re-grinding of the powder 
produced a wider range of particle sizes thus improving particle packing with the 
aim of minimising bubble formation from trapped air during melting.  The powder 
containing crucibles were then placed in larger mulite crucibles (Dyson Thermal) 
and heat-shock protected using a bed of calcined alumina (VWR).  The crucibles 
were then preheated to 500°C at 10K.min
-1
 (Elite BCF 13/12-2416 furnace) and held 
at this temperature for 5 minute before being transferred to a furnace pre-heated to 
1400°C (Pyrotherm 1600°C).  The furnace temperature was immediately increased 
to 1450°C and the samples heated for 90 minutes.  The temperature of the furnace 
was then increased to 1500°C for 30 minutes to help reduce the viscosity of the melt 
when pouring.  The molten glass was then poured into a carbon mould, pre-heated to 
750°C, and placed in a furnace at 750°C and allowed to cool at the furnace rate.  
After cooling, the rods were removed from the moulds and visually inspected for 
trapped bubbles and signs of crystallisation. 
2.2.3.3 Dense Disc Formation 
Discs, roughly 4mm thick, were cut from the glass rods using an abrasive cutter 
(Brillant 220) and diamond saw blade (Beneteo-121097).  A disc speed of 1200rpm 
and feed rate of 3mm.min
-1
 were used.  The cutting surface was then polished flat 
using P1200 grade grinding paper (Hermes).  The thickness of the samples was then 
measured using vernier callipers. 
The discs were placed on a digital radiographic plate (Kodak CS7600 size 1) and 
clinical radiographs were taken (Philips Oralix X-ray head) at 65kVp, 7.5mA and a 
15mm aluminium filter with a 2 second exposure.  The films were then digitally 
scanned using a Carestream CS7600 system and viewed using the native software.  
The resulting images were loaded into ImageJ software.  The image was assigned a 
32 bit grey scale, inverted and then the pixel intensity was read at 3 points on each 
disc and an average taken.  Care was taken to ensure that sections of disc that may 
contain bubbles were not used for intensity measurements.  The intensity (I) was 
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then calculated as a percentage of the fully exposed film (I0).  The relative linear 
absorption coefficient could then be calculated using equation 11. 
2.3 Glass Production Results 
2.3.1 Mastersizer Results 
The laser diffraction particle size analysis results for the 45-90µm fraction glass 
compositions are shown in figure 14.  In all compositions the grinding process has 
produced powders composed of a regular distribution of particle sizes.  Each graph 
is composed from 10 runs, the results of which have been layered.  It is clear to see 
that the sampling method used is highly repeatable as almost exactly the same 
particle size distribution was recorded for each subsequent run. 
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Figure 14: Mastersizer 2000 results for 45-90µm particle fractions of novel 
strontium containing glasses.  Each graph contains the layered results of 10 
runs indicating excellent repeatability. 
The output of the Mastersizer 2000 is expressed as a series of size bands that are 
optimised to match the detector geometry and optical configuration, for example the 
79.43 to 91.20 band.  The midpoint of the bands must be calculated in order to 
determine distribution parameters.  The midpoint, D, of the bands is calculated as 
the geometric mean of the size band limits as opposed to the arithmetic mean, see 
equation 15, where d is the particle size of partition i.  The frequency curves of the 
size distribution data are all plotted using the geometrical midpoint.  A comparison 
of the histogram and frequency curve plots for composition 0 Mol % strontium  is 
shown in figure 15. 
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Equation 15 
 
Figure 15: The size distribution histogram and frequency curve according to volume 
percentage for glass composition 0 Mol % strontium. 
The 10 results recorded for each sample were then averaged and compared, 
figure 16.  The particle size distribution ranges from the 26.30-30.20µm to the 
208.9296-239.88µm size bands.  No particles were detected outside of this range.  
The particle size is the diameter of a spherical particle that would produce laser 
scattering equivalent to the analysed particle.  The peak particle size for all 
compositions lay within the 79.43-91.20 µm band.  The 3.25 Mol % strontium 
composition had a flatter distribution producing a lower peak volume percentage.  
For the 6.24 Mol % Sr composition a volume percentage of 0.0288 % was detected 
in the 208.93-239.88µm range. 
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Figure 16: The average particle size distribution of the 45-90µm fraction glass 
powders. 
The Mastersizer 2000 outputs all data as a volume percentage but this can be 
converted to a number percentage using equation 16[119], where i=1,2, ······ n, zi is 
the particle diameter, Vi the volume percentage and Ni the number volume. 
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Equation 16 
The particle size range, peak particle size, the mean particle size according to 
particle number and the mean particle size according to the particle volume 
percentage for the glass compositions tested are summarised in table 8. 
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Table 8: Summary of the laser diffraction results for the 45-90µm size fraction of 
the different glass compositions. 
Strontium 
Content  
(Mol %) 
Minimum 
Particle 
Size Band 
(µm) 
Maximum 
Particle Size 
Band (µm) 
Peak Particle 
Size Band 
(µm) 
Mean Particle Size 
(µm) 
Number 
Weighted 
Volume 
Weighted 
0.00 30.20-34.67 181.97-208.93 79.43-91.20 66.70 91.94 
3.12 26.30-30.20 181.97-208.93 79.43-91.20 64.09 89.08 
6.24 26.30-30.20 208.93-239.88 79.43-91.20 63.68 93.32 
9.35 30.20-34.67 181.97-208.93 79.43-91.20 65.04 90.62 
12.47 26.30-30.20 181.97-208.93 79.43-91.20 63.46 88.50 
 
The mean particle size weighted to volume sits within the range of 91 ± 2.5 µm for 
all compositions while the particle size weighted to particle number was lower at 
65 ± 1.75 µm.  The 6.24 Mol % Sr composition produced the highest volume 
weighted mean of 93.32 µm though had a relatively low number weighted mean of 
63.68 µm.  This is highlighted in figure 17 where composition 6.24 Mol % strontium 
is shown to have a higher volume of large particles and also higher number of small 
particles compared to composition containing 0 Mol % Sr, which is a good 
representation of the remaining compositions. 
 
Figure 17: The particle size distribution for the 45-90µm fraction according to 
particle number and volume percentage for compositions 0 Mol % strontium 
and 6.24 Mol % strontium. 
It can be seen in figure 17 that the distribution is not normally distributed about a 
linear axis and is instead skewed towards lower particle sizes.  The distribution 
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according to volume is skewed less to lower sizes than that according to number due 
to volume being weighted towards larger particles. 
2.3.2 Scanning Electron Microscope Results 
From figure 18 it can be seen that the all compositions produced irregularly shaped, 
sharp edged, shards that are typical of a brittle glass or ceramic. 
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Figure 18: SEM secondary electron images taken at 100x and 500x magnification of 
45-90 µm particle fraction for compositions (a-b) 0 Mol % Sr (c-d) 
3.12 Mol % Sr (e-f) 6.24 Mol % Sr (g-h) 9.35 Mol % Sr and (i-j) 
12.47 Mol % Sr.  Submicron particles can be seen on the larger shards. 
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Although irregular in shape, the size of the particles in figure 18 are consistent.  
Though some particles exceed 90µm in one dimension, their other visible dimension 
is below it.  An attempt was made to characterise the dimensions of the particles 
using image analysis software but this was not possible due to the image being two-
dimensional and particle surfaces lying outside of the plane of the image.  
Submicron particles can be seen on the surface of the larger glass shards.  This is 
consistent throughout all the glass compositions. 
2.3.3 EDX Results of the Glass Particles 
Tables 9 to 13  show the experimental and theoretical elemental compositions of the 
glass powders as recorded via EDX.  The values given are an average of sampling 
points from three different particles per sample.  Low levels (<1%) of aluminium 
were detected in all of the glasses, though they were small enough not to skew the 
percentage contents of the remaining elements. 
Table 9: Experimental (EXP) and theoretical (THEO) EDX results for composition 
0 Mol % strontium of the 45-90µm fraction glass powder, the standard 
deviations are shown (±). 
0 Mol 
% Sr 
Atomic Composition (Mol %) 
Ca Sr Mg Si 
EXP  22.01 ± 0.93 0.00 ± 0.00 2.70 ± 0.10 11.12 ± 0.70 
THEO  25.08 ± 0.00 0.00 ± 0.00 3.57 ± 0.00 11.81 ± 0.00 
 O F P Al 
EXP  60.03 ± 1.44 0.72 ± 0.08 3.20 ± 0.09 0.22 ± 0.08 
THEO  57.23 ± 0.00 0.27 ± 0.00 2.04 ± 0.00 0.00 ± 0.00 
 
Table 10: Experimental (EXP) and theoretical (THEO) EDX results for composition 
3.12 Mol % strontium of the 45-90µm fraction glass powder, the standard 
deviations are shown (±). 
3.12 
Mol 
% Sr 
Atomic Composition (Mol %) 
Ca Sr Mg Si 
EXP  19.07 ± 1.37 2.91 ± 0.31 2.69 ± 0.22 10.45 ± 1.08 
THEO  21.96 ± 0.00 3.12 ± 0.00 3.57 ± 0.00 11.81 ± 0.00 
 O F P Al 
EXP  60.04 ± 3.08 0.78 ± 0.06 3.23 ± 0.41 0.84 ± 0.35 
THEO  57.23 ± 0.00 0.27 ± 0.00 2.04 ± 0.00 0.00 ± 0.00 
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Table 11: Experimental (EXP) and theoretical (THEO) EDX results for composition 
6.24 Mol % strontium of the 45-90µm fraction glass powder, the standard 
deviations are shown (±). 
6.24 
Mol 
% Sr 
Atomic Composition (Mol %) 
Ca Sr Mg Si 
EXP  17.03 ± 1.38 6.39 ± 0.61 2.56 ± 0.31 11.12 ± 0.77 
THEO  18.84 ± 0.00 6.24 ± 0.00 3.57 ± 0.00 11.81 ± 0.00 
 O F P Al 
EXP  58.59 ± 1.47 0.79 ± 0.13 3.08 ± 0.43 0.44 ± 0.37 
THEO  57.23 ± 0.00 0.27 ± 0.00 2.04 ± 0.00 0.00 ± 0.00 
 
Table 12: Experimental (EXP) and theoretical (THEO) EDX results for composition 
9.35 Mol % strontium of the 45-90µm fraction glass powder, the standard 
deviations are shown (±). 
9.35 
Mol 
% Sr 
Atomic Composition (Mol %) 
Ca Sr Mg Si 
EXP  13.65 ± 0.90 8.40 ± 0.49 2.92 ± 0.43 10.37 ± 1.28 
THEO  15.72 ± 0.00 9.35 ± 0.00 3.57 ± 0.00 11.81 ± 0.00 
 O F P Al 
EXP  60.32 ± 2.27 0.37 ± 0.26 3.27 ± 0.23 0.71 ± 0.34 
THEO  57.23 ± 0.00 0.27 ± 0.00 2.04 ± 0.00 0.00 ± 0.00 
 
Table 13: Experimental (EXP) and theoretical (THEO) EDX results for composition 
12.47 Mol % strontium of the 45-90µm fraction glass powder, the standard 
deviations are shown (±). 
12.47 
Mol 
% Sr 
Atomic Composition (Mol %) 
Ca Sr Mg Si 
EXP  11.57 ± 0.97 12.65 ± 0.85 2.78 ± 0.22 10.63 ± 1.14 
THEO  12.61 ± 0.00 12.47 ± 0.00 3.57 ± 0.00 11.81 ± 0.00 
 O F P Al 
EXP  58.11 ± 3.51 0.69 ± 0.05 3.28 ± 0.22 0.29 ± 0.09 
THEO  57.23 ± 0.00 0.27 ± 0.00 2.04 ± 0.00 0.00 ± 0.00 
 
From tables 9 to 13 it can be seen that the experimental results are a close match to 
the theoretical values.  The experimental values for Mg and F are consistently below 
that which would be expected while P is higher.  Though Mg, F and P are within 1% 
of the predicted values, their overall contributions are low and thus represents a 
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large percentage error.  This trend is repeated for all elements in the different 
compositions. 
Standard samples of CaSiO3, CaMg(CO3)2 and CaPO were quantified using EDX 
configured with the same settings used for the glass powders, table 14.  The trend 
seen in the glass compositions was repeated in the standards with Mg under reading 
and P over reading. 
Table 14: Experimental and theoretical EDX values for CaSiO3, CaMg(CO3)2 and 
CaPO standards including standard deviations (±). 
 
Atomic Content (Mol %) 
Ca P Mg Si 
CaSiO3 
THEO  19.31 ± 0.50 - ± - - ± - 19.75 ± 0.81 
EXP  19.97 ± 0.00 - ± - - ± - 19.77 ± 0.00 
CaMg(CO3)2 
THEO  10.61 ± 0.21 - ± - 8.04 ± 0.25 - ± - 
EXP  10.40 ± 0.00 - ± - 8.81 ± 0.00 - ± - 
CaPO 
THEO  21.07 ± 0.80 16.98 ± 0.73 - ± - - ± - 
EXP  23.32 ± 0.00 15.15 ± 0.00 - ± - - ± - 
  
The experimental and theoretical calcium to strontium ratios for the different 
compositions are shown in table 15.  The experimental Ca/Sr ratios are a close 
match to the theoretical values in all the novel strontium containing compositions. 
 
Table 15: Calcium to strontium ratios for the experimental and theoretical glass 
compositions.  Standard deviations (±) are shown. 
Composition 
Ca/Sr Mol % Ratio 
Experimental Theoretical 
0 Mol % Sr N/A N/A 
3.12 Mol % Sr 6.55 ± 0.85 7.04 
6.24 Mol % Sr 2.66 ± 0.33 3.02 
9.35 Mol % Sr 1.63 ± 0.14 1.68 
12.47 Mol % Sr 0.91 ± 0.10 1.01 
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2.3.4 X-Ray Diffraction Results 
The x-ray diffraction (XRD) traces for the glass powders are shown in figure 19.  
All samples display a broad peak centred around 30°2θ.  This peak is often referred 
to as the amorphous hump or amorphous halo and indicates that the material 
sampled is x-ray amorphous.  There are no sharp peaks present in any of the glasses 
that would indicate the presence of crystalline phases.  
 
Figure 19: The x-ray diffraction traces for the glass compositions tested. 
The XRD traces were converted from °2θ to d-spacing (nm) utilising the wavelength 
of the x-ray source, λ (1.5418nm for Cu K α), and equation 17, taken from Bragg’s 
Law.  An asymmetric double sigmoid peak was fitted to each of the XRD 
amorphous humps using Origin graphing software and the peak position calculated, 
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table 16.  The quality of the fit was reported using the adjusted R
2
 output and the 
accuracy of the peak value represented by the standard error of the parameter. 
  
 
    (
  
 )
 
Equation 17 
Table 16: The output of the asymmetric double sigmoid peak fitting to the glass 
powder XRD traces. 
Strontium Content 
(Mol %) 
d-spacing (nm) Standard Error Adj. R
2
 
0 0.2944 1.57x10
-04
 0.989 
3.12 0.2982 2.82x10
-04
 0.993 
6.24 0.2992 9.00x10
-05
 0.994 
9.35 0.3012 9.20x10
-05
 0.993 
12.47 0.3025 1.23x10
-04
 0.993 
 
A good fit was achieved for all the glass powders showing that they could be well 
represented using the asymmetric double sigmoid function.  The low standard errors 
represent a parameter with which a small variation in would result in a curve that fits 
the data much worse.  The low standard error and good fit allow for accurate 
calculation of the peak position.  The peak shifts to a higher d-spacing with 
increasing levels of strontium substitution, this is highlighted in figure 20.  The 
average increase in d-spacing was 0.0020nm per 3.12 Mol % strontium substitution. 
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Figure 20: The effect of increasing strontium substitution on the d-spacing of the 
amorphous peak. 
2.3.5 Density Results 
The densities of the glass powders are shown in table 17.  The density of the sample 
increased with increasing strontium substitution.  The average increase in density 
was 0.1029 g.cm
-2
 per 3.12 Mol % substitution of strontium.  The increase was 
shown to be linear, with a fit producing an adjusted R
2
 value of 0.996, see figure 21. 
Table 17: The effect of strontium substitution on the density of the glass powders. 
Strontium Content (Mol 
%) 
Density (g.cm
-2
) 
Standard Deviation 
(g.cm
-2
) 
0 2.9325 0.0075 
3.12 3.0447 0.0199 
6.24 3.1322 0.0123 
9.35 3.2536 0.039 
12.47 3.3442 0.0044 
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Figure 21: The effect of strontium substitution on the density of glass particles.  
2.3.6 Casting Glass Rods 
Initially glass rods were cast using a mould of 20mm diameter and a melt 
temperature of 1450°C but this failed to produce visibly crystal free rods.  The 
mould diameter was subsequently reduced to 15mm and the temperature of the 
furnace increased to 1500°C for the last 30 minutes of melting.  This allowed for the 
casting of glass rods that contained no visible crystals and a minimal amount of 
bubbles, see figure 22.  While bubbles were present in the glass they had not 
nucleated crystals and formed mainly in the centre of the rods providing bubble free 
regions for subsequent x-ray attenuation readings. 
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Figure 22: Glass rods cast from glasses with strontium substitutions of 
(a) 0 Mol % Sr (b) 3.12 Mol % Sr (c) 6.24 Mol % Sr (d) 9.35 Mol % Sr and 
(e) 12.47 Mol % Sr.  Small bubbles can be seen in the centre of the rods but no 
crystals are visible. 
2.3.7 X-Ray Attenuation 
Figure 23 shows the initial radiograph of the glass discs alongside the inverted 
image and the sites from which pixel intensity readings were taken.  Visually it is 
clear that there was a discernible difference between the brightness of the samples 
with increasing strontium substitutions.  Darkening of the initial radiograph 
represents exposure of the film to x-rays.  Therefore the darker the film, the greater 
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the number of x-rays that have passed through the material.  As each x-ray that 
reaches the film will cause an increase in the darkening of the film at that point, the 
overall darkening can be used as a measure of the intensity of the x-ray beam that 
has passed through the sample.  In the inverted image the opposite is true, the more 
white the image, the greater the number of x-rays that have passed through the 
sample to the film and thus the greater the intensity of the x-ray beam.  Bubbles are 
visible in the centre of 6.24 Mol % sample. 
 
Figure 23: The initial radiographic (left) and inverted radiographic (right) images of 
the glass discs.  The discs are positioned the same on each image with 
(a) 0 Mol % Sr (b) 3.12 Mol % Sr (c) 6.24 Mol % Sr (d) 9.35 Mol % Sr and 
(e) 12.47 Mol % Sr.  The points from which pixel intensities were taken are 
shown on the inverted image. 
The pixel intensity is a measure of how white (on a 32-bit gray scale) a point on the 
image is with whitest being 255 and the least white 0.  An area with high pixel 
intensity represents a high x-ray beam intensity. 
The average pixel intensities taken from figure 23, the average disc thickness and 
the calculated linear attenuation increases are shown in table 18.  The pixel intensity 
decreases with increasing strontium substitutions indicating an increase in 
attenuation. 
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Table 18: The parameters involved in the calculation of the increase in linear 
attenuation.  Standard deviations (±) are shown. 
Sr Content  
(Mol %) 
Average Pixel 
Intensity 
Average 
Thickness (cm) 
Linear Attenuation 
Increase (cm
-1
) 
0 228.0 ± 1.7 0.3656 ± 1.8*10
-6
 0.000 ± 0.0000 
3.12 131.0 ± 2.0 0.3621 ± 3.2*10
-5
 1.531 ± 0.0087 
6.24 62.7 ± 3.51 0.3622 ± 1.5*10
-5
 3.565 ± 0.0162 
9.35 27.3 ± 2.52 0.3610 ± 4.7*10
-5
 5.877 ± 0.0468 
12.47 15.7 ± 0.577 0.3617 ± 4.9*10
-6
 7.403 ± 0.0168 
 
The effect of strontium substitution on the transmitted intensity (I/I0) relative to the 
0 Mol % strontium composition (I0) is shown in figure 24.  The relative intensity 
decreases at a non-linear rate and is best modelled with a 2
nd
 order polynomial fit. 
 
 
Figure 24: The effect of strontium substitution on the transmitted x-ray intensity 
relative to the 0 Mol % strontium glass. 
The linear attenuation was calculated from the transmitted intensity and the sample 
thickness using the Beer-Lambert law, equation 11.  It can be seen that the linear 
attenuation increases linearly with increasing strontium substitutions, figure 25. 
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Figure 25: The linear attenuation increase with increasing strontium substitutions. 
The theoretical mass attenuations of the novel strontium compositions were 
calculated from elemental mass attenuation coefficients on the NIST website [120] 
for excitation voltages of 60, 50 and 40 keV.  Bulk material mass attenuations were 
calculated using equation 18 where w is the weight percentage and µ the mass 
attenuation coefficient for element i.  A 2
nd
 order polynomial was fit to the 
theoretical data, with each producing an adjusted R
2
 of 1, figure 26.  The gradient of 
the fitted curve increased as the excitation energy decreased.  The experimental 
mass attenuation coefficient increases were calculated by dividing the linear 
increases by the experimentally determined densities in table 17.  The calculated 
values are shown in table 19.  A second order polynomial fit of the data produced an 
adjusted R
2
 of 0.990.  The experimental data lay within the theoretical values for 50 
and 40 keV, figure 26.  The experimental linear attenuation increase, densities and 
mass attenuation coefficients are summarised in table 20. 
  ∑     
 
 
Equation 18 
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Table 19: Theoretical mass attenuations at different excitation voltages. 
Strontium Content 
(Mol %) 
Mass Attenuation at Different Excitation Energies (cm
2
.g
-1
) 
40 keV 50 keV 60 keV 
0 0.9984 0.5922 0.4102 
3.12 1.9006 1.0752 0.6978 
6.24 2.7038 1.5053 0.9539 
9.35 3.4236 1.8907 1.1834 
12.47 4.0722 2.2380 1.3902 
 
Table 20: The effect of strontium on the linear attenuation, density and mass 
attenuation of the glass compositions.  Standard deviations (±) are shown. 
Sr Content  
(Mol %) 
Increase in Linear 
Attenuation (cm
-1
) 
Denisty (g.cm
-2
) 
Increase in Mass 
Attenuation  
(cm
2
.g
-1
) 
0 0.000 ± 0.0000 2.9325 ± 0.0075 0.000 ± 0.0000 
3.12 1.531 ± 0.0087 3.0447 ± 0.0199 0.503 ± 0.0044 
6.24 3.565 ± 0.0162 3.1322 ± 0.0123 1.138 ± 0.0068 
9.35 5.877 ± 0.0468 3.2536 ± 0.0390 1.806 ± 0.0260 
12.47 7.403 ± 0.0168 3.3442 ± 0.0044 2.214 ± 0.0058 
 
 
Figure 26: The increase in the experimental mass attenuation coefficient with 
subsequent substitutions of strontium.  Polynomial fits of the theoretical mass 
attenuations for 60, 50 and 40 keV are also shown. 
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2.4 Discussion 
The aim of this first section of work was to determine if a strontium containing glass 
could be formed and to confirm that the processing route used produced powders 
with consistent size distributions and geometries.  Subsequent work looking at 
crystallisation, sintering and mechanical testing relies on a consistent particle size.  
Crystallisation of wollastonite from the apatite-wollastonite parent glass is a surface 
nucleation process [60] and as such is affected by the surface area to volume ratio of 
the powder.  The results from the Mastersizer 2000 show excellent repeatability for 
individual powders.  A comparable distribution was achieved for the all the glass 
powders tested.  Though the 6.24 Mol % strontium powder had a slightly flatter 
distribution, it was skewed by very few larger volume particles.  Its peak size band 
and mean according to number all lay within the range of the other powders. 
The maximum particle size of all the distributions is greater than the 90µm diameter 
that would be expected from a 90µm sieve.  This is because the particle sizes given 
by the Mastersizer are the diameters of an equivalent sphere that would have the 
same volume as the particle tested.  From the SEM images it can be seen that the 
analysed particles are not spheres.  The simplest representation of the particles 
would be as cuboids.  The peak particle size band according to volume was 79.43-
91.20µm, the geometric mid-point of this range is 85.11µm, a sphere of this 
diameter would have the same volume as a cube of 68.60µm.  Thus the peak particle 
size is within the limits expected of the 45µm and 90µm sieves used.   
A sphere of diameter 111.66µm would produce a cube of 90µm edge length, the 
largest cube that would fit through the 90µm sieve.  An average of 29 % of the 
volume and 6 % of the number of particles fell into a size band larger than this.  
Very few particles exceeded this size though the volume of particles exceeding it is 
much larger, due to the volume ratio being skewed towards larger particle sizes.  
Sieves sort particles according to the second largest dimension, as such a rectangular 
cubic particle could have two dimensions of 90µm and one much larger and still 
pass through the sieve.  This is visible in the SEM images, where a single dimension 
of the larger particles is seen to exceed 90µm.  The maximum size band for the 
6.24 Mol % strontium composition was 208.93-239.88µm with a mid-point of 
223.87µm and 181.97-208.93µm with a midpoint of 194.98µm, larger than the 
theoretical maximum particle size.  If we assume that the maximum value for the 
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two smallest dimensions is 90µm, then the largest dimension recorded must be 
725.27µm in order to produce a cuboid with the equivalent volume.  There was no 
evidence of particles this size in any of the SEM images taken.  The inconsistency 
between the Mastersizer and SEM results could be down to errors in the 
assumptions made.  Firstly, an assumed refractive index was assigned to the 
particles (1.520, that as for glass beads), however, a weighted residual of below 1% 
was achieved for all samples, suggesting this was a good representation of the data 
[121].  The Mastersizer assumes that the particles would scatter the laser light in the 
same manner as the equivalent sphere.  This would not be the case for the irregular 
particles analysed and scattering would be enhanced for the wide angle (larger 
particle size) detectors [122].  The Mastersizer takes measurement of a particle 
cross-section and assumes the volume from it.  This requires the particles to be 
randomly oriented to ensure all dimensions of a sample are measured.  Particles with 
a high aspect ratio, as is the case with the larger particles, may align with the flow, 
causing the longer dimension to dominate and the particle size being given relative 
to the cross-section of the largest face [122].   
The midpoint of the minimum size band (26.30-30.20µm) is 28.81µm, a plate like 
particle of this volume could have two dimensions of 45µm (too large to pass 
through a 45µm sieve) and a smaller dimension of 6.19µm.  The submicron particles 
seen on the SEM images are not present in the Mastersizer data.  Some of the 
particles are below the size range of the Mastersizer (0.5µm) but others are at least 
1µm in diameter.  A dispersant was not used and so the particles may have remained 
attached to the larger particles.  Also, the output of the Mastersizer is in volume %, 
these particles would have produced such a small volume that they may not have 
been recorded and as such would not have been visible even after conversion to a 
distribution according to number. 
It has been shown that the Mastersizer data does not indicate the true size of the 
glass powders.  It does however show that the processing method used produced 
glass powders with the same particle size distributions, crucial for comparison in 
later experiments, such as differential scanning calorimetry.  This is also emphasised 
by the SEM images of the glass powders. 
 The EDX results of the glass particles show a strong agreement between the 
experimental and theoretical results, suggesting that the substitution of calcium with 
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strontium had been successful.  A good match for the calcium to strontium ratio was 
achieved for all the compositions tested.  The mismatch for the values of Mg, F and 
P are each out by less than 1%, this is well within the error range to be expected of a 
semi-quantitative EDX setup.  The standards analysed also produced Mg and P 
values that were below and over (respectively) their predicted values.  The 
difference was much less than that recorded on the glass particles but this is what 
would be expected for the highly polished and precisely prepared standard materials.  
The calcium in the experimental standard was not always under the predicted value, 
as in the glass compositions, the variations observed are due to different matrix 
effects in the materials and the inability of the peak-to-background ZAF algorithm to 
fully model them. 
The EDX analysis was performed on particles and so is prone to effects not seen 
when analysing a flat polished surface.  The angle with which the particle is scanned 
can strongly affect the ratios of an element due to the particle absorption effect.  
This is most pronounced in elements with emissions under 4 keV [123].  This could 
explain why oxygen is over read in all the samples.  Oxygen is not always measured 
directly from an EDX spectra and is sometimes calculated from the ratio of oxides, 
though in this instance a close match was achieved using the spectra only.  The 
experimentally recorded value for F has a large experimental error.  This is due to it 
being present in very small amounts.  Also, fluorine has a very low photon energy 
and is thus difficult to quantify.  The small levels of aluminium detected are likely to 
be from the alumina crucibles used for the glass melting.  The quantities are very 
small and will not have an influence on the properties of the glass. 
X-ray diffraction analysis revealed the broad peaks or humps centred around 30 °2θ 
that are indicative of an x-ray amorphous glass.  The hump appears due to the glass 
network having a short range order [94] with bonds that vary around the peak d-
spacing.  All the samples tested were seen to be x-ray amorphous, and thus a glass 
had been formed in all cases.  Goel has previously synthesised glasses in the same 
system, though with a higher molecular content of MgO and lower total molecular 
percentage of CaO and SrO.  The amorphous halo was visible in the their results, 
with a peak centred around 30 °2θ [86].  The peak shift to a smaller °2θ/larger d-
spacing is a result of the larger ionic radii of strontium compared to calcium, 
reducing the interaction between the divalent cations and the non-bridging oxygens 
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in the network [81, 124].  This behaviour has also been reported by 
Lotfibakhshaiesh [125] and Fredholm [81] in bioactive glasses substituted with 
strontium.  Substituting strontium for calcium in phosphosilicate glasses has been 
shown to have no effect on the co-ordination of the silicate tetrahedra which remain 
predominately networked with two bridging oxygens [81, 86].  The average peak 
shift recorded was 0.0020 nm per 3.12 Mol % strontium substitution.  Both 
strontium and calcium are thought to have a coordination of 6 within the glass 
network [126], as such would have ionic radii of 0.1nm for calcium and 0.118nm for 
strontium [83], thus an increase in radius of 0.018nm.  Using equation 19, where r is 
the ionic radius and x the molar ratio, the theoretical increase in ionic radii with each 
3.12 Mol % strontium substitution is 0.0022nm, an excellent match to the 
experimental data. 
             (
   
       
) 
Equation 19 
The mass and x-ray densities of the material were investigated to further confirm the 
successful substitution of strontium and to investigate the application of the material 
as a radiographic contrast medium.  The linear increase in the density of the glasses 
with increasing strontium occurred as well as a recorded increase in the bond length 
of the glass.  Strontium has a larger ionic radius than calcium but is also more dense.  
Strontium has a higher atomic number (Z) than calcium (30 to 20, respectively) but 
crucially a smaller atomic number to mass ratio (0.43369 to 0.49903), due to the 
inclusion of extra neutrons.  This makes strontium more dense than calcium 
(2.540g/cm
3
 to 1.550g/cm
3
, respectively).  Similar densities were reported by Kansal 
et. al. [127] and Galliano et. al. [126] for other phosphosilicate glasses with divalent 
cation concentrations close to those reported here. 
To the writers knowledge, casting of apatite-wollastonite parent glass rods has not 
previously been reported [61].  Though initial attempts failed, the increase in melt 
temperature and reduction in rod diameter proved successful.  The use of a smaller 
diameter mould will help reduce temperature gradients across the glass as it cools, 
minimising the chance of crystal nucleation.  A higher temperature results in a lower 
viscosity melt, this helps in attaining a smooth pour which not only minimise bubble 
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formation but also reduces contamination of the rod with insoluble impurities that 
would almost certainly initiate crystallisation upon cooling. 
The intensity measured from the radiographs is actually a measure of the blackening 
of the film, known as radio density.  The exposure time used produced a good 
radiographic density in the samples but over exposed the bare film [128], meaning 
that measurements had to be made relevant to the 0 Mol % strontium glass and not 
the air (intensity prior to passing through any glass).  A relatively long exposure 
time of 2 seconds was used.  A 0.25 second dose would be more clinically relevant.  
A 100% dense material was required in order to correctly measure the linear 
attenuation coefficient and the thickness was limited by the ability to machine thin 
sections of the glass rod.  As such, a long exposure was required to ensure contrast 
between the materials. 
The linear increase that is observed is the result of a number of interactions between 
the x-rays and the material.  Two interactions dominate at the low energies used: the 
photoelectric effect and the Compton effect.  The photoelectric effect is a pure 
absorption interaction where high energy photoelectrons are emitted from a material 
following their interaction with and absorption of energy from an incoming X-ray 
photon.  The Compton effect is an absorption and scattering effect as a result of 
inelastic scattering from a free charged particle.  It results in a decrease in the energy 
of the x-ray photon [128].  The remaining two interactions are Rayleigh scattering 
and pair production, but these are insignificant at the energies examined.  Thus the 
observed increase in the linear attenuation is a result of an increase in the interaction 
of the x-ray beam and the material as the average atomic number of the material 
increases.  The number of interactions is dependent on the number of atoms per 
volume of a material.  Normalisation of the linear attenuation to the density of the 
material allows for determination of the mass attenuation coefficient. 
The theoretical mass attenuations increased non-linearly with strontium 
substitutions.  This was due to the substitutions being calculated according to molar 
percentage and the mass attenuation from the weight percentage.  While the molar 
ratios of everything but calcium and strontium remain constant, the weight ratio of 
all the elements changes with each substitution.  The theoretical mass attenuation 
decreases with increasing x-ray energy as a result of the contribution of the 
photoelectric effect becoming smaller and Compton scattering increasing [118]. 
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The head of the x-ray device has a rating of 65kVp, this means that the peak x-ray 
energy is 65keV but the true x-ray energy will be a range of values below this.  A 
1.5mm aluminium filter on the x-ray head removes some of the low energy x-rays 
producing the equivalent to a monoenergetic beam of a third or half of the kVp 
[118, 129].  The samples tested will also attenuate the low energy x-rays, a process 
known as beam hardening.  All the experimental attenuations are calculated using 
the intensity of the 0 Mol % strontium glass as the initial beam intensity, this 
effectively adds another filter to the beam and so the average energy will be higher 
still.  The experimental values sit between the 40 keV and 50 keV theoretical 
calculations, indicating both successful measurement of the attenuation increase and 
also the successful substitution of strontium into the material. 
Cortical bone has a theoretical mass attenuation of 0.314 cm
2
.g
-1
 [120], much less 
than the theoretical value of the glasses tested.  The increase in mass attenuation 
increases the contrast of the material on a radiographic image.  This is useful for 
non-invasive postoperative monitoring of an implant.  On a two-dimensional 
radiograph the interface between the implant and bone may be obscured by the x-ray 
dense material however the loss of definition that occurs with remodelling of the 
implant will be more noticeable with increasing attenuation [130].  Computed 
tomography (CT) can be used to better view the placement of an implant and also 
the interface between the body tissue and prosthesis.  High attenuating devices, such 
as metal prosthesis, can be difficult to image on CT due to low levels of x-rays 
passing through the material and creating a void in a slice image.  This produces a 
star like artefact when back projecting and forming the complete CT image [131].  
Another artefact that metal implants can induce is beam hardening due to attenuation 
of low energy x-rays by the high attenuator, which subsequently effects the beam 
interaction with softer tissues [132].  This produces problems when reconstructing 
the slices taken at multiple angles.  Titanium implants have been shown to be easier 
to image using CT than stainless steel and cobalt chrome implants due to their lower 
mass attenuations [133].  As can be seen from table 21 only the attenuation 
12.47 Mol % strontium glass is equal to or exceeds that of iron and cobalt (the main 
constituent of common orthopaedic implants) while compositions 0 and 3.12 Mol % 
strontium have a lower attenuation than titanium making them more suitable implant 
materials for CT imaging. 
- 63 - 
Table 21: Theoretical mass attenuations for bone and orthopaedic metals [120]. 
Material 40 keV 50 keV 60 keV 
Cortical Bone 0.6655 0.4242 0.314 
Titanium (Ti) 2.214 1.213 0.766 
Iron (Fe) 3.629 1.958 1.205 
Cobalt (Cr) 3.981 2.144 1.314 
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Chapter 3: Crystallisation 
3.1 Introduction 
The aim of this section was to characterise devitrification of the strontium 
containing glasses.  The glasses formed are metastable and given an adequate input 
of energy will first nucleate and then grow crystals.  The formation of crystals 
within the bulk glass is crucial in determining the bulk mechanical properties, 
sinterability and biocompatibility of the material.  The particle size and heating rate 
used for devitrification are known to influence the crystal phases formed in apatite-
wollastonite glass ceramic and so both were investigated.  The temperature to which 
the parent glass is heated also influences the phases that are formed, this was 
investigated by heating all samples to the same temperature and also by heating of 
individual compositions according to regimes defined by the crystallisation 
temperatures. 
The first step in the characterisation is determining under what conditions crystals 
form in the material.  The effect of heating on devitrification was assessed using 
differential scanning calorimetry (DSC).  The effect on the thermodynamic events of 
strontium substitution into the parent glass was analysed via DSC at different 
heating rates and for different particle sizes.  Whilst the DSC provides information 
on crystallisation temperatures, it does not provide any information about the phases 
that have formed.  X-ray diffraction (XRD) and the International Centre for 
Diffraction Data (ICDD) database were used to identify the phases formed in the 
glasses following heating with quantification performed via a Rietveld refinement.  
Surfaces of the devitrified glass-ceramics were analysed via SEM and EDX to 
observe the morphology and composition of any crystals that were visible on the 
surface of the material. 
3.2 Experimental Methodologies 
3.2.1 Differential Scanning Calorimetry 
All DSC experiments were performed on a Netsch DSC 404 F3 with a PC running 
the Proteus data collection and analysis software.  The DSC was calibrated using 
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indium, zinc, aluminium and gold standard materials.  Matched platinum-rhodium 
crucibles with lids were used.  All DSC pans were cleaned by soaking in 
hydrofluoric acid for 24 hours followed by 30 minutes sonication in an ultrasonic 
bath and 2 hours in boiling ultrapure water before being dried thoroughly.  All 
experiments were performed in an air atmosphere and a protective nitrogen gas 
flow.  A mass of 20±0.2mg of sample was used each time and the differential 
calculated against an empty pan.  All of the five compositions tested in chapter 2 
were analysed.  The effect of heating rate on the glass was assessed using the 45-
90µm particle fraction and heating rates of 2, 5, 10 and 15 K.min
-1
.  The effect of 
particle size on devitrification of the glass was analysed by using the <45µm, 45-
90µm and 1-2mm size fractions with a constant heating rate of 10 K.min
-1
.  The 
position of the glass transition temperature and exothermic peaks were measured 
using Proteus Analysis.  The glass transition was determined using the inbuilt glass 
transition function and thermal event peaks and onsets were determined using the 
complex peak function.  The activation energy for crystallisation was calculated 
from multiple DTA curves, performed at the different heating rates, using the 
Kissinger equation, equation 20 [134]. 
  (
 
  
 )   
 
   
   
Equation 20 
Where ø is the heating rate (K/min), R the gas constant (J/K Mol), Tp the 
crystallisation peak temperature (K), E the activation energy (KJ/Mol) and C a 
constant.  The gradient of the line produced by plotting ln(ø/TP
2
) versus 1000/Tp 
gives E. 
3.2.2 X-Ray Diffraction (XRD) 
1g of each of the 45-90µm powders were heated (in an Elite BCF 13/12-2416 
furnace) to temperatures TO1-15, TP1+10, TP2+10 and 1050°C at a constant rate of 
10K.min
-1
 and held at that temperature for 2 hours.  The powders were then ground 
using a (Gy-Ro Mill) for 2 seconds.  10 Wt % of calcined alumina (Fisher Scientific) 
was added to each sample as an internal standard and thoroughly mixed in using an 
agate pestle and mortar.  Samples were scanned using a Philips X’Pert run at 40kV 
and 40mA outputs logged using the X’Pert Data Collector software.  A 15x15mm 
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fixed incident beam mask was used.  A step size of 0.0334225°, dwell of 3.18 
seconds and disc rotation speed of 4 seconds were used to scan between the range of 
10-70°2θ.  All analysis of the XRD pattern was done using HighScore Plus 
software.  An ultra-low background off-cut silicon sample holder was used.  The 
diffraction peaks were then matched to powder diffraction files (PDF) contained 
within the ICDD database using HighScore software.  A search match was run on 
the diffraction data using the elemental restrictions determined from previous EDX 
of the parent glasses.  A Rietveld refinement was then run on the powders.  
Figure 27 shows the systematic protocol used for the refinement, the matched phases 
were added into the refinement and it was then applied to all samples.  The most 
intense peaks were first matched and refined and then the residual peaks were 
matched and refined using the same method.  Any factor that did not lead to 
convergence or produced impossible values (Peak Shape 1 and size broadening 
factor W becoming negative) were removed.  A refinement producing a weighted R-
profile (Rwp) less than 10 was taken as a good fit. 
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Figure 27: The initial Rietveld refinement strategy. 
A silicon standard was scanned using the same equipment settings and the 
instrumental broadening calculated using PDF 04-016-4861.  The instrumental 
values calculated were then used in all subsequent Rietveld refinements.  For each 
phase the weight percentage (Wt %), unit cell dimensions, unit cell volume and size 
and strain broadening factors were reported along with the R-profile and weighted 
R-profile fits for the whole refinement.  The known weight percentage of internal 
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standard, WSTD, and the experimental value, WEXP, were used to calculate the weight 
percentage of the residual amorphous phase, WAMO, equation 21.  
     
  (
    
    
)
        
 
Equation 21 
3.2.3 Scanning Electron Microscopy (SEM) 
0.25g of each of the 45-90µm glass fractions was heated in a furnace (Elite BCF 
13/12-2416 furnace) to 1050°C at a constant heating rate of 10K.min
-1
 and held 
there for 2 hours before being cooled at the furnace rate.  1050°C was chosen as it 
exceeded the first exotherm for all the compositions tested while being low enough 
below the melting point to minimise dissolution of phases back into the melt.  XRD 
had shown the secondary phase to form at this temperature for all compositions.  
Samples were then fixed to SEM aluminium stubs using carbon adhesive pads.  
Samples were sputtered with a 6nm gold coating.  Samples were imaged using a 
Hitachi S3400N SEM with the native software and elemental analysis was 
performed using a Bruker XFlash detector and analysed with Quantax analysis 
software.  Eneregy dispersive x-ray analysis (EDX) was performed using both a 
surface elemental map and point scans on specific crystal structures.  Care was taken 
to ensure that EDX data was taken from as flat a surface as possible to ensure that 
the x-ray takeoff angle remained constant. 
3.3 Crystallisation Results 
3.3.1 DSC 
The 45-90µm particle size fraction was first examined with a heating rate of 
10K.min
-1
 to determine the effect of strontium substitution on the observable 
thermodynamic events, figure 28. 
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Figure 28: Offset DSC traces of the 45-90µm size fraction for glass compositions 
0-12.47 Mol % strontium heated at 10K.min
-1
. 
Figure 29 highlights the main exothermic events that occurred in the samples, 
Tg = glass transition temperature, TO = peak onset temperature TP = peak 
temperature and Tm = melting point.  The values of Tg, TO and TP are summarised in 
figure 30 and table 22 .  Tm was not included as it was not possible to identify a 
definite point where melting had occurred in all samples. 
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Figure 29: Examples of the thermodynamic events observed in the DSC traces. 
 
Figure 30: The major thermodynamic events observed in DSC traces of the 45-90 
µm glass compositions heated at 10 K.min
-1
. 
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Table 22: Summary of the thermodynamic events observed in DSC traces of the 
45-90µm glass compositions heated at 10 K.min
-1
. 
Sr Content 
(Mol %) 
Tg (°C) TO1 (°C) TP1 (°C) TO2 (°C) TP2 (°C) 
0 750.4 856.7 898.0 947.9 963.8 
3.12 743.6 860.7 890.9 970.9 1000.3 
6.24 742.3 863.0 887.9 998.2 1040.9 
9.35 741.8 861.4 882.6 1020.2 1065.2 
12.47 741.5 849.4 875.1 1047.6 1084.5 
 
Both Tg and TP1 occurred at lower temperatures with increasing strontium 
substitution into the parent glass.  Tg decreased by only 9°C across the whole range 
of compositions tested while TP1 decreased by 22.9°C.  An increase in TO1 was 
observed between compositions 0-6.24 Mol % strontium and then decreased for 
subsequent additions.  An increase in both TO2 and TP2 was observed for all 
sequential substitutions of strontium, with TP2 increasing by 120.7°C for the 
compositional range of 0-12.47 Mol % strontium.  Though a definite value could not 
be assigned to the melting point, the presence of the endothermic slope became more 
pronounced with increasing strontium substitution. 
The effect of particle size on the thermodynamic events was then observed.  The 
resulting DSC traces are shown in figure 31. 
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Figure 31: Comparison of offset DSC traces recorded for particle size fractions 
<45µm, 45-90µm and 1-2mm at a heating rate of 10K.min
-1
 for compositions 
0-12.47 Mol % strontium. 
Tg and TP1 varied by a maximum of 4.3°C and 6.7°C, respectively, over the whole 
range of particles tested.  TP2 varied most for composition 0 Mol % strontium with 
an increase of 79.5°C between particle fractions <45µm and 1-2mm.  The increase 
in peak temperature with increasing particle size became less pronounced with 
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increasing strontium substitution, but still produced a minimum increase of 29.3°C.  
Melting occurred at a higher temperature with increasing particle size.  The change 
in TP1 and TP2 are summarised in figure 32 and the values of Tg, TP1 and TP2 shown 
in table 23. 
 
Figure 32: The effect of particle size on TP1 and TP2 for the glass compositions 
heated at 10 K.min
-1
. 
Table 23: The effect of particle size on TP1 and TP2 for the glass compositions heated 
at 10 K.min
-1
. 
Event 
Size 
Fraction 
Strontium Content (Mol %) 
0 3.12 6.24 9.35 12.47 
Tg (°C) 
0-45µm 752.1 747.8 743.2 742.5 742.1 
45-90µm 750.4 743.6 742.3 741.8 741.5 
1-2mm 751.7 743.5 741.8 740.8 740.5 
TP1 (°C) 
0-45µm 892.7 885.3 885.9 882.3 875.2 
45-90µm 898 890.9 887.9 882.6 875.1 
1-2mm 896.9 892 882.2 876 874.8 
TP2 (°C) 
0-45µm 955.2 980.2 1017.1 1048 1062.3 
45-90µm 963.8 1000.3 1040.9 1065.2 1084.5 
1-2mm 1034.3 1035.5 1074 1077.3 1098.6 
 
The effect of heating rate on the 45-90µm size fractions was then examined, figure 
33. 
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Figure 33: Comparison of offset DSC traces recorded at different heating rates for 
particle size fraction 45-90µm for compositions 0-12.47 Mol % strontium. 
The height of the exothermic peaks increased with increasing heating rate.  Both TP1 
and TP2 shifted to higher temperatures with increasing heating rate.  The position of 
the exothermic peaks at different heating rates was used to determine the activation 
energy via the Kissinger method.  The derived graphs are shown in figure 34 and the 
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resulting gradients, m, adjusted R
2
 values and activation energies, E, are shown in 
table 24. 
 
Figure 34: The Kissinger plots for 45-90µm size fractions of glass compositions 
0-12.47 Mol % strontium heated at 2, 5, 10 and 15 K.min
-1
. 
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Table 24: The gradient and activation energies for particle size fraction 45-90µm of 
compositions 0-12.47 Mol % strontium calculated using the Kissinger method. 
Sr 
Content 
(Mol %) 
Tp1 Tp2 
m Adj. R
2
 
E 
(kJ.mol
-1
) 
m Adj. R
2
 
E 
(kJ.mol
-1
) 
0 -61.099 1.000 508.006 -54.572 1.000 453.737 
3.12 -62.042 0.976 515.847 -42.932 0.996 356.957 
6.24 -59.070 1.000 491.136 -35.994 0.989 299.271 
9.35 -59.689 1.000 496.283 -34.606 0.997 287.731 
12.47 -59.606 1.000 495.592 -35.537 0.985 295.471 
 
All fits achieved an adjusted R
2
 value of 0.97 or greater, indicating a good fit to the 
data.  The calculated activation energy as a function of strontium content of the 
parent glass is shown in figure 35.  TP1 was higher than TP2 for all compositions with 
a value of 499.5 ± 8.5 kJ.mol
-1
.  A large decrease, 154.45 kJ.mol
-1
, was observed in 
TP2 between compositions 0 -6.24 Mol % strontium.  Subsequent additions resulted 
in little change in activation energy, 293.5 ± 6 kJ.mol
-1
 for the range 6.24-
12.47 Mol % strontium. 
 
Figure 35: The effect of strontium substitution on the activation energy of 
thermodynamic events TP1 and TP2. 
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3.3.2 X-Ray Diffraction / Rietveld 
3.3.2.1 Phase Identification 
The Rietveld refinement strategy was first applied to samples heated to 1050°C at 
10Kmin
-1
 and held for 2 hours.  The results are shown in figures 36 to 41 and tables 
25 to 35 on pages 80 to 86.  The data shows the observed data, the calculated fit, the 
calculated background, the position of matched peaks and the difference plot 
(observed-calculated). 
3.3.2.1.1 0 Mol % Strontium 
The most intense diffraction peaks were matched to an apatite phase. fluorapatite 
(FA), Ca5 (PO4)3F, ICDD: 04-009-4021.  Following refinement of FA residual 
peaks were matched to a silicate, monoclinic wollastonite-2M (Wol-2M), CaSiO3, 
ICDD: 04-009-5600.  The completed refinement is shown in figure 36 with the 
results shown in tables 25 and 26.  A good fit was achieved with a weighted R-
profile of 7.688.  The maximum peak intensity occurred at 31.6997°2θ and was 
matched to FA.  The largest difference between the observed and calculated 
intensities occurred around the second most intense apatite peak at 31.9°2θ, with a 
ratio of 1:5 to the maximum peak intensity. 
3.3.2.1.2 3.12 Mol % Strontium 
Both FA and Wol-2M were successfully refined for composition 3.12 Mol % 
strontium, producing a weighted R-profile of 7.746, figure 37 and tables 27 and 28.  
The maximum peak intensity was at 31.4997°2θ and was matched to FA.  Again the 
largest difference occurred around the second most intense apatite peak at 31.7°2θ 
with a ratio of 1:4 with the maximum intensity. 
To reduce the size of the difference peaks, an alternative match for the apatite phase 
was found.  Fluorstophite (SrFA), Sr3.65Ca1.35(PO4)3F, ICDD: 04-009-1806, was 
used instead of FA and the refinement re-run, figure 38 and tables 29 and 30.  
Though the ratio of the largest difference to the highest intensity was reduced to 1:5, 
the weighted R-profile increased to 8.063. 
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3.3.2.1.3 6.24 Mol % Strontium 
Convergence was not achieved for the apatite phase using FA 04-009-4021 and so 
SrFA was used, figure 39 and tables 31 and 32.  The silicate phase was successfully 
matched to Wol-2M with the final refinement producing a weighted R-profile of 
4.928.  The maximum peak intensity was at 31.3077°2θ and was matched to SrFA.  
The maximum difference was observed around 31.4°2θ and the difference to 
maximum ratio was 1:10. 
3.3.2.1.4 9.35 Mol % Strontium 
FA and Wol-2M were both successfully refined for composition 9.35 Mol % 
strontium producing a weighted R-profile fit of 4.335, figure 40 and tables 33 and 
34.  The maximum peak intensity, occurring at 31.2027, was matched to SrFA.  The 
maximum difference occurred around 32.4°2θ, with the maximum difference to 
maximum height ratio of 1:15. 
3.3.2.1.5 12.47 Mol % Strontium 
SrFA and Wol-2M were both successfully refined for composition 12.46 Mol % 
strontium producing a weighted R-profile of 9.333, figure 41 and tables 35 and 36.  
The maximum peak intensity, matched to SrFA, occurred at 31.1697.  The largest 
difference occurred at 31.2°2θ producing a ratio of the difference to the maximum 
intensity of 1:5. 
A strong residual peak was observed around 45°2θ.  An attempt was made to 
identify the phase producing the peak.  Monoclinic pseudo wollastonite (PsWol), 
CaSiO3, ICDD: 04-012-1776, was fitted but conflicted with Wol-2M.  Wol-2M was 
removed and the residual peaks were matched to tetragonal strontium calcium 
magnesium silicate (SCMS), SrCaMg(Si3O7), ICDD: 04-009-1844, resulting in a 
weighted R-profile of 5.461, figure 42 and tables 37 and 38.  Though a good fit was 
achieved using PsWol and SCMS, there was an increase in the number of un-
matched reference peaks, with 1 in 10 of the PsWol peaks failing to match.  The 
ratio of the maximum difference to the peak intensity dropped to 1:4 in part due to 
the PsWol peaks overlapping strongly with the apatite peaks, producing large 
differences in intensity around the 31.2°2θ apatite peak.  Multiple large, negative, 
differences were also observed. 
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Though a stronger fit was achieved using PsWol and SCMG in place of Wol-2M for 
composition 12.47 Mol % strontium, the increase in the intensity of the difference 
plot and the non-matching of multiple peaks meant the it’s values were not included 
in subsequent analysis of weight percentages and unit cell volumes. 
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Figure 36: Rietveld refinement of 0 Mol % strontium heated at 10Kmin
-1
 to 1050°C 
and held for 2 hours. 
Table 25: The unit cell dimensions and volume calculated using the developed 
Rietveld refinement for composition of 0 Mol % strontium heated at 10Kmin
-1
 
to 1050°C and held for 2 hours.  Standard deviations (SDEV) are shown. 
Phase 
Unit Cell Dimensions Volume 
(nm
3
) a (Å) SDEV b (Å) SDEV c (Å) SDEV 
FA 9.422 0.001 9.422 0.001 6.947 0.001 534.000 
Wol-2M 6.949 0.002 7.214 0.002 15.209 0.005 758.874 
Amorphous - - - - - -  
 
Table 26: Refinement factors U and W and weight percentages calculated with the 
Rietveld refinement of 0 Mol % strontium heated at 10Kmin
-1
 to 1050°C and 
held for 2 hours.  Standard deviations (SDEV) are shown. 
Phase 
Refinement Factors 
Wt% 
U SDEV W SDEV 
FA 0.1799 0.0518 0.032198 0.005501 33 
Wol-2M 0.4438 0.2042 0.0592 0.0195 27 
Amorphous - - - - 40 
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Figure 37: Rietveld refinement of 3.12 Mol % strontium heated at 10Kmin
-1
 to 
1050°C and held for 2 hours. 
Table 27: The unit cell dimensions and volume calculated using the developed 
Rietveld refinement for composition of 3.12 Mol % strontium heated at 
10Kmin
-1
 to 1050°C and held for 2 hours.  Standard deviations (SDEV) are 
shown. 
Phase 
Unit Cell Dimensions Volume 
(nm
3
) a (Å) SDEV b (Å) SDEV c (Å) SDEV 
FA 9.481 0.001 9.481 0.001 7.003 0.001 545.167 
Wol-2M 6.970 0.001 7.215 0.000 15.213 0.001 761.641 
Amorphous - - - - - -  
 
Table 28: Refinement factors U and W and weight percentages calculated with the 
Rietveld refinement of 3.12 Mol % strontium heated at 10Kmin
-1
 to 1050°C 
and held for 2 hours.  Standard deviations (SDEV) are shown. 
Phase 
Refinement Factors 
Wt% 
U SDEV W SDEV 
FA 0.2504 0.0678 0.0298 0.0065 39 
Wol-2M 1.0240 0.3367 0.1415 0.0296 18 
Amorphous - - - - 43 
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Figure 38, Rietveld refinement using SrFA of 3.12 Mol % strontium heated at 
10Kmin
-1
 to 1050°C and held for 2 hours. 
Table 29: The unit cell dimensions and volume calculated using the SrFa containing 
Rietveld refinement for composition of 3.12 Mol % strontium heated at 
10Kmin
-1
 to 1050°C and held for 2 hours.  Standard deviations (SDEV) are 
shown. 
Phase 
Unit Cell Dimensions Volume 
(nm
3
) a (Å) SDEV b (Å) SDEV c (Å) SDEV 
SrFA 9.481 0.001 9.481 0.001 7.003 0.001 545.183 
Wol-2M 6.970 0.001 7.215 0.000 15.212 0.001 761.636 
Amorphous - - - - - -  
 
Table 30: Refinement factors U and W and weight percentages calculated with the 
SrFA containing Rietveld refinement of 3.12 Mol % strontium heated at 
10Kmin
-1
 to 1050°C and held for 2 hours.  Standard deviations (SDEV) are 
shown. 
Phase 
Refinement Factors 
Wt% 
U SDEV W SDEV 
SrFA 0.2504 0.0678 0.0298 0.0065 20 
Wol-2M 1.1965 0.6114 0.1043 0.0489 16 
Amorphous - - - - 64 
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Figure 39: Rietveld refinement of 6.24 Mol % strontium heated at 10Kmin
-1
 to 
1050°C and held for 2 hours. 
Table 31: The unit cell dimensions and volume calculated using the developed 
Rietveld refinement for composition of 6.24 Mol % strontium heated at 
10Kmin
-1
 to 1050°C and held for 2 hours.  Standard deviations (SDEV) are 
shown. 
Phase 
Unit Cell Dimensions Volume 
(nm
3
) a (Å) SDEV b (Å) SDEV c (Å) SDEV 
SrFA 9.536 0.001 9.536 0.001 7.067 0.001 556.456 
Wol-2M 7.003 0.005 7.283 0.004 15.253 0.015 774.346 
Amorphous - - - - - -  
 
Table 32: Refinement factors U and W and weight percentages calculated with the 
Rietveld refinement of 6.24 Mol % strontium heated at 10Kmin
-1
 to 1050°C 
and held for 2 hours.  Standard deviations (SDEV) are shown. 
Phase 
Refinement Factors 
Wt% 
U SDEV W SDEV 
SrFA 0.2306 0.0457 0.0279 0.0045 23 
Wol-2M 2.0021 0.8731 0.3365 0.0785 17 
Amorphous - - - - 60 
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Figure 40: Rietveld refinement of 9.35 Mol % strontium heated at 10Kmin
-1
 to 
1050°C and held for 2 hours. 
Table 33: The unit cell dimensions and volume calculated using the developed 
Rietveld refinement for composition of 9.35 Mol % strontium heated at 
10Kmin
-1
 to 1050°C and held for 2 hours.  Standard deviations (SDEV) are 
shown. 
Phase 
Unit Cell Dimensions Volume 
(nm
3
) a (Å) SDEV b (Å) SDEV c (Å) SDEV 
SrFA 9.569 0.001 9.569 0.001 7.117 0.001 564.387 
Wol-2M 7.024 0.005 7.316 0.005 15.295 0.018 782.779 
Amorphous - - - - - -  
 
Table 34: Refinement factors U and W and weight percentages calculated with the 
Rietveld refinement of 9.35 Mol % strontium heated at 10Kmin
-1
 to 1050°C 
and held for 2 hours.  Standard deviations (SDEV) are shown. 
Phase 
Refinement Factors 
Wt% 
U SDEV W SDEV 
SrFA 0.3846 0.0581 0.0241 0.0051 27 
Wol-2M 1.5636 0.8698 0.0222 0.0594 13 
Amorphous - - - - 60 
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Figure 41: Rietveld refinement of 12.47 Mol % strontium heated at 10Kmin
-1
 to 
1050°C and held for 2 hours. 
Table 35: The unit cell dimensions and volume calculated using the developed 
Rietveld refinement for composition of 12.47 Mol % strontium heated at 
10Kmin
-1
 to 1050°C and held for 2 hours.  Standard deviations (SDEV) are 
shown. 
Phase 
Unit Cell Dimensions Volume 
(nm
3
) a (Å) SDEV b (Å) SDEV c (Å) SDEV 
SrFA 9.574 0.001 9.574 0.001 7.127 0.001 565.722 
Wol-2M 7.203 0.005 7.012 0.004 15.800 0.016 793.749 
Amorphous - - - - - -  
 
Table 36: Refinement factors U and W and weight percentages calculated with the 
Rietveld refinement of 12.47 Mol % strontium heated at 10Kmin
-1
 to 1050°C 
and held for 2 hours.  Standard deviations (SDEV) are shown. 
Phase 
Refinement Factors 
Wt% 
U SDEV W SDEV 
SrFA 0.2537 0.0768 0.0149 0.0068 30 
Wol-2M 0.2846 0.4664 0.0144 0.0332 11 
Amorphous - - - - 59 
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Figure 42: Rietveld refinement using PsWol and SCMS for the glass composition 
12.47 Mol % strontium heated at 10Kmin
-1
 and held at 1050°C for two hours. 
Table 37: The unit cell results of the Rietveld refinement using PsWol and SCMS 
for the 12.47 Mol % strontium composition heated at 10Kmin
-1
 and held at 
1050°C for two hours.  Standard deviations (SDEV) are shown. 
Phase 
Unit Cell Dimensions Volume 
(nm
3
) a (Å) SDEV b (Å) SDEV c (Å) SDEV 
SrFA 9.576 0.001 9.576 0.001 7.126 0.001 565.873 
PsWol 6.987 0.004 12.093 0.007 19.902 0.005 1681.523 
SCMS 7.933 0.002 7.933 0.002 5.099 0.002 320.916 
Amorphous - - - - - -  
 
Table 38: The refinement factor U and W and weight percentages calculated using 
the Rietveld refinement containing PsWol and SCMS for the 12.47 Mol % 
strontium composition heated at 10Kmin
-1
 and held at 1050°C for two hours.  
Standard deviations (SDEV) are shown. 
Phase 
Refinement Factors 
Wt% 
U SDEV W SDEV 
SrFA 0.3068 0.0383 0.0106 0.0035 34 
PsWol 0.0074 0.0616 0.0301 0.0100 17 
SCMS 0.3297 0.0000 0.3792 0.0000 11 
Amorphous - - - - 38 
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3.3.2.2 Final Refinement Strategy 
A summary of the refinement strategy including the matched phases is shown in 
figure 43. 
 
Figure 43: The final Rietveld refinement strategy including the phases identified. 
FA = Fluorapatite ICDD: 04-009-4021 SrFA = fluorstophite ICDD: 04-009-
5600, Wol-2M = wollastonite 2M ICDD: 04-009-5600, PsWol = pseudo 
wollastonite ICDD: 04-012-1776 and SCMS = strontium magnesium calcium 
silicate ICDD: 04-0091844. 
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3.3.2.3 Phase Content Determination 
The weight ratios for the glass-ceramics formed by a 2 hour hold at 1050°C and 
heating rate of 10K.min
-1
 are shown in figure 44. 
 
Figure 44: The variation in weight percentage of the phases present following a 2 
hour hold at 1050°C with a heating rate of 10Kmin
-1
.  Ap = apatite phase, Sil = 
silicate phase, Amo = amorphous phase Alt. = alternative values determined 
using SrFA for composition 3.12 Mol % strontium. 
For composition 0 Mol % strontium the amorphous content, calculated from the 
observed and known weight percentage of Al2O3, accounted for 40% of the weight 
of the material, apatite 33% and silicate 27%.  An increase in the amorphous and 
apatite phases weight percentage was observed with the first substitution of 
strontium when refining using FA as well as a reduction in the weight percentage of 
the silicate phase.  A large reduction in the apatite phase and a large increase in the 
amorphous phase weight percentages were observed when SrFA was utilised in 
place of FA for the refinement of composition 3.12 Mol % strontium.  A small 
reduction in the quantity of the silicate phase was also observed.  The refinement of 
12.47 Mol % strontium using PsWol and SCMS, not included in figure 44, produced 
an increase in the total silicate phase present (PsWol + SCMS) compared to the 
refinement using Wol-2M, increasing from 11 to 28 Wt%.  A small increase was 
also observed in the weight percentage of the apatite phase.  A large reduction was 
observed in the amount of residual amorphous phase, dropping by 21 Wt%. 
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3.3.2.4 The Effect of Strontium Substitution on Unit Cell volume 
From figures 45 and 46 it can be seen that the unit cell volume calculated using the 
Rietveld refinement of both the apatite and silicate phase increases with increasing 
strontium substitution into the parent glass. 
 
Figure 45: The effect of glass composition on the unit cell volume of the apatite 
phase formed during devitrification. 
 
Figure 46: The effect of glass composition on the unit cell volume of the silicate 
phase formed during devitrification. 
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Figure 45 shows that the apatite unit cell volume increased linearly between 
compositions 0-9.35 Mol % strontium with an average increase of 0.010129 nm
3
 per 
3.12 Mol % strontium increase.  A small increase of 0.00135 nm
3
 was observed 
between compositions 9.35 and 12.47 Mol % strontium.  A linear fit was achieved 
for the increase in the silicate phase unit cell volume with an average increase of 
0.008719 nm
3
 with each 3.12 Mol % strontium substitution.   
For composition 3.12 Mol % strontium, utilising SrFA instead of FA produced unit 
cell volumes for the apatite and silicate phases that differed from the previously 
calculated by only 1.6x10
-5
 and 5x10
-6
 nm
3
, respectively. 
3.3.2.5 The Effect of Heating on Crystallisation 
The Rietveld refinement strategy was then applied to powders that had been heated 
at 10Kmin
-1
 to TO1-15°C, TP1+10°C and TP2+10°C and held at the respective 
temperature for 2 hours.  The results are shown in figures 47-51 and tables 39-43. 
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3.3.2.5.1 0 Mol % Strontium 
 
Figure 47: The effect of a 2 hour hold at increasing temperatures on the crystal 
phases formed in glass composition 0 Mol % strontium. 
Table 39: The results of the Rietveld refinements shown in figure 47. 
Temperature Phase 
Volume 
(nm
3
) 
Refinement 
Factor Wt% 
U W 
9
7
4
 °
C
 
FA 0.534332 0.2606 0.0350 33 
Wol-2M 0.759656 0.9281 0.0815 21 
Amorphous - - - 46 
9
0
8
 °
C
 FA 0.535611 0.2037 0.0309 24 
Wol-2M 0.757900 1.0130 0.1321 10 
Amorphous - - - 66 
8
4
7
 °
C
 
FA 0.536881 0.0704 0.0134 37 
W-2M - - - 0 
Amorphous - - - 63 
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3.3.2.5.2 3.12 Mol % Strontium 
 
Figure 48: The effect of a 2 hour hold at increasing temperatures on the crystal 
phases formed in glass composition 3.12 Mol % strontium. 
Table 40: The results of the Rietveld refinements shown in figure 48. 
Temperature Phase 
Volume 
(nm
3
) 
Refinement 
Factor Wt% 
U W 
1
0
1
0
 °
C
 
SrFA 0.544078 0.2705 0.0270 13 
Wol-2M 0.766470 2.3605 0.2864 24 
Amorphous - - - 63 
9
0
1
 °
C
 SrFA 0.542739 0.0849 0.0147 21 
Wol-2M 0.765442 2.1106 0.1082 4 
Amorphous - - - 75 
8
4
6
 °
C
 
SrFA 0.543408 0.0931 0.0147 19 
Wol-2M - - - 0 
Amorphous - - - 81 
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3.3.2.5.3 6.24 Mol % Strontium 
 
Figure 49: The effect of a 2 hour hold at increasing temperatures on the crystal 
phases formed in glass composition 6.24 Mol % strontium. 
Table 41: The results of the Rietveld refinements shown in figure 49. 
Temperature Phase 
Volume 
(nm
3
) 
Refinement 
Factor Wt% 
U W 
1
0
5
0
 °
C
 
SrFA 0.556456 0.2306 0.0279 23 
Wol-2M 0.774346 0.8731 0.0785 17 
Amorphous - - - 60 
8
9
8
 °
C
 SrFA 0.551194 0.0870 0.0147 25 
Wol-2M 0.778748 1.5396 0.6608 6 
Amorphous - - - 69 
8
4
8
 °
C
 
SrFA 0.552066 0.0864 0.0128 26 
Wol-2M - - - 0 
Amorphous - - - 74 
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3.3.2.5.4 9.35 Mol % Strontium 
 
Figure 50: The effect of a 2 hour hold at increasing temperatures on the crystal 
phases formed in glass composition 9.35 Mol % strontium. 
Table 42: The results of the Rietveld refinements shown in figure 50. 
Temperature Phase 
Volume 
(nm3) 
Refinement 
Factor Wt% 
U W 
1
0
5
0
 °
C
 
SrFA 0.564387 0.3846 0.0241 27 
Wol-2M 0.782779 1.5636 0.0222 13 
Amorphous - - - 60 
8
9
3
 °
C
 SrFA 0.559394 0.0547 0.0121 27 
Wol-2M - - - 0 
Amorphous - - - 73 
8
4
6
 °
C
 
SrFA 0.560823 0.1001 0.0120 27 
Wol-2M - - - 0 
Amorphous - - - 73 
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3.3.2.5.5 12.47 Mol % Strontium 
 
Figure 51: The effect of a 2 hour hold at increasing temperatures on the crystal 
phases formed in glass composition 12.47 Mol % strontium. 
Table 43: The results of the Rietveld refinements shown in figure 51. 
Temperature Phase 
Volume 
(nm
3
) 
Refinement 
Factor Wt% 
U W 
1
0
5
0
 °
C
 
SrFA 0.565722 0.2537 0.0149 31 
Wol-2M 0.793749 0.2846 0.0144 10 
Amorphous    59 
8
8
5
 °
C
 SrFA 0.568975 0.0618 0.0107 31 
Wol-2M    0 
Amorphous    69 
8
3
4
 °
C
 
SrFA 0.570183 0.0983 0.0117 29 
Wol-2M - - - 0 
Amorphous - - - 71 
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In all samples crystal peaks became visible following a 2 hour hold at TO1-15.  The 
matched peaks corresponded to the apatite phase.  To aid comparison between 
strontium containing samples, SrFA and Wol-2M were used for all strontium 
containing samples.  The hold temperature decreased with increasing strontium 
content.  An initial drop in apatite weight percentage was observed with the first 
substitution of strontium followed by an increase with each subsequent substitution.  
In all samples no other crystalline phases were detected at TO1-15 and the residual 
weight percentage was composed of an amorphous phase. 
At TP1+10 apatite was again detected but in compositions 0-6.24 Mol % strontium 
secondary peaks were observed which were matched to silicate phase Wol-2M.  
These peaks were most prominent in composition 0 Mol % strontium but were still 
detectable in the strontium containing materials.  The amount of this phase 
decreased with strontium substitution but was higher in composition 6.24 than 3.12, 
6 to 4 Wt% respectively.  No secondary phase was detected in compositions 9.35 
and 12.46 Mol % strontium.  Compared to TO1-15, there was a reduction in the 
weight percentage of the amorphous phase in all samples, apart from composition 
0 Mol % strontium which showed a small increase from 63 to 66 Wt%.  A reduction 
in the weight percentage of the apatite phase was also detected in this composition 
as the secondary phase formed.  The weight percentage of the apatite phase varied 
by a maximum of 2 Wt% in the strontium containing compositions compared to the 
previous hold temperature. 
At TP2+10 both the apatite and silicate phase peaks were clearly visible in all the 
compositions tested.  The weight percentage of the silicate phase increased in 
samples which had been shown to form it at lower temperatures.  The weight 
percentage of the apatite phase increased by 9 Wt% in the 0 Mol % strontium 
composition but reduced by a maximum of 1 Wt% in the strontium containing 
samples when compared to the previous hold temperature.  When comparing 
samples held at TP2+10, the weight of the residual amorphous phase increased from 
46 to 63 Wt% between compositions 0 and 3.12 Mol % strontium, respectively.  
Subsequent additions of strontium resulted in little change in amorphous phase 
weigh percentage with all samples coming within 60±3 Wt% of each other.  The 
weight contribution of the silicate phase got smaller with increasing strontium 
substitution. 
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3.3.3 Surface Analysis 
3.3.3.1 SEM 
Samples heated at 10K.min
-1
 to 1050°C and held there for 2 hours were then imaged 
using a scanning electron microscope, figures 52-56 on pages 99 to 103. 
3.3.3.1.1 0 Mol % Strontium 
Small domains were observed on the surface of the material that appear to be 
interlocked with a small void visible in figure 52 (c).  Brighter, whiter, seams can be 
seen to run throughout figure 52 (a) and (b).  Though small variations in domain size 
can be observed, there are no visible changes in morphology.  From the high 
magnification image, figure 52 (c), the larger structures appear to be formed from 
small crystallites of fibrous form. 
3.3.3.1.2 3.12 Mol % Strontium 
Three morphologically different phases are clearly visible in figure 53 (a) (labelled 
1-3).  Phase 2 appears brighter than phase 3 while phase 1 resides in boundaries 
between the two other phase and appears most bright.  From figure 53 (b) it can be 
seen that phase 1 is composed from a phase exhibiting a homologous morphology of 
equant granular domains or crystals.  There is no definable structure visible in 
phase 3.  From figure 53 (c) it can be seen that phase 2 is composed of two different 
morphologies, small, equant, granular and larger elongated, branching crystals. 
3.3.3.1.3 6.24 Mol % Strontium 
From figure 54 three clearly define phases are again visible.  Phases 1 and 2 appear 
to form on the surface of the material with phase 1 forming in the bulk.  Phase 1 
retains the equant granular structure observed in pervious structures but is more 
exposed than previously.  Phase 2 forms long extensions which from figures 54 (b) 
and c are seen to run either parallel to each other or grow perpendicular from a 
central spine.  Phase 1 is partially visible through phases 1 and 2 while no other 
surface morphologies are visible.  Phase 3 is present in distinct regions on the 
surface of the material and forms as dendrites that appear to have grown outwards 
from a central point. 
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3.3.3.1.4 9.35 Mol % Strontium 
Three different morphologies are clearly visible in figure 55 (a).  Phase 1 retains the 
granular  morphology observed in previous compositions.  Phases 1 and 2 are yet 
more clearly defined than in previous samples and lie predominantly isolated from 
each other.  Phase 2 presents thin extensions which are not seen to branch but extend 
from a single point, growing out in a manner comparable to spherulitic crystal 
growth.  Phase 3 forms much broader extensions than phase 2 and appears much 
more angular.  High magnification image 55 (c) shows that phase 2 has small voids 
between some of the domains.  Regions of a similar morphology to phase 1 can be 
observed within phase 3, however the voids are not visible. 
3.3.3.1.5 12.47 Mol % Strontium 
In figure 56 the phases are yet more differentiated.  Phase 2, while retaining its 
spherulitic growth, has become broader and has taken on an almost leaf like form 
with the large crystals having serrated edges.  Phase 3 remains more angular than 
phase 2 with the crystals having flattened ends that finish perpendicular to the long 
axis of the crystal.  A phase of similar morphology to phase 1 is visible within 
phase 3 at high magnification, figure 56 (c). 
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3  
Figure 52: SEM SE images at different magnifications of composition 0 Mol % 
strontium following heat treatment. 
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Figure 53: SEM SE images of composition 3.12 Mol % strontium following heat 
treatment with morphologically different regions labelled 1-3.  (b) magnified 
area encompassing regions 1-3.  (c) high magnification of region 2. 
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Figure 54: SEM SE images of composition 6.24 Mol % strontium following heat 
treatment with morphologically different regions labelled 1-3.  (b and c) higher 
magnification images from the top right of (a). 
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Figure 55: SEM SE images of composition 9.35 Mol % strontium following heat 
treatment with morphologically different regions labelled 1-3.  (b and c) higher 
magnification images of region 3. 
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Figure 56: SEM SE images of composition 12.35 Mol % strontium following heat 
treatment with morphologically different regions labelled 1-3.  (b and c) higher 
magnification examples from a second site on the powder. 
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3.3.3.2 EDX Maps 
EDX map scans of the surface of the glass ceramics were run to determine any 
inhomogeneous elemental surface distributions, figures 57 to 61. 
3.3.3.2.1 0 Mol % Strontium 
 
Figure 57: SEM and EDX images of the surface of composition 0 Mol % strontium 
following devitrification.  (a) SE (b) SE + EDX map overlay (c) Ca (d) Mg (e) 
Si and (f) P. 
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3.3.3.2.2 3.12 Mol % Strontium 
 
Figure 58: SEM and EDX images of the surface of composition 3.12 Mol % 
strontium following devitrification.  (a) SE (b) SE + EDX map overlay (c) Ca 
(d) Mg (e) Si (f) P and (g) Sr. 
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3.3.3.2.3 6.24 Mol % Strontium 
 
Figure 59: SEM and EDX images of the surface of composition 6.24 Mol % 
strontium following devitrification.  (a) SE (b) SE + EDX map overlay (c) Ca 
(d) Mg (e) Si (f) P and (g) Sr. 
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3.3.3.2.4 9.35 Mol % Strontium 
 
Figure 60: SEM and EDX images of the surface of composition 9.35 Mol % 
strontium following devitrification.  (a) SE (b) SE + EDX map overlay (c) Ca 
(d) Mg (e) Si (f) P and (g) Sr. 
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3.3.3.2.5 12.47 Mol % Strontium 
 
Figure 61: SEM and EDX images of the surface of composition 12.47 Mol % 
strontium following devitrification.  (a) SE (b) SE + EDX map overlay (c) Ca 
(d) Mg (e) Si (f) P and (g) Sr. 
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From figure 57 (b) it is clear that there are definable regions of varying composition.  
The lighter areas of the SE image correspond to regions high in calcium while the 
darker regions are high in magnesium.  The magnesium rich areas are high in silicon 
but low in phosphorous. 
In figure 58 the three phases previously observed can be clearly defined according to 
their relevant calcium, magnesium, silicon and strontium contents.  Phase 2 is high 
in calcium, silicon and strontium.  Phase 3 is high in magnesium and silicon while 
showing relatively lower levels of strontium and calcium compared to phase 2.  
Phase 1 is rich in strontium, calcium and phosphorous.  This is repeated for 
compositions 6.24, 9.35 and 12.46 Mol % strontium with the contrast between the 
phases increasing as the strontium content of the parent glass increases.  Strontium is 
present in higher amounts in phases 1 and 2 than in phase 3.  Magnesium is 
preferentially taken into phase 3 but is present in phase 2 at higher levels than in 
phase 1. 
3.3.3.3 EDX Point Scans 
Point scans were then performed on the individual phases.  Phase 2 was designated 
silicate phase A and phase 3 silicate phase B.  The location of the point scans are 
shown in figure 62.  The main constituents on the silicate phases are shown in 
figures 64 and 65. 
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Figure 62: the site of EDX point scans on devitrified compositions (a) 0 Mol % 
strontium (b) 3.12 Mol % strontium (c) 6.24 Mol % strontium (d) 9.35 Mol % 
strontium and (e) 12.47 Mol % strontium. 
Phase 1 was identified as an apatite due to its low silicon levels and high calcium 
and phosphate levels.  Phases 2 and 3 were identified as silicates due to their 
relatively high silicon and low phosphorous levels.  Phases 2 and 3 are subsequently 
referred to as silicate phase A and B, respectively. 
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Table 44: The results of the EDX point scans shown in figure 62. 
Comp. Phase 
Composition (Mol %) 
Ca Sr Mg Si O F P 
0 Mol % 
Strontium 
Apatite  17.72 0.00 0.63 9.04 66.10 0.87 5.65 
Silicate  16.37 0.00 1.65 12.16 65.10 0.76 3.97 
3.12 Mol 
% 
Strontium 
Apatite  14.93 2.53 0.53 8.86 66.29 1.05 5.82 
Silicate 
A 
15.97 2.11 0.36 11.52 65.05 0.78 4.22 
Silicate 
B 
13.83 1.62 3.36 12.57 63.60 0.66 4.36 
6.24 Mol 
% 
Strontium 
Apatite  13.15 6.13 0.85 9.17 63.35 0.32 7.03 
Silicate 
A 
15.12 3.20 2.37 11.45 63.58 0.53 3.75 
Silicate 
B 
11.03 2.72 3.55 12.04 66.42 0.52 3.73 
9.35 Mol 
% 
Strontium 
Apatite 
Phase 
10.56 7.45 1.05 10.70 63.16 0.73 6.34 
Silicate 
A 
9.04 7.17 2.66 12.29 64.37 0.26 4.21 
Silicate 
B 
10.50 4.24 4.39 13.43 63.15 0.37 3.93 
12.47 
Mol % 
Strontium 
Apatite 
Phase 
6.73 8.05 1.79 10.61 66.01 1.02 5.79 
Silicate 
A 
6.88 7.87 3.81 12.95 65.44 0.53 2.52 
Silicate 
B 
8.70 5.48 4.42 13.70 63.62 0.25 3.84 
 
Fluorine levels were below 1.05 Mol % in the apatite phase for all compositions 
tested.  Figure 63 shows the variation in the EDX point scans of the apatite phase.  
Oxygen was not included as it is not accurately quantified via EDX.  A 1.16 Mol % 
increase in magnesium levels was observed between compositions 0 and 
12.47 Mol % strontium.  The silicon levels remained constant for compositions 0 to 
6.24 Mol % strontium and increased for compositions 9.35 and 12.47 Mol % 
strontium.  Phosphorous levels increased between 0 and 6.24 Mol % strontium and 
decreased for subsequent compositions.  The calcium levels decreased and the 
strontium levels increased in the apatite phase as the strontium content of the parent 
glass increased. 
For composition 0 Mol % strontium, only one silicate phase (high silicon and low 
phosphorous) was identifiable.  Figures 64 and 65 show the variations in the main 
elements detected following point scans of the silicate phases.  It can be seen that the 
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silicon in both phases remained relatively constant, increasing by less than 1 Mol % 
between compositions 0 and 12.47 Mol % strontium.  For the strontium containing 
compositions, two silicate phases were identified, silicate phases A and B.  A drop 
in silicon was observed between compositions 0 and 3.12 Mol % strontium for 
silicate phase A while an increase was observed in silicate phase B.  The 
phosphorous levels of the silicate phases decreased with increasing strontium 
substitution into the parent glass.  In silicate phase A, the magnesium levels were 
much lower than silicate phase B.  The strontium and calcium levels were higher in 
silicate phase A than silicate phase B.  The calcium levels in both silicate phases A 
and B decreased and strontium levels increased as the strontium level of the parent 
glass was increased.  In silicate phase A, the strontium levels exceed the calcium 
levels at composition 12.47 Mol % strontium; this was not the case for silicate phase 
B.  Silicate phase A consistently contained more strontium than magnesium.  This 
was the not case for silicate phase B for compositions 3.12 and 6.24 Mol % 
strontium but magnesium and strontium levels were the same for composition 
9.35 Mol % strontium and strontium levels were higher for composition 
12.47 Mol % strontium. 
 
Figure 63: The effect of parent glass strontium content on the composition of the 
apatite phase measured using EDX. 
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Figure 64: The effect of parent glass strontium content on the composition of silicate 
phase A measured using EDX. 
 
Figure 65: The effect of parent glass strontium content on the composition of silicate 
phase B measured using EDX. 
A comparison of Mg, Ca and Sr content variation for the silicate phases is shown in 
figure 66.  It can be seen that for compositions 3.12 to 12.47 Mol % strontium, 
strontium levels were consistently higher and magnesium levels lower in silicate 
phase A than silicate B.  Calcium levels were higher for silicate phase A for 
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compositions 3.12 and 6.24 Mol % strontium but dropped lower than silicate phase 
B for compositions 9.35 and 12.47 Mol % strontium. 
 
Figure 66: Comparison of the composition of silicate phases A and B at different 
parent glass strontium contents. 
3.4 Discussion 
The aim of this chapter was to determine what crystalline phases, if any, could be 
formed in the glass following a controlled heat treatment.  Differential scanning 
calorimetry (DSC) was used to observe any thermodynamic events that occurred in 
the glass during heating.  To best understand the process of devitrification of the 
glass, the thermodynamic events will be discussed in the order in which they occur, 
starting with the lowest temperature and finishing with the highest, before discussing 
the material as a whole. 
The first event observed during heating is the glass transition temperature, Tg.  The 
glass transition is an endothermic event where an amorphous or polymeric material 
transforms from a brittle  material to a molten or rubber-like one.  The glass 
transition recorded at 10K.min
-1
 for the 0 Mol % strontium composition was 
750.4°C, this is in agreement with previously reported values for glasses with a 
similar composition.  Kokubo [135] reported a Tg of 750°C for particles of 44µm 
average diameter when a heating rate of 5K.min
-1
 was used.  Goel [86, 109] reported 
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a Tg within the range of 740-755°C for glasses composed of a higher magnesium to 
calcium ratio.  Cannillo [110] reported a lower Tg of 719.85°C for the same glass 
composition formed via the melt quench route but with a smaller particle size of 
<38µm.  Likitvanichkul [60] measured Tg of bulk glass rods using dialometric push 
rods at a heating rate of 3K.min
-1
 and recorded a value of 740°C.  The addition of 
strontium into the parent glasses resulted in a reduction in the glass transition 
temperature.  This was observed by Goel [86] in glasses in the same system, but 
with higher magnesium to calcium ratios, where a reduction in Tg from 745°C to 
738°C was observed following a substitution of SrO for CaO up to a maximum of 
3:1 Ca:Sr molar ratio.  Hill [87] observed a reduction in Tg in a SiO2-Al2O3-P2O5-
CaO-CaF2 system glass with additions of strontium.  A maximum reduction of 34°C 
was observed with additions up to a 2:3 Ca:Sr molar ratio but an increase was 
observed for the 100 Mol % strontium composition.  A reduction in Tg with 
strontium for calcium substitution in BioGlass 45S was also reported by, O’Donnel 
[69, 136], Salman [70], Fredholm [81] and Fujikura [68] where a reduction of 32°C 
was observed in Tg up to a 1:1 Ca:Sr molar ration and a further 30°C up to 
100 Mol % strontium substitution for calcium.  The reason for the reduction in Tg 
can be explained by looking at the connectivity of the glass network.  Ray [137] 
proposed that glass could be treated as an inorganic polymer of oxygen (bridging-
oxygens, BOs) cross-linked with network formers (NFs) with chains modified by 
cations and hydrogen that can break cross-links (producing non-bridging-oxygens, 
NBOs) or distort the network via expansion.  This introduces the idea of network 
connectivity, NC, equation 22, which can be used to determine the stability of the 
network [136]. 
   
            
     
 
Equation 22 
The coordination distribution, Q
n
, of [SiO4]
4-
 tetrahedrons can also be used to 
describe the polymerised state of the glass.  One Q
n
 species consists of [81, 138]: 
 One Si4+ 
 n/2 BO 
 (4-n) NBO 
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 (4-n) alkali metal ions or (4-n)/2 alkaline earth cations to equilibrate the 
electronic charge if NBOs are present. 
Calcium and strontium ions each produce 2 NBOs, thus substituting Sr for Ca at a 
molar ratio will not produce a change in the network connectivity of the glass.  They 
also present the same charge and so will not produce a change in the distribution of 
Q
n
 species in the glass.  This was observed in the systems mentioned previously [68-
70, 81, 86, 87, 136] where the effect of strontium on the network connectivity and 
silica coordination was observed using magic angle spinning nuclear magnetic 
resonance (MAS-NMR) and Fourier transform infrared (FTIR) spectroscopy.  In all 
samples Sr was found to have no effect on the connectivity or Q
n
 distribution of the 
glass network.  Equation 22  does not however take into account the distortion of the 
network due to variations in field strengths and charge-to-size ratios [85].  This was 
observed in the discussed glasses [68-70, 81, 86, 87, 136] and also in the novel 
compositions developed here (see chapter: Glass Production).  The expansion of the 
network is a result of strontium ions being larger than calcium and this leads to a 
greater degree of distortion and a weaker network, due to weaker Sr-O bonds, 
producing a reduced barrier for transition resulting in a drop in the glass transition 
temperature [68, 81, 86, 125, 136]. 
The next thermodynamic event that occurs is an exothermic peak, indicating a 
crystallisation event.  For composition 0 Mol % strontium, 45-90µm particles and a 
heating rate of 10K.min
-1
, the exotherm/crystallisation onset occurred at 856.7°C 
and peaked at 898.0°C.  XRD of samples heated to TO-15 indicate that the phase 
forming is an apatite with an activation energy calculated as 508.01kJ.mol
-1
.  A 
match was achieved for fluorapatite (ICDD: 04-009-4021).  This is in keeping with 
previous reports of the same system where the first exotherm was attributed the 
formation of apatite crystals.  For particles <45µm in size and a heating rate of 
5K.min
-1
, Kokubo [135, 139] recorded a peak temperature of 870°C and identified 
that this peak was attributed to the crystallisation of both fluorapatite and oxyapatite.  
A heating rate of 1K.min
-1
 and hold of 4 hours at 870°C produced a material that 
was 35% apatite and 65% glass by weight[139], comparable to the 0 Mol % 
strontium composition, which with a heating rate of 10K.min
-1
 and hold at 855°C for 
2 hours was composed of 37% apatite and 63% glass.  Calver [140] reported the 
formation of a fluorapatite/oxyapatite solid solution that had a peak at 887°C.  
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Cannillo [110] reported the formation of an oxyapatite phase with an activation 
energy of 385±11kJ.mol
-1
 and an onset at 863°C and peak at 886.85°C.  
Likitvanichkul [60] reported an apatite phase that formed with an activation energy 
of 514kJ.mol
-1
 and exothermic peak at 880°C.  Magallanes-Perdomo [141] reported 
the formation of a calcium deficient apatite for samples heated to 900°C.  The 
variation between the reported values is likely the result of different analysis 
methods such as mass of the sample, heating rate, particle size, atmosphere, use of 
DSC/DTA, quality of calibration and variations in the composition of the parent 
glass.  The DSC used in this report was calibrated with 4 pure high temperature 
standards to ensure accuracy.  A mass of 20±2mg was used for all samples to ensure 
peak temperatures were accurate.  The temperature of the exothermic peak shifts 
with changing sample mass while onset remains constant [142].  In metals, the onset 
is a clear, well defined point.  However, in these glass ceramics the onset is more 
gradual due to variations and distortions in bond lengths and as such the peak 
position is more often given despite its reliance on sample mass. 
The position of the peak of the first exotherm reduced with increasing strontium 
substitution.  This was seen following the substitution of strontium into apatite-
mullite glass ceramics [87] where a reduction in Tp1 (fluorapatite) was observed up 
to a 2:1 Ca:Sr substitution, an increase was seen following the next substitution to 
2:3 Ca:Sr.  The same behaviour was observed following the substitution of 
strontium into BioGlass [68, 81, 85].  However, in the case of BioGlass the first 
exotherm is attributed to the formation of both a sodium calcium silicate and sodium 
calcium phosphate phase and not an apatite.  The addition of strontium had no effect 
of the formation of the sodium calcium silicate phase but suppressed the formation 
of the sodium phosphate phase [85].  It is proposed that the reason for the reduction 
in Tp1 is due to the distortion and destabilisation of the glass network due to the 
larger Sr
2+
 ion.  As with the glass transition, this results in less resistance to 
transition and the transformation to a crystalline state can progress more readily.  It 
should be noted that very little change was observed in the activation energy of the 
formation of the apatite phase.  An increase in the temperature of the first exotherm 
was observed by Goel [86] following the addition of strontium into a high 
magnesium A-W system.  The exotherm corresponded to predominantly diopside 
(CaMgSi2O6) and also fluorapatite.  Strontium was taken into the fluorapatite phase 
but not reported in the diopside phase and thus a reduction in the amount of 
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available calcium with increasing strontium substitution may force the 
nucleation/growth peak to a higher temperature. 
XRD reveals that strontium was taken into the fluorapatite crystal structure of the 
novel materials tested.  This resulted in a change in diffraction file being used 
between compositions 3.12-6.24 Mol % strontium from fluorapatite (FA) to 
strontium fluorapatite (SrFA), ICDD: 04-009-4021 to 04-009-1806 respectively.  An 
increase in the intensity of the maximum fluorapatite peak was observed with 
increasing strontium content of the parent glass, suggesting incorporation of a more 
electron dense element   The uptake of strontium produced a shift in peak position to 
lower °2θ/larger d-spacing, indicating expansion of the crystal planes.  The Rietveld 
refinement of the crystal phases confirmed the expansion of the unit cell along both 
the a and c axis, resulting in a linear unit cell volume increase up to 9.35 Mol % 
strontium and only a small increase up to 12.47 Mol % strontium.  It should be noted 
that successful refinements could be produced for composition 3.12 Mol % 
strontium using either FA or SrFA diffraction data with each producing the same 
unit cell volume, indicating accurate unit cell determination.  The unit cell volume 
for the apatite phase formed in the 0 Mol % strontium composition had a unit cell 
volume of 534.00 nm
3
, larger than the reference pattern, which presented a volume 
of 527.74nm
3
, suggesting the crystals formed were not of a stoichiometric 
composition.  Though the reference diffraction pattern had to be changed in order to 
allow for refinement, the linear change in unit cell volume with increasing strontium 
suggests the formation of a solid solution of fluorapatite and strontium fluorapatite 
and not two distinct phases, as predicted by Vegard’s law [87].  The maximum unit 
cell volume measured was 564.39nm
3, if Vegard’s law is obeyed and no magnesium 
or other elements are substituted into the system then the strontium fluorapatite 
crystals would have a calcium to strontium ratio close to that of the reference, 
1.35:3.65 Ca:Sr.  Similar observations were made by Hill [87] in apatite-mullite 
glass ceramics where the addition of strontium produced a solid solution in the 
fluorapatite phase with all calcium sites being fully replaced with strontium 
following 100 % substitution of strontium for calcium.  The uptake of strontium into 
the FA phase was also observed in glass ceramics by Goel [86].  Sr incorporation 
into hydroxyapatite has been reported for crystals produced via a wet chemical 
route [71, 91] where, again, a shift towards smaller °2θ was observed with 
increasing strontium substitution.  The Sr
2+
 ions have been shown to preferentially 
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occupy the CaII site in the hexagonal crystal structure.  This matches the 
information in the reference diffraction pattern, see table 45. 
Table 45: Position and site occupancy factors of ICDD: 04-009-1806 strontium 
calcium phosphate fluoride. 
No. Name Element 
Position Site 
Occupancy 
Factor 
X Y Z 
1 O1 O 0.4886 0.1528 0.747 1 
2 O2 O 0.5356 0.1212 0.23 1 
3 F1 F 0 0 0.286 1 
4 SR1 Sr 0.33333 0.66666 0 0.3 
5 O3 O 0.329 0.257 0.091 1 
6 SR2 Sr 0.2388 0.9853 0.2591 0.87 
7 O4 O 0.356 0.264 0.434 1 
8 CA1 Ca 0.33333 0.66666 0.5049 0.25 
9 P1 P 0.4005 0.3708 0.263 1 
10 CA2 Ca 0.33333 0.66666 0 0.7 
11 CA3 Ca 0.2388 0.9853 0.2591 0.13 
12 SR3 Sr 0.33333 0.66666 0.5049 0.75 
 
The width of the first exotherm got smaller with increasing strontium substitution, 
this resulted in an onset that increases between composition 0-6.24 Mol % strontium 
before reducing between 6.24-12.47 Mol % strontium [60].  The broad peak for 
composition 0 Mol % strontium could suggest a surface nucleation process, 
however, the peak temperature did not vary much with particle size and so a bulk 
nucleation process is the likely mechanism.  This is supported by the results of 
Kokubo [135] who showed the apatite phase to form via a bulk nucleation process.  
Hill observed that strontium substitution for calcium shifted apatite nucleation in 
apatite-mullite glass/glass-ceramics from a bulk to a surface nucleated process.  No 
large change in nucleation was observed in the apatite peak temperature with 
changing particle size for any of the novel strontium containing glasses tested in this 
report. 
A second exotherm is visible at temperatures above 940°C.  Heating of the 0 Mol % 
strontium composition to TP1+10 and TP2+10 reveals that this peak was attributed to 
the crystallisation of wollastonite-2M, ICDD:04-009-5600, with an onset at 947.9°C 
and a peak of 963.8°C.  The formation of monoclinic wollastonite-2M (Wol-2M) 
has been reported previously for the temperature range 900-1200°C [60, 88, 110, 
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111, 135, 140, 141].  The weight percentage of wollastonite increases between 
TP1+10 and TP2+10.  The hold at TP1+10 results in the formation of wollastonite at 
the expense of the apatite phase, with the glass weight percentage remaining the 
same as a hold at TO1-15.  Whereas a hold at TP2+10 results in an increase in the 
overall crystallinity of the material and an increase in the wollastonite to fluorapatite 
ratio indicating that higher temperatures favours wollastonite formation.  TP2 
exotherms corresponding to wollastonite were reported as 912°C and 1008°C for 
<90µm powders and frits respectively, by Likitvanichkul [60], with an activation 
energy of 374±34kJ.mol
-1
 for the frits and 346±30kJ.mol
-1
 for the fine particles.  
This was below the activation energy reported for the first exotherm 
(514±57kJ.mol
-1
), in keeping with the results for composition 0 Mol % strontium.  
Both Calver [140] and Cannillo [110] reported TP2s of 927°C for fine particle 
powders with Calver [140] reporting an increase to 1025°C for frits.  Cannillo 
reported an activation energy of 550±16kJ.mol
-1
, higher than the activation energy 
for the apatite phase.  The temperature of TP2 recorded for 0 Mol % strontium, 45-
90µm size fraction was within the temperature ranges reported in the literature for 
fine particles and frits. 
XRD showed expansion of the wollastonite structure following strontium 
substitution into the parent glass.  A linear increase was observed in the unit cell 
volume, suggesting a solid solution forming.  The unit cell volume ranged from 
758.87 to 793.75 Å
3
, smaller than or equal in size to the unit cell volume of the 
reference material, 794Å
3
.  This suggests that a smaller element may be substituted 
into the crystal structure, most likely magnesium, this will be examined further when 
the bulk material is discussed.  The expansion of the network with increasing 
strontium suggests that a larger element is being taken into the structure.  A residual 
peak around 45°2θ becomes more apparent with increasing strontium substitution.  
In the 12.47 Mol % strontium sample this was matched to pseudowollastonite, 
ICDD: 04-012-1776, a high temperature polymorph of wollastonite.  Labelling of 
this form of wollastonite varies in the literature [71, 73, 143-145] but for the purpose 
of this work pseudowollastonite will refer to the form that produces powder 
diffraction peaks around 45°2θ and not around 30°2θ (as in the case of wollastonite-
2M) and has been shown by Yang [146] to be a monoclinic crystal with C2/c 
symmetry.  This behaviour has been observed in wollastonite crystals formed by a 
wet chemical and sol-gel routes [71, 73, 145].  Carrodegaus [145] showed that the 
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transformation from wollastonite-2M to pseudowollastonite occurred at 
temperatures above 1125°C and that the transformation was permanent in that the 
pseudowollastonite form was retained following cooling.  Wu showed that the 
transformation temperature was reduced following the substitution of strontium for 
calcium.  Wollastonite samples that did not contain strontium and were sintered at 
1100°C were found to contain wollastonite-2M only, samples that contained 5% 
strontium or greater produced pseudowollastonite only and intermediary 
compositions produced a mixture of the two phases.  A residual phase of strontium 
calcium magnesium silicate (SCMS) was found in the sample having fit 
pseudowollastonite to the XRD trace for 12.47 Mol % strontium.  This phase was 
not found in samples that were fit with Wol-2M, however this does not mean that it 
wasn’t present.  Wol-2M may have been fit to the SCMS peaks and obscured any 
residuals.  This may suggest that a solid solution is not forming in the material and 
in fact up to 3 distinct calcium silicates are forming in the material: wollastonite-2M, 
pseudowollastonite and the strontium calcium magnesium silicate. 
A large increase in the temperature of TP2 was observed with strontium substitution.  
The increase was linear between 0-6.24 Mol % strontium and the rate of increase 
reduced between 6.32-12.47 Mol % strontium.  The delay in onset is observed in the 
XRD results of samples heated to TP1+10 where wollastonite-2M was detected in 
samples 0-6.24 Mol % strontium but not in samples 9.35 and 12.47 Mol % 
strontium.  The activation energy reduces rapidly between 0-3.12 Mol % strontium 
and stabilises between 6.24-12.47 Mol % strontium.  The change in activation 
energy suggests that the composition of the phases formed may be approaching a 
metasilicate eutectic point.  The reduction in activation seems to contradict the 
increase in peak temperature with increasing strontium substitution.  However, TP2 is 
an indication of the maximum rate of transformation and so will not always match 
trends in the activation energy due to the influence of other factors.  An example 
being that the two phases do not form independently and so the formation of an 
initial phase will strongly influence the formation of subsequent phases.  The 
increase in peak temperature may be due to the reduction in the onset temperature of 
the apatite phase.  The increased crystallisation of the apatite phase will remove 
divalent cations from the residual glass.  The glass will then be depleted with 
respects to Ca
2+
/Sr
2+
, providing a reduced reservoir from which to form the calcium 
silicate phase.  This is supported by the observed change in peak shape: TP2 becomes 
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less intense and wider with increasing strontium substitution, indicating a loss of 
nuclei [147].  The loss of Ca
2+
/Sr
2+
 from the glass network will also increase the 
viscosity of the amorphous phase further inhibiting subsequent transformations [148, 
149]. 
For all compositions tested, the position of TP2 shifted to higher temperatures 
following an increase in particle size indicating a surface nucleation process.  The 
exotherm also gets wider and not as intense/high as the particle size increases, 
indicating a loss of nuclei, again supporting a surface dominated nucleation process.  
Wollastonite is known to surface nucleate in apatite-wollastonite glass ceramics [60, 
135, 139, 140, 150], an issue that has prevented the use of cast devices and limited 
its use to sintered powders.  The addition of strontium reduces the shift observed 
between different particle sizes, but in all samples an increase of at least 29.3°C 
between <45µm and 1-2mm fractions indicates that TP2 was still surface nucleation 
dominated.  The reduction in dependence on particle size may be due to an overall 
reduction in the number of nuclei, as observed by the change in peak profile, 
minimising the effect of surface nucleation site availability, which may have 
previously been a limiting factor. 
Having examined the thermodynamic events individually it makes sense to consider 
them as a whole.  Composition 0 Mol % strontium presents few surface details 
visible via SEM.  High magnification images reveal small domains of interlocked 
crystals similar to that observed by Kokubo [135].  Magallanes-Perdomo observed 
more distinct domains, though these had been etched, which were composed of 
interlocked apatite and wollastonite crystals.  The weight ratio of 
apaite:wollastonite:residual glass for composition 0 Mol % strontium heated at 
10K.min-1 to 1050°C and held for 2 hours was 32.9:26.7:40.4.  Kokubo [139] 
reported a ratio a 35:40:25 for samples held at 1050°C for 4 hours.  The increase in 
crystallinity may be a result of the extended hold, while the ratio of crystal phases 
remains comparable to the values reported here.  Magallanes-Perdomo [88] reported 
a ratio of 44.8:28.0:27.2, the increase in apatite phase compared to composition 0 
Mol % strontium may be due to an extended 2 hour hold at 820°C (which would 
favour apatite nucleation) before the final 1 hour hold at 1100°C. 
XRD revealed an increase in the ratio of apatite to silicate with increasing strontium 
substitution into the parent glass.  It should be noted however that the refinement did 
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not take into account the variation in peak intensity that would occur with strontium 
substitution which would influence the quantifications.  This is clearly visible for 
composition 3.12 Mol % strontium which was modelled using both fluorapatite and 
strontium fluorapatite references.  The fluorapatite reference will have overestimated 
the apatite content where-as the strontium containing reference will have 
underestimated it.  This also true for the silicate phase where the uptake of strontium 
in the crystal will cause its weight ratio to be over-estimated. 
The addition of strontium resulted in the formation of more clearly defined surface 
structures.  In composition 3.12 Mol % strontium a phosphorous rich and silicon 
depleted phase is visible, attributed to the strontium fluorapatite phase.  Two silica 
rich phase are visible.  One phase, depleted in magnesium, presents a structure 
similar to that observed by Magallanes-Perdomo, which was attributed, via 
transmission electron microscopy, to apatite and wollastonite crystals within a glass 
matrix.  The second silicate phase is higher in magnesium and showed no visible 
surface features.  The addition of strontium further separated out these phases with 
their boundaries becoming more and more distinct.  The area of exposed apatite rich 
phase increases with increasing strontium substitution into the parent glass.  This 
complements the XRD data which shows an increase in the ratio of apatite to 
silicate.  The silicate phase has been shown to be predominately surface nucleating 
and so a reduction in its overall weight contribution is likely to result a loss the 
phase from the material surface, as observed.  Silica is detected in the apatite phase, 
supporting Magallanes-Perdomo’s [88, 89, 141] observation of distinct domains 
containing apatite, wollastonite and residual glass.  The domains in the compositions 
tested do however look like the crystals that were formed by Kokubo in apatite glass 
ceramics containing no wollastonite [135].  Zhang [91] reported hydroxypatite 
crystals that grew in size with strontium substitution and their morphology and 
shape matches the crystals visible in compositions 6.32-12.47 Mol % strontium.  
The strontium content of the apatite rich phase increased with substitution, 
complementing the XRD results, while an increase in magnesium levels was also 
detected, suggesting magnesium may be taken into the structure to relieve stresses 
induced by the expansion on the unit cell by the larger strontium ions.  From EDX 
of the two isolated silicate phases it is clear strontium is taken into both of their 
crystal structures.  Phase A is definable from phase B by its lower magnesium 
content and more spherulitic morphology compared to phase 2’s more rod like 
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shape.  Phase A had an increased capacity to substitute strontium for calcium, a 
transformation which was accompanied by the uptake of magnesium, possibly to 
relax the induced lattice stresses.  Phase B already contained a higher ratio of 
magnesium and this may have limited its ability to take on strontium.  The increase 
in the presence of silicate phase B with increasing strontium coincides with an 
increase in the intensity of peaks attributed to pseudowollastonite.  The crystals 
display the morphology and size of the pseudowollastonite crystals reported by 
Carrodeguas [145].  The range of silicate phase compositions is supported by the 
XRD results.  Although for compositions 0-9.35 Mol % strontium only a single 
phase was matched to the silicate phase, a larger value of U was determined.  U 
represents the peak broadening due to stress caused by compositional 
inhomogeneities.  A value of <0.2 is usually expected but in the results reported here 
U exceeds 1.5.  This can be explained by taking the compositional range of the 
silicate phase from the EDX data and using data from the ICDD database to 
calculate a theoretical value for U that would be produced by the measured 
compositional inhomogeneity.  The powder diffraction files of quality Star or Index 
were found for monoclinic forms of CaSiO3, SrSiO3, MgSiO3 and MgCaSi2O6 and 
the unit cell volume and number of elemental units were taken from the data, table 
46.  The average divalent cation radius was calculated utilising the ionic radii 
reported by Shannon [83] with all three cations having a coordination number of 6 
[111].  The primitive volume was calculated (volume divided by number of units, Z) 
and plotted against the calculated average ionic radii and a linear regression fitted, 
figure 67. 
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Figure 67: Calculation of the theoretical primitive volumes. 
The EDX data of the silicate phases was then used to determine the range of 
compositions of (xMg.yCa.zSr)SiO3,where x+y+z=1, that were present in the 
samples in the form of silicate phases A and B.  Unit volumes were then calculated 
for the theoretical compositions using the average radii vs. unit volume fit and 
finally unit cell dimensions were determined (the cube root of the volume).  These 
values were taken as the minimum (amin) and maximum (amax) values.  The strain, ε, 
was then calculated using equation 23.  The maximum reported strain was measured 
in composition 3.12 Mol % strontium and so will be examined here.  The average 
strain was calculated as 0.662%, see table 47.  A modified version of the Scherrer 
equation that assumes no broadening due to size can be used to determine the strain 
broadening parameter, UTHEO, utilising the instrumental strain broadening, USTD, 
measured from a silicon standard, equation 24.  A theoretical value of 3.190 was 
determined, the maximum value of U observed experimentally, UObs, was 3.199, this 
relatively high value is thus justified due to the large strains induced by the 
formation of phases with varying composition, as observed with EDX, see table 47 
for a summary of the values used.  A variation in the composition of the evolved 
phases can be explained by considering the environment in which they form.  As 
crystals form in the glass they remove elements from it.  This leaves regions of glass 
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depleted in these elements causing subsequent crystals to form with varying 
compositions and even form new phases. 
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Table 46: Calculation of the average ionic radius and primitive volumes of 
monoclinic cationic silicates from the literature. 
ICDD 
Ref. 
Grade Comp. 
Cation Ratio 
Cell 
Volume 
(Å
3
) 
Z 
Average 
Cation 
Ionic 
Radii 
(Å) 
Primitive 
Volume 
(Å
3
) 
Mg Ca Sr 
04-
009-
5600 
S CaSiO3 0 1 0 794.34 12 1.00 66.20 
00-
034-
0099 
I SrSiO3 0 0 1 891.35 12 1.18 74.28 
00-
035-
0610 
S MgSiO3 1 0 0 415.9 8 0.72 51.99 
00-
019-
0239 
I MgCaSi2O3 1 1 0 439.55 8 0.86 54.94 
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Table 47: The calculation of the strain and strain broadening factor for composition 
3.12 Mol % strontium. 
Phase 
Element Average 
Cation 
Ionic 
Radii (Å) 
Primitive 
Volume 
(Å
3
) 
Estimate
d a (Å) Mg Ca Sr 
Silicate 
Phase A 
0.4 16 2.1 1.01 65.70 
4.035 
(amax) 
Silicate 
Phase B 
3.4 13.8 1.6 0.96 63.14 
3.982 
(amin) 
 
 y (Å) x (Å) ε (%) UStd UTheo 
Max 
UObs 
Results 0.027 4.009 0.662 0.009 3.190 3.199 
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Chapter 4: Scaffold Formation 
4.1 Introduction 
The previous chapters described the synthesis and devitrification of novel parent 
glasses and glass-ceramics, this chapter looks at the application of the material to 
form porous bone replacement scaffolds for tissue engineering.  Bone replacements 
need to be porous to best mimic native bone and allow cellular in-growth but must 
also maintain a mechanical strength that is matched to their application.  This 
section of work focuses on assessing the formability of the novel powders. 
Porosity was achieved by the sintering of loose powders, with sintering being 
terminated prior to complete densification and the resulting loss of porosity.  Porous 
bars were formed from the powders using graphite moulds.  The level of sintering 
that occurred in the bars was assessed visually using SEM imaging of the surface of 
the bars and also their cross-sections.  A bone replacement material must not only be 
biologically attractive but must also be mechanically strong, a property affected by 
both the macro-structure of the material and its compositional makeup.  With this in 
mind, the degree of sintering and mechanical strength of the bars was assessed via a 
three-point bend test with the fracture surfaces examined via SEM and EDX. 
4.2 Experimental Methodology 
4.2.1 Sintering of Porous Bars 
To form uniform structures, the 45-90µm glass particle fractions were transferred to 
carbon moulds and heat treated.  The mould dimensions are shown in figure 68.  
Moulds were milled from rods of grade EE250 graphite (Tokai carbon).  The moulds 
also included a 3mm thick lid machined from the same material.  Both the mould 
and lid were cleaned prior to use with both a cloth and compressed air.  To ensure 
repeatability, the moulds were filled using a layer by layer method with glass being 
swept across the surface and into the moulds until they were full.  Lids were then 
placed on the moulds and the samples heat treated in a Elite BCF 13/12-2416 
furnace with a heating rate of 10K.min
-1
 and a 2 hour hold at 1050°C. 
- 129 - 
 
Figure 68: (left) schematic of the mould with dimensions marked and (right) 
photograph of the finished mould. 
4.2.2 Scanning Electron Microscopy 
The scaffolds were then cut into 3mm long sections using an Accutom with a 
diamond blade fitted.  The native/outer surface and also the cross-section surfaces of 
the scaffolds were then imaged using a scanning electron microscope (Hitachi 
S3400N variable pressure SEM) using the proprietary software.  All samples were 
secured to aluminium stubs using adhesive conducting carbon pads.  Silver dag was 
applied to the edges of the samples to minimise charge build up and all samples 
were sputtered with a 6nm thick gold coating.  The level of sintering was assessed 
by observation of the shape and morphology of the particles visible at the surface.  
The level of densification was measured from the cross-section images with residual 
pore size being measured using imageJ software. 
4.2.3 3-point Bend Test 
Sintered bars were mechanically tested using a Universal Testing Machine, Lloyd 
LR10K, with a 500N head.  Test parameters were chosen to comply with BS ENISO 
6872:EN, Dentistry – Ceramic materials [115].  The width and breadth of each bar 
was measured using a screw gauge micrometer.  Measurements were made in the 
central 1/3
rd
 of the samples, as this was where the samples were loaded and would 
be most likely to fail.  Each measurement was made three times per sample and an 
average taken.  A three point bend test was performed on the bars using a head 
diameter of 1.5mm, cross-head span of 15mm and head speed of 2mm.min
-1
, see 
figure 69.  Care was taken to ensure that the samples were correctly aligned. 
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Figure 69: The 3-point bend test setup. 
10 samples were tested per group (n=10).  The fracture stress was calculated from 
the peak force.  In instances where multiple fractures occurred, only the single 
highest value was recorded.  The flexural strength (σflex) was then determined using 
equation 25, where F is the peak force, l the head spacing, w is the sample width 
(mould width) and b the breadth (mould depth). 
      
   
    
 
Equation 25 
Statistical analysis was performed using SPSS software.  The normality of the 
results was first determined using a Shapiro-Wilk test.  Significant differences were 
then determined using an ANOVA test for normally distributed data.  A post-hoc 
Tukey test was used for multiple comparisons when a significant difference was 
observed. 
The fractured samples were then cut 2mm from the fracture surface using the 
Accutom with a diamond saw blade.  The samples were then prepared for imaging 
using a Hitachi S3400N variable pressure SEM, as previously described.  Fracture 
surfaces were also imaged using EDX, Bruker XFlash, and Quantax software, to 
observe any local compositional inhomogeneities. 
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4.3 Results 
4.3.1 Bar Surface 
Sintered porous bars were successfully formed from all glass compositions.  
Following heat treatment, the graphite mould outer surfaces had degraded but the 
inner surfaces had not.  The bars were easily removed from the moulds post heat 
treatment.  The moulds were not reused.  The surfaces of the sintered bars were 
imaged using a scanning electron microscope, figures 70 and 71. 
 
Figure 70: SEM backscattered electron images of the surface of the bars formed 
following a heating rate of 10K.min
-1
 and 2 hour hold at 1050°C.  (a) 0 Mol % 
strontium (b) 3.12 Mol % strontium (c) 6.24 Mol % strontium (d) 9.35 Mol % 
strontium and (e) 12.47 Mol % strontium. 
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Figure 71: High magnification secondary electron images of the bar surfaces.  
(a) 0 Mol % strontium (b) 3.12 Mol % strontium (c) 6.24 Mol % strontium 
(d) 9.35 Mol % strontium and (e) 12.47 Mol % strontium. 
From figure 70 it can be seen that a well sintered structure was achieved in all the 
compositions tested.  The particles have clearly fused forming necks, and the 
angular structure of the glass particles has been lost with the particles becoming 
rounded.  The sintering process has been terminated prior to complete densification 
and large micro pores are visible from the surface.  Compositions 0-6.24 Mol % 
strontium produced a network that contains thicker necks than compositions 9.35 
and 12.47 Mol % strontium.  Composition 6.24 Mol % strontium has the thickest 
necks of all the samples.  In compositions 9.35 and 12.47 Mol % strontium the 
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particles appeared more rounded than in the lower strontium containing 
compositions. 
The high magnification images, figure 71, reveal that the surface architecture 
previously observed when the powders were heat treated without moulds has been 
retained.  As with the previous samples, increasing the strontium content of the 
parent glass results in a breakdown of the surface, exposing what has previously 
been identified as apatite crystals.  The surface nucleating silicate crystals are clearly 
definable in the higher strontium containing compositions and their prevalence 
decreases with increasing strontium substitution. 
4.3.2 Bar Cross-Sections 
Bars were cross-sectioned and imaged to better show the residual porosity, figures 
72 and 73. 
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Figure 72: Low magnification SEM secondary electron images of the bar cross-
sections.  (a) 0 Mol % strontium (b) 3.12 Mol % strontium (c) 6.24 Mol % 
strontium (d) 9.35 Mol % strontium and (e) 12.47 Mol % strontium. 
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Figure 73: High magnification SEM secondary electron images of the bar cross-
sections.  (a) 0 Mol % strontium (b) 3.12 Mol % strontium (c) 6.24 Mol % 
strontium (d) 9.35 Mol % strontium and (e) 12.47 Mol % strontium. 
From figure 72 it can be seen that residual pores were present throughout the bars.  
In all compositions the porosity was evenly distributed, with pores present at both 
the centre and the periphery of the cross sections.  There was no discernible 
difference between the porosity of compositions 0-9.35 Mol % strontium.  However 
there was a large decrease in the both the number and size of the pores in the 
12.47 Mol % strontium sample.  This is highlighted further in figure 73.  
Compositions 0-9.35 Mol % strontium were composed of pores of varying size and 
shape with areas of pore collapse that have formed a highly interconnected structure.  
From figure 73 (e), composition 12.47 Mol % strontium, it is clear that pores have 
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both shrunk and been occluded.  The area occupied by material has increased 
dramatically and individual particles are no longer visible.  An attempt was made to 
quantify the pore size distribution but this was not possible due to their irregular 
shape.  In figure 74 it can be seen that the dimensions of the pores could not easily 
be described using a single measurement, as would be the case if they were 
spherical.  The width of the pores ranged from a few microns up to 200µm.  The 
interconnectivity is also highlighted in figure 74.  The continuation of the 
interconnectivity throughout the materials was confirmed using a coloured ink.  In 
samples 0-9.35 Mol % strontium, the ink was drawn up into the scaffolds and 
permeated the whole cross-section.  In composition 12.47 Mol % strontium the ink 
remained on the scaffold surface, indicating that the porosity was not 
interconnected. 
 
Figure 74: An example of the range of sizes and shapes of the pores present in the 
bar cross-sections.  The red bordered area highlights an example of 
interconnected porosity. 
The mechanical integrity of the bars was then tested using a 3-point flexural 
strength, figure 75 and tables 48 and 49, all errors are the standard deviations 
calculated directly from values or by the propagation of errors method.  All groups 
were found to be normally distributed, according to both Shapiro-Wilks and 
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Kolmogorov-Smirnov methods.  Statistical significance was then assessed using a 
one-way ANOVA analysis and the post-hoc Tukey method.  Also included are the 
sizes of the sintering windows for the parent glasses.  The sintering windows were 
calculated from the DSC results, see chapter 3, whereby the sintering window is 
defined as the difference in temperature between the first exotherm and the glass 
transition temperature (TP1-Tg).  The size of the sintering window decreased with 
increasing strontium levels, the rate of reduction increased with increasing 
strontium.  A significant reduction in the flexural strength of the bars was observed 
between compositions 3.12-9.35 Mol % strontium.  This coincided with a reduction 
in the sintering window.  There was a significant difference between the flexural 
strength of compositions 6.24 and 9.35 Mol % strontium.  Composition 
12.47 Mol % strontium produced a flexural strength that was significantly higher 
than any of the compositions tested while at the same time had a sintering window 
that was 14.0°C smaller than the 0 Mol % strontium composition.  The breadth and 
width of the samples increased for samples 3.12-9.35 Mol % strontium compared to 
composition 0 Mol % strontium.  The breadth and width of composition 
12.47 Mol % strontium was smaller than compositions 3.12-9.35 Mol % strontium 
but larger than composition 0 Mol % strontium. 
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4.3.3 3-Point Flexural Strength 
 
Figure 75: The effect of the parent glass strontium content on the width of the 
working window (TP1-Tg) and the flexural strength of the devitrified and 
sintered bars, the error bars represent the standard deviations.  n=10.  
* indicates samples that are not significantly different, p=0.05. 
Table 48: The average bar width and breadths for the samples tested in figure 75.  
Standard deviations are shown (±). 
Strontium 
Content 
(Mol %) 
Average Width 
(mm) 
Average Breadth 
(mm) 
0 3.281 ± 0.034 2.291 ± 0.055 
3.12 3.449 ± 0.031 2.604 ± 0.041 
6.24 3.335 ± 0.031 2.532 ± 0.058 
9.35 3.623 ± 0.023 2.682 ± 0.054 
12.47 3.386 ± 0.051 2.331 ± 0.034 
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Table 49: Numerical values shown in figure 75, the errors shown are the calculated 
standard deviations.  Standard deviations are shown (±). 
Strontium 
Content 
(Mol %) 
Sintering 
Window 
(°C) 
Average Force 
at Rupture (N) 
Flexural 
Strength (MPa) 
0 147.6 29.81 ± 2.05 38.94 ± 3.01 
3.12 147.3 26.51 ± 1.99 25.51 ± 2.01 
6.24 145.6 26.23 ± 1.85 27.59 ± 2.16 
9.35 140.8 26.89 ± 2.24 23.22 ± 2.05 
12.47 133.6 37.59 ± 2.02 45.99 ± 2.73 
 
4.3.4 Fracture Surfaces 
4.3.4.1 Low Magnification SEM 
The fracture surfaces of the bars were then investigated using scanning electron 
microscopy.  Low magnification images were taken to provide on overall image of 
how the fracture had progressed through the material, figure76.  All samples failed 
via a brittle mechanism.  In compositions 0-9.35 Mol % strontium, where sintering 
had produced individual particles connected by necks, fracture had occurred through 
both the particles and the necks.  The fracture surfaces are aligned, lying 
perpendicular to the length of the bar.  The overall fracture surface is not perfectly 
flat and undulations are visible.  In composition 12.47 Mol % strontium, where 
individual particles are not so clearly defined, fracture has occurred through the 
material in a single plane. 
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Figure 76: Secondary electron SEM images of the bar fracture surfaces taken at 
x100 (left) and x250 (right) magnifications.  (a-b) 0 Mol % strontium 
(c-d) 3.12 Mol % strontium (e-f) 6.24 Mol % strontium (g-h) 9.35 Mol % 
strontium and (i-j) 12.47 Mol % strontium. 
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4.3.4.2 High Magnification SEM 
High magnification images of the fracture surfaces were taken to identify any 
exposed crystal phases, figures 82 to 86 pages 142 to 146. 
4.3.4.2.1 0 Mol % Strontium 
In figure 77, it can be seen that the fracture surface is relatively flat with a small 
degree of roughness.  There are white areas that may be individual crystals but they 
are too small and not exposed enough to be clearly defined. 
4.3.4.2.2 3.12 Mol % Strontium 
In figure 78, the surface becomes rougher and individual surface details become 
apparent. 
4.3.4.2.3 6.24 Mol % Strontium 
In figure 79, two different surfaces are visible.  The majority of the fracture surfaces 
showed the morphology visible in figure 79 (c).  These regions were similar to those 
observed in composition 3.12 Mol % strontium but with larger crystals.  The region 
in figure 79 (b) contains multiple exposed crystals that are 0.5-1µm in length and 
appear to be a continuation of the crystals visible on the surface that were previously 
identified as the apatite phase. 
4.3.4.2.4 9.35 Mol % Strontium 
The exposed crystals in figure 80 were larger than in previous compositions.  In 
figure 80 (b) it can be seen that as well as the areas of exposed crystals there are also 
smoother areas that appear to contain crystals.  In figure 80 (c) it can be seen that in 
areas the internal crystal structures matches that on the surface but in other regions a 
smooth surface is aligned with the apatite crystals visible on the surface of the 
material. 
4.3.4.2.5 12.47 Mol % Strontium 
The morphologies visible in the 9.35 Mol % strontium composition are visible in 
12.47 Mol % strontium composition, figure 81.  There is an increase in the amount 
of the smooth fracture surface compared to the rough.  In figure 81 (a) an internal 
pore is visible displaying the same features observed on the surface of the material. 
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Figure 77: Secondary electron images of the fracture surface of composition 
0 Mol % strontium.  (a) x5,000 and (b) x10,000 magnification. 
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Figure 78: Secondary electron images of the fracture surface of composition 
3.12 Mol % strontium.  (a) x5,000 and (b) x10,000 magnification. 
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Figure 79: Secondary electron images of the fracture surface of composition 
6.24 Mol % strontium.  (a) x2,000 magnification and x5,000 magnification of 
(b) a region of exposed crystals and (c) the remaining fracture surface. 
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Figure 80: Secondary electron images of the fracture surface of 
composition9.35 Mol % strontium.  (a) x2,000 magnification showing two 
distinct regions (b) x5,000 magnification of the fracture surface and (c) the 
boundary between the fracture surface and outer surface, x5,000 
magnification. 
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Figure 81: Secondary electron images of the fracture surface of composition 
12.47 Mol % strontium.  (a) x2,500 magnification of the fracture surface and 
an internal pore surface and (b) x4,500 magnification of the fracture surface. 
4.3.4.3 EDX 
The fracture surfaces were then imaged using EDX to observe any elemental 
distribution inhomogeneities, figures 82 to 86 on pages 149 to 153.  Both oxygen 
and fluorine were homogenous throughout the materials, except in areas where the 
take-off angle inhibited their detection and so were not included in the individual 
maps.  In all samples the distribution of magnesium was shown to vary throughout.  
A comparison of the calcium and magnesium maps is shown for each composition 
as magnesium had previously been shown to substitute for calcium into the different 
structures.  In all compositions there were regions in the elemental maps that showed 
no elements present.  These areas were constant between all elements and are not 
included when describing depleted areas. 
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4.3.4.3.1 0 Mol % Strontium 
In composition 0 Mol % strontium, figure 82, both phosphorous and silicon were 
homogenously distributed across the fracture surface.  Magnesium was more 
concentrated around the surface of the material and its location corresponded with 
areas that were depleted in calcium.  The areas of increased magnesium were in 
distinct, isolated regions that occurred all around the outer boundary of the fracture 
and penetrated roughly 5µm into that material. 
4.3.4.3.2 3.12 Mol % Strontium 
The magnesium distribution was also observed in composition 3.12 Mol % 
strontium, figure 83.  Again magnesium was more concentrated around the outer 
surface of the fracture cross-section.  Unlike in composition 0 Mol % strontium, the 
magnesium in 3.12 Mol % strontium was not found all around the boundary of the 
cross-section and penetrated further into the material, in excess of 10µm in some 
instances.  The magnesium regions appear smoother on overlaid SE image than the 
surrounding surfaces, this was observed in all subsequent compositions.  An isolated 
magnesium rich region can also be observed in the bulk of the material.  As in the 
previous composition, the areas of high magnesium corresponded with areas of low 
calcium.  The magnesium rich regions appear to be depleted with respects to 
phosphorous and strontium, but the variation in phosphorous is minimal and it is 
hard to differentiate from regions that have failed to capture data. 
4.3.4.3.3 6.24 Mol % Strontium 
Localised increases of magnesium were also observed in composition 6.24 Mol % 
strontium, figure 84.  Though present in regions around the periphery, isolated 
regions were also observed in the bulk.  Depletion of strontium in the magnesium 
rich regions was more pronounced than in lower strontium containing samples. 
4.3.4.3.4 9.35 Mol % Strontium 
The magnesium rich regions are most obvious in sample 9.35 Mol % strontium, 
figure 85.  In this sample the magnesium regions could be found throughout the 
material but can also be seen to propagate from the surface features, visible on the 
right of the material.  The magnesium rich regions were depleted with respect to 
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strontium.  Calcium depletion was not as clear due to it being substituted with 
strontium in the parent glass. 
4.3.4.3.5 12.47 Mol % Strontium 
In composition 12.47 Mol % strontium, figure 86, magnesium rich regions were 
visible throughout the material and corresponded to regions that were depleted in 
calcium.  The regions were not as distinct as in previous samples and covered a 
much larger area.  Depletion of strontium in magnesium rich regions was not 
observed in composition 12.47 Mol % strontium. 
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Figure 82: EDX maps of a fracture surface of composition 0 Mol % strontium  (a)SE 
overlaid with all elements (b) SE overlaid with Ca and Mg (c) Ca (d) Mg (e) Si 
and (f) P. 
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Figure 83: EDX maps of a fracture surface of composition 3.12 Mol % strontium  
(a)SE overlaid with all elements (b) SE overlaid with Ca and Mg (c) Ca (d) 
Mg (e) Si (f) P and (g) Sr. 
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Figure 84: EDX maps of a fracture surface of composition 6.24 Mol % strontium  
(a)SE overlaid with all elements (b) SE overlaid with Ca and Mg (c) Ca (d) 
Mg (e) Si (f) P and (g) Sr. 
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Figure 85: EDX maps of a fracture surface of composition 9.35 Mol % strontium  
(a)SE overlaid with all elements (b) SE overlaid with Ca and Mg (c) Ca (d) 
Mg (e) Si (f) P and (g) Sr. 
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Figure 86: EDX maps of a fracture surface of composition 12.47 Mol % strontium  
(a)SE overlaid with all elements (b) SE overlaid with Ca and Mg (c) Ca (d) 
Mg (e) Si (f) P and (g) Sr. 
 
. 
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4.4 Discussion 
This section of work was not concerned with the optimisation of the sintering 
process but in observing the effect of strontium substitution on the sinterability of 
the new materials.  As such, graphite moulds were chosen to form the bars as they 
offered a simple and repeatable process by which porous materials could be formed.  
Graphite was chosen as mould material due to its good thermal conductivity, 
machinability and low cost.  The 45-90µm particle size fraction has previously been 
shown to sinter well for apatite-wollastonite and apatite-mullite glass ceramics [62, 
65].  The moulds were not re-used even though the interiors appeared visibly 
unchanged as the outer surface had undergone some degree of combustion and re-
use may have altered the thermal conductivity of the materials reducing the 
reproducibility of the process.  It is clear from the high magnification images of the 
sintered materials surface that the crystals structures observed are the same as in 
powders sintered without moulds.  This indicates that the moulds did not affect the 
crystallisation of the powders. 
The surface of the sintered bars for all the materials tested indicated that sintering 
had occurred following the described processing route and that porosity, at least at 
the surface had been retained.  The formation of necks in compositions 0-
6.24 Mol % strontium indicates that sintering had occurred via a predominantly 
solid state mechanism.  The morphology of the particles in compositions 9.35-12.47 
Mol % strontium are much more rounded and necks less visible, indicating that 
these particles sintered by a predominantly liquid phase mechanism [65].  The 
change in sintering mechanism is likely due to the reduction in melting point with 
increasing strontium substitution as observed in chapter 3.  In both mechanisms, 
sintering proceeds due to the drive to minimise interfaces and contact angles 
between particles.  Solid state sintering occurs at temperatures well below the 
melting point and proceeds via two primary mass transport mechanisms, bulk or 
surface [108].  The necks are likely to have formed from a combination of the two.  
Bulk transport in the discussed materials is likely to have occurred via grain 
boundary diffusion and viscous flow mechanisms.  As these mechanisms involve the 
transport of material from the interior of the particle they all result in densification 
as well as neck formation.  Viscous diffusion will be the dominant mechanism for 
the glass phase.  As the temperature increases and the viscosity of an amorphous 
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phase decreases, the ability of the material to flow and reduce surface tension 
increases.  The lower the viscosity of the amorphous phase, the thicker the necks 
that are produced following sintering [108].  Increasing substitutions of strontium 
into the parent glasses reduced the glass transition temperature, indicating a 
reduction in connectivity and viscosity of the glass.  The amorphous phase content 
of the samples also increased with increasing strontium substitution.  Compositions 
containing higher levels of strontium would therefore be more susceptible to viscous 
flow sintering.  This may explain the increase in the neck size observed in 
composition 6.24 Mol % strontium compared to composition 3.12 Mol % strontium.  
The increase in necking thickness was not observed in compositions 9.35-12.46 Mol 
% strontium despite a reduction in the glass transition temperature due to a change 
in mechanism toward liquid phase sintering.  As the samples are heated they will 
begin to crystallise.  The devitrification of the glass inhibits viscous flow sintering 
[151] and grain boundary diffusion and volume diffusion begin to dominate the bulk 
transportation mechanism.  Inhomogeneities and stresses within grain boundaries 
allow for reduced activation energies for mass transport.  Thus transport of material 
towards a neck can proceed along these boundaries.  Grain boundary diffusion also 
supports crystal growth [152].  Volume diffusion is a result of vacancy 
transportation through a materials bulk.  The most common mechanism of sintering 
in ceramics is surface diffusion [108].  Surface diffusion does not result in 
densification and is a result of mass transport from the material surface to the 
necking region.  Previous reports of the glass ceramic system discussed show that 
neck formation is predominantly a result of viscous flow [127] and as such sintering 
and densification proceed more rapidly prior to crystallisation.  The systems will 
however continue to sinter and densify following crystallisation, suggesting viscous 
flow is not the only mechanism occurring [110]. 
Liquid phase sintering occurs when a phase in the materials melts.  It can be 
especially prevalent in materials that show large melting temperature ranges, such as 
the discussed glasses/glass ceramics.  The liquid phase that forms upon melting wets 
the particle’s surface.  This surface coating, if in large enough quantities, allows for 
rearrangement of the solid particles.  The particles are also drawn closer via 
capillary forces, inducing high levels of densification.  Liquid phase sintering leads 
to the formation of liquid bridges that subsequently re-precipitate, as opposed to the 
necks observed in solid state sintering.  In glass ceramics the glass phase is generally 
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less stable than the crystalline phase and has a lower melting point [65].  Thus less 
crystalline materials, as in the case of the higher strontium containing compositions, 
are more likely to undergo liquid phase sintering.  From the bar cross-section it can 
be seen that composition 12.47 Mol % strontium has undergone the highest level of 
densification of all the compositions tested, further indicating that the material has 
undergone liquid phase sintering.  This composition was also shown to contain the 
lowest weight percentage of the surface nucleating silicate phase.  The surface 
nucleating phase would inhibit liquid phase sintering as it is the melting of the 
surface that is crucial for the mechanism to occur [153].  Though the morphology of 
the particles in composition 9.35 Mol % strontium appear to indicate liquid phase 
sintering, the lack of densification suggests that amount of liquid phase present was 
insufficient for re-arrangement and densification to occur.  This may be due to the 
increased melting temperature range or increase in surface crystals compared to 
composition 12.47 Mol % strontium. 
All the sintered bars had well dispersed porosity and dense regions were not 
concentrated around specific surfaces or regions indicating that sintering had not 
been influenced adversely by temperature gradients.  Heating of samples at high 
rates can sometimes induce temperature gradients, leading to non-uniform 
densification [154, 155].  While the samples do contain areas of increased density, 
they are randomly distributed and are likely a result of packing of the moulds.  The 
arrangement of the particles in the moulds prior to sintering will be highly 
disordered, due to their irregular shape, size range and the fact they were not 
compressed.  While there have been many attempts to describe densification in 
compacted glass systems, Frenkel Mackenzie, Shuttleworth, Scherer (all 
summarised nicely by Prado [154]), the theory and mechanisms do not apply to 
uncompacted systems.  It is useful to think of particle packing, for sintering 
purposes, in terms of connections/coordinations between neighbouring 
particles [108].  It is at these contact points that necks form and as a result the higher 
the coordination number, the greater the capacity of that material to sinter and 
densify.  Random packing of monosized spheres produces and average coordination 
of around 6 or 7 [108].  Compaction and use of smaller particles can increase this 
value as both variables increase the density of the sample, ultimately bringing more 
particles into contact with each other and minimising the initial pore volume [151].  
Loose particle sintering, such as reported here, with a low initial density leads to 
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particles forming into long chains with an open porous structure [151].  This process 
is essential for the described materials as it retains the open, connected, porous 
structure required for a successful bone replacement material. 
Mechanical testing was performed on the material to assess the capacity of the 
material to be used in load bearing applications and also attempt to quantify the level 
of sintering in the materials.  Densification as a result of sintering increases the 
mechanical strength of a material by effectively increasing the cross-sectional 
area [151] and as such the flexural strength should correlate with the level of 
sintering.  Because of the effect of crystals on the solid state sintering mechanism, 
the ability of glasses to densify is also often assessed in terms of the size of the 
temperature range between the glass transition temperature and the formation of 
crystals in the material, often referred to as the working or sintering window, 
measured via DSC or DTA [125].  For this work the sintering window was defined 
as the difference in temperature between the glass transition temperature, Tg, and the 
first exotherm peak, TP1.  The onset of crystallisation was not used as this was not as 
clearly definable.  Composition 0 Mol % strontium produced bars with a flexural 
strength that was close to those formed from apatite-wollastonite via a 2-stage 
selective laser sintering process [62].  A reduction in the size of the sintering 
window in the tested compositions coincides with a reduction in the flexural strength 
between 0 Mol % strontium and 3.12-69.35 Mol % strontium.  Though a significant 
difference was not achieved, the increase in mechanical strength observed between 
compositions 3.12 and 6.24 Mol % strontium must be due to a factor other than the 
size of the sintering window.  As previously discussed, this increase may be due to 
an increase in the amorphous content of the material, enhancing viscous flow 
sintering.  This is supported by the reduction in both width and breadth of the bars 
compared to composition 3.12 Mol % strontium.  There was very little increase in 
the amorphous phase ratio between compositions 6.24 and 9.35 Mol % strontium 
(though the values calculated in chapter 3 may be incorrect due to intensity 
mismatches, as discussed) and so the significant reduction in flexural strength may 
be due to the large reduction in the sintering window.  It may also be due to the loss 
of necking due to liquid phase sintering, which was observed from the morphology 
of the particles.  The lack of viscous flow (as a result of a small working window) 
and low levels of liquid phase sintering in the sample is evident in the increase in 
breadth and width compared to the other compositions.  The increase in flexural 
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strength for composition 12.47 Mol % strontium compared to all other compositions 
correlates with the increase in densification as a result of advanced liquid phase 
sintering.  The flexural strength of the scaffold may also be affected by the loss of 
the silicate phase, as previously identified via XRD, the crystallisation of fibrous 
wollastonite has been shown to strengthen apatite-wollastonite glass ceramics [135, 
139].  Though this may contribute to the reduction in flexural strength, it does not 
explain the increases observed in composition 6.24 Mol % strontium compared to 
3.12 Mol % strontium (though not significant) and the increase in composition 12.47 
Mol % strontium compared to all other compositions.  The flexural strength of glass 
ceramics has been shown to increase as the crystal volume percentage increase up to 
40% and drops off after 60% [156].  The crystallinity of the glass ceramics tested 
peaks in composition 0 Mol % strontium at 60 % before dropping off.  This may 
contribute to the reduction in flexural strength of the material. 
The porosity of the sample not only determines the mechanical properties of the 
scaffolds, but also contributes to its ability to support neo-bone formation.  Though 
this work was not focussed on optimising the porosity of the material, the presence 
of pores was still considered essential for subsequent oesteogenic potential 
assessment.  The minimum pore size to support bone growth was originally shown 
to be 100µm [50, 157], though smaller pores will still form osteoid and show signs 
of mineralisation.  What has since shown to be more important is the presence of 
and size of interconnected porosity [158].  The interconnection size (cross-section) 
should be a minimum of 100µm for the formation of new bone [159].  This is in part 
due to new bone formation requiring a blood supply, which requires 
neovascularisation which in turn requires an interconnected porosity large enough to 
accommodate capillaries [160].  The pores formed in compositions 0-9.35 Mol % 
strontium were irregular in shape but had cross sections that ranged from 45-200µm.  
Though most pores were smaller than 100µm in at least one dimension.  This was 
also the case with the interconnected porosity.  Although the materials were highly 
interconnected, the porosity was narrower than the 100µm lower limit stated in the 
literature.  However, the materials being produced were to be used for initial 
assessment of the effect of the chemical/crystal composition on bone forming cells 
and the porosity, as stated, was not be optimised.  The porosity that was achieved 
was suitable for in vitro studies where endothelial cells (capillary wall forming cells) 
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would not be present and as such true neobone formation would not be possible, 
even with an ideal porosity. 
Investigation of the fracture surface revealed that all samples failed by a brittle 
fracture mechanism, as would be expected for a glass ceramic.  In compositions 
0-9.35 Mol % strontium the fracture surfaces do not lie in a single plane.  This is due 
to the highly porous structure and irregular shape and distribution of the sintered 
particles.  High magnification images of the fracture surfaces revealed that fracture 
had occurred in both the glass matrix and crystalline phases.  The lack of definable 
structures in composition 0 Mol % strontium indicates that the phases are well 
distributed and interdispersed and matches the fracture surfaces reported by 
Kokubo [139].  However, EDX revealed a magnesium rich phase around the particle 
perimeter.  This is likely to be the silicate phase, which was shown to take on 
magnesium and form via a surface nucleation mechanism.  The surface nucleation 
mechanism was shown to reduce with increasing strontium substitution and this may 
explain the increase in the amount of the magnesium rich phase observed in the bulk 
in higher strontium containing compositions.  EDX of composition 9.35 Mol % 
strontium revealed areas of high magnesium that were a continuation of the silicate 
surface crystals and showed a similar morphology when in the bulk.  This was also 
observed in composition 6.24 Mol % strontium, but to a lesser extent.  This indicates 
that the crystals are not limited to nucleation or growth on the surface of the 
material.  The morphology of the magnesium rich phase was not visible via non-
elemental analysis, suggesting that it lies within another phase, most likely an 
amorphous phase.  The same morphology was not observed in compositions 0-
3.12 Mol % strontium, but it was also not observed on the surface of the material. 
As the strontium levels increased, crystals became visible on the fracture surface.  
These crystals grew in size with increasing strontium substitution.  The crystals are 
likely to be the apatite crystals resting within a residual glass matrix.  Though this 
was not confirmed with EDX, the highly crystalline areas did correspond to areas 
depleted in magnesium, suggesting that they were the apatite phase.  The apatite 
phase was shown to take on strontium as the strontium content of the parent glass 
increased and it has been reported that this leads to an increase in the size of apatite 
crystals formed [91].  In composition 6.24 Mol % strontium, an area of crystals has 
been exposed at the fracture surface.  This was observed only in two places on the 
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fracture surface, but was included as it demonstrated how the crystals of the surface 
continued into the bulk of the material.  The crystals are a continuation of what was 
previously identified as the apatite phase, but may contain both the silicate phase 
and glass [88, 89, 135, 141].  The crystals are likely to have been exposed by flow of 
the amorphous phase during sintering.  The formation of crystals in the glass 
ceramics has been shown to increase their flexural strength by deflecting a 
propagating crack [156].  In compositions 9.35-12.47 Mol %, there were regions of 
high crystallinity and also areas that appeared much smoother.  The smoother areas 
are likely areas with a higher glass content.  They display the fracture surfaces 
associated with a glass [156].  In composition 12.47 Mol % strontium, the smooth 
regions correspond with areas of high magnesium.  The reduction in the weight 
percentage of the silicate phase in this composition would leave higher levels of 
magnesium in the residual amorphous phase, again indicating that the smooth 
regions may be areas where the glass has fractured.  The increase in the amount of 
glass fracture sites would reduce the flexural strength of the material and so the 
increase that was observed is likely due to enhanced densification and reduction in 
porosity that was observed in the composition. 
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Chapter 5: Biological Assessment 
5.1 Introduction 
The materials developed in this work were next assessed for their biocompatibility.  
In order to be of use for the formation of a bone replacement device the materials 
investigated here must be biocompatible.  With calcium phosphate glasses and 
ceramics this can take the form of being able to form a surface apatite layer when 
submerged in biologically relevant solutions.  Ceramics and glasses able to form a 
surface apatite layer are often referred to as bioactive.  The materials must also be 
biocompatible, in that they illicit no negative response from the body when 
implanted.  Biocompatibility can be investigated in vitro by monitoring the response 
of cells exposed to the material.  The materials may also be bioactive in that they are 
capable of directing the response of cells, such as their rates of proliferation, 
migration and differentiation down a desired lineage. 
Biocompatibility testing took two forms: the ability of the materials to form a 
surface apatite layer following submersion in simulated body fluid and the 
interaction of the materials with primary human mesenchymal stem cells.  Saos-2 
osteosarcoma cells were used as positive controls for expression of alkaline 
phosphatase and of mineralisation.  Soas-2 are a non-transformed cell line that 
display osteoblastic like properties and features and their use as a permanent cell 
line allows for comparison between groups and experiments.  Cylindrical scaffolds 
were utilised and formed using the same heat treatments that were previously 
reported.  The scaffolds were then submerged in SBF for up to 7 days and assessed 
via pH measurements of the reacted SBF and via SEM and EDX analysis of the 
scaffold surfaces.  To test the interaction of cells with the scaffold, human 
mesenchymal stem cells were isolated from knee explants and expanded in vitro.  
The cells’ ability to differentiate and their expression of known MSC markers was 
then assessed via flow cytometry.  The method by which cells were seeded on to the 
scaffolds was then optimised using SEM.  SEM was also used to observe the cells 
ability to proliferate across the scaffold surface.  The ability of the cells to undergo 
osteogenic differentiation on the materials was assessed via pNPP alkaline 
phosphatase assay with the results normalised to DNA. 
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5.2 Experimental Methodology 
5.2.1 Scaffold Formation 
Porous discs were formed of dimension 2mm diameter by 3mm depth using graphite 
moulds (Grade EE250, Tokai Carbon) and the heat treatment reported in chapter 2. 
5.2.2 Simulated Body Fluid (SBF) Analysis 
5.2.2.1 SBF Preparation 
Simulated body fluid solution was made up according to BS ISO 23317/2007-
Implants for surgery – in vitro evaluation for apatite-forming ability of implant 
materials.  The solution was made up in a 1000ml plastic beaker that had not been 
used for any other purpose.  A stirring bar was placed in the beaker which was then 
set in a water bath on a heated stirring plate and covered with foil.  700ml of ion-
exchanged water was added to the beaker, a temperature probe was added and the 
water heated to 36.5±1.5°C.  The reagents shown in table 50 were then sequentially 
dissolved in the water. 
Table 50: The reagents used in the preparation of SBF solution. 
Order Reagent Amount (g) Purity Supplier 
1 NaCl 8.035 99.5 
Sigma-
Aldrich 
2 NaHCO3 0.355 99.5 
Fisher 
Scientific 
3 KCl 0.225 99.5 
Sigma-
Aldrich 
4 K2HPO3•3H2O 0.231 99.0 
Fisher 
Scientific 
5 MgCl2•6H2O 0.311 98.0 
Fisher 
Scientific 
6 c(HCl) = 1mol/l 39 (ml) N/A 
Sigma-
Aldrich 
7 CaCl2 0.292 95.0 
Sigma-
Aldrich 
8 Na2SO4 0.072 99.0 
Fisher 
Scientific 
9 TRIS 1.18 99.0 
Fisher 
Scientific 
10 c(HCl) = 1mol/l 0-5 (ml) N/A 
Fisher 
Scientific 
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Reagents were added slowly to minimise temperature or pH fluctuations.  CaCl2 was 
in granular form and each granule was added individually and allowed to dissolve 
before another was added.  Each reagent was only added after the previous had fully 
dissolved.  The graduated cylinder was rinsed with HCl before it was used to 
measure the volume of HCl.  Reagents KCl, K2HPO4•3H2O, MgCl2, CaCl2 and 
Na2SO4 are hydroscopic so were measured as quickly as possible.  A pH electrode 
was added prior to the addition of TRIS and the pH found to be 2.0±1.0.  The 
solution was made up to 900ml and then heated to 36.5±1.5°C.  TRIS was added to 
solution a small amount at a time whilst maintaining the temperature at 36.5±0.5.  
Each addition of TRIS was allowed to fully dissolve and the pH to stabilise before 
the next addition.  TRIS was added until the pH was raised to 7.45±0.01 at 36.5±0.5.  
HCl was then added to lower the pH to 7.42±0.01   TRIS was then added to bring 
the pH to ≤7.45.  The process was then repeated until all the TRIS had been 
dissolved.  The pH of the solution was then adjusted to 7.40 at a temperature of 
36.5°C using HCl.  The electrode was removed and rinsed above the beaker so that 
the washings were added to the solution.  The solution was then transferred to a 
1000ml volumetric flask and ultra-pure water was added up to the mark.  The 
solution was then allowed to cool to 20°C, at which point ultra-pure water was 
added to bring the final solution volume up to 1000ml.  The solution was then stored 
at 5°C for up to 28 days before use.  The solution remained clear throughout the 
process.  Had precipitate formed, the solution would have been discarded. 
5.2.2.2 Specimen Soaking 
The sintered discs were rinsed with ultra pure water and dried.  15ml centrifuge 
tubes were then rinsed with the SBF solution.  The nominal surface area of the 
scaffolds, SA, calculated from the disc radius, r, and height, h, equation 26, was used 
to calculate the volume of SBF, Vs, to add to each sample, equation 27. 
      
       
Equation 26 
         
Equation 27 
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4.3ml of SBF was added to each tube and heated to 36.5°C in an incubator.  The 
samples were then added and positioned as in figure 87.  The samples were held at 
36.5°C and left to soak for 0, 1, 3 and 7 days.  After the desired soaking period, 
samples were removed and washed gently with ultra-pure water and dried in a 
desiccator.  The pH of the SBF solutions was then measured at 36.5°C using a 
calibrated pH electrode.  The dried samples were then attached to aluminium SEM 
stubs with carbon adhesive pads and imaged using a Hitachi S3400N variable 
pressure SEM.  EDX was also performed on the surface of the scaffolds using a 
Bruker XFlash detector and analysed with Quantax analysis software. 
 
Figure 87: Sample (S) positioning for SBF soaking. 
5.2.3 Cell Culture 
5.2.3.1 Culture Conditions 
All cell culture was performed in a sterile class II hood.  All reagents used were 
sterile.  All cultures were incubated at 37°C in a 5% CO2 atmosphere at near 95% 
humidity.  T175 tissue culture flasks with gas exchange lids were used for cell 
expansions.  Basal media consisted of Dulbecco’s modified eagle medium (DMEM) 
+ 10 % FBS (unless stated) + 1 % penicillin streptomycin (all from Sigma-Aldrich).  
Osteogenic media consisted of basal media + 5mM β-glycerophosphate + 50µg/ml 
ascorbic acid + 10 nm dexamethasone (all from Sigma-Aldrich).  Where osteogenic 
media was used, cells were first allowed to attach in basal media and osteogenic 
media was added after 24 hours (day 0).  Harvesting of cells was done with 0.1% 
trypsin-ethylenediaminetetraaceticacid (trypsin-EDTA).  All cell counting was done 
using a haemocytometer.  Observation of cells during culture was done using a 
phase contrast microscope.  Cells were passaged as they approached 75-90% 
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confluence and were not allowed to exceed 90% confluence.  Primary cells were 
used up to but not exceeding passage 5.  The passage of cell line Saos-2 was 
recorded prior to use.   
5.2.3.2 Mesenchymal Stromal/Stem Cell (MSC) Isolation 
Femoral condyles removed from patients undergoing total knee arthroplasty at 
Harrogate District Hospital were collected.  They were then minced into sections 
roughly 20mm in diameter using a surgical clamp and scissors.  The bone fragments 
were then placed in adherent petri dishes along with basal media containing 15% 
foetal bovine serum (FBS).  Bone fragments were cultured for 3-4 days in an 
incubator, after which the fragments were removed and the cells were cultured for a 
further 10 days or until a confluence of 20-50% was achieved.  The media was 
changed every 3-4 days.  The cells were then harvested and seeded at a density of 
1000 cells.cm
2
.  The donor information of the isolated cells are shown in table 51. 
Table 51: Donor information for the primary mesenchymal stem cell lines. 
Cell Donor 
Reference 
Sex DoB BMI Smoker Diseased 
K17 Male 03/12/49 Not Available No Arthritis 
K28 Male 26/03/49 26.6 No Arthritis 
K41 Female 18/07/49 25.6 No Arthritis 
K56 Female 06/12/45 35.5 No Arthritis 
 
5.2.3.3 Osteogenic differentiation capacity via alkaline phosphatase (ALP) and 
von Kossa straining 
MSC and Saos-2 human carcinoma cells were seeded onto adherent 24 well tissue 
culture plates at a density of 10,000 cells/cm
2
 and cultured in basal and osteogenic 
media for 21 days.  After 21 days culture, cells were stained for extracellular ALP 
using a Fast Red stain (Sigma-Aldrich) and mineralisation using a von Kossa stain 
(Sigma-Aldrich).  The ALP mixture was made up of 0.2mg/ml naphthol in 1% N,N-
dimethylformamide diluted in 0.1M Tris (Sigma-Aldrich) pH 9.2 plus 1mg/ml Fast 
Red TR.  The solution was then filtered.  A 1% silver nitrate solution was made up 
for the von Kossa staining by dissolving 100mg silver nitrate in 10ml distilled H2O.  
Cells were washed twice with phosphate buffered saline (PBS).  The filtered ALP 
reagent mix was then added and the cells left for 2 minutes.  The cells were then 
washed a further two times with PBS.  4% paraformaldehyde was added to and the 
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cells left for 5 minutes before being washed with PBS and then with distilled H2O.  
1% silver nitrate solution was added and the samples left on a light box for 15 
minutes.  The samples were then washed three times with distilled H2O.  2.5% 
sodium thiosulphate was added and the samples left for 5 minutes.  The samples 
were then washed twice with distilled H2O before being left in 20% glycerol in PBS 
solution.  The samples were then imaged.. 
5.2.3.4 Flow Cytometry 
Cells were analysed via flow cytometry for the surface markers shown in table 52.  
Media was aspirated and cells were washed twice with PBS.  Cells were harvested 
using a 10 minute soak at 37°C in a washing buffer consisting of 0.2% bovine serum 
albumen (BSA) and 5mM EDTA in PBS.  Cells were then centrifuged at 450g for 3 
minutes and the supernatants collected.  Cells were then resuspended in washing 
buffer and counted.  An appropriate volume of cell suspension containing 50x10
5
-
1x10
6
 cells per marker was then pelleted using a 450g spin for 3 minutes.  The cells 
were then resuspended in 100µl of washing buffer per sample.  100µl of cell 
suspension was then transferred to 15ml Eppendorf tubes, 1 per marker plus one 
marker free control, and 1ml of washing buffer was added to each tube.  The tubes 
were the spun for 5 min at 450g at 4°C and the supernatants carefully aspirated.  All 
cell surface markers were made up using the concentrations shown in table 52.  For 
the fluorescein isothiocyanate (FITC)/ phycoerythrin (PE) conjugated antibodies, the 
pellets were resuspended in 400µl washing buffer and kept on ice in the dark until 
needed.  For the markers requiring secondary antibodies, the cells were resuspended 
in 100µl washing buffer containing the PE or FITC conjugated secondary antibody 
(Alexa fluor 647) and incubated on ice in the dark for 30 minutes.  1ml washing 
buffer was then added to each Eppendorf, they were spun at 450g at 4°C for 5 
minutes and the supernatants were then aspirated.  Cell pellets were then 
resuspended in 400µl of washing buffer each and kept on ice in the dark until 
required.  Flow cytomtery was performed on a MofLo system using the 488 nm 
laser with excitation/emissions at 495 nm/519 nm for FITC, 496 nm/578 nm for PE 
and 495 nm/519 nm for AlexaFluor.  Populations were gated to exclude debris and a 
minimum of 10,000 cells were counted per sample. 
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Table 52: The markers analysed via flow cytometry. 
+ve/-
ve 
Target Conjugate 
Concentration 
Used 
Supplier 
- CD45 FITC 1:100/1µl Caltag Labs 
+ CD166 PE 1:50/2µl 
BD 
Pharmagen 
+ CD44 FITC 1:10/10µl 
BD 
Pharmagen 
+ 
CD90 
Clone 
eBio5E10 
Purified, 
Needs 2° 
Ab 
1:100/1µl ebioscience 
+ CD105 
Purified, 
Needs 2° 
Ab 
1:100/1µl ebioscience 
+ CD29 
Purified, 
Needs 2° 
Ab 
1:100/1µl 
BD 
Pharmingen 
+ CD73 
Purified, 
Needs 2° 
Ab 
1:100/1µl 
BD 
Pharmingen 
- CD34 FITC 1:50/2µl 
Miltenyi 
Biotec 
Secondary for use with 
purified antibodies 
 
N/A 
Donkey 
Anti-
mouse 
Alexa 
fluor 647 
1:200/0.5µl Invitrogen 
 
5.2.3.5 Scaffold Seeding 
Scaffolds were placed in basal media and then allowed to equilibrate in an incubator 
at 37°C with a 5% CO2 atmosphere.  Cell cultures that were approaching but not 
exceeding 90% confluence were collected using a 0.1% tryspsine-EDTA solution, 
pelleted in a centrifuge, resuspended then counted.  The volume of cell suspension, 
VC, required to seed a scaffold with the required number of cells, NC, was calculated 
from the cell suspension concentration, CC, using equation 28 and the cells pelleted 
and resuspended in 100µL of basal media per scaffold. 
   
  
  
 
Equation 28 
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The scaffolds were removed from the media and placed in individual wells of flat 
bottomed 96-well plates.  100µl of cell suspension, of the desired cell concentration, 
was then pippeted onto the surface of each scaffold, which were then placed in the 
incubator for 1 hour.  The cell suspensions were then resuspended over the scaffold 
and left in the incubator for a further hour.  The cell suspensions were then aspirated 
and the scaffolds transferred to empty wells of the 96-well plate.  200µl of fresh 
basal media was then added to each scaffold.  Cells were cultured for 1-21 days with 
media changed every 3-4 days or when required.  The optimum seeding density for 
the scaffolds was determined by seeding at concentrations 5x10
5
, 2.5x10
5
, 1x10
5
, 
7.5x10
4
 and 5x10
4
.  Cells were cultured on the scaffolds for 24 hours before being 
imaged using an SEM. 
5.2.3.6 Scaffold Preparation for SEM 
The media was aspirated from the constructs and they were then washed 3 times 
with PBS.  The constructs were then fixed in 2.5% gluteraldehyde in 100mM 
phosphate buffer at 4°C over-night.  200mM phosphate buffer of pH 7.2-7.6 was 
made up from 77ml 0.2M Na2PO4 and 23ml 0.2M NaH2PO4 this was used to dilute 
25% gluteraldehyde stock solution.  The constructs were washed 3 times with 
100mM phosphate buffer.  They were then dehydrated with graded alcohol, 25, 50, 
70 and 90% for 30 minutes each and then three changes of 100% for another 30 
minutes each (with the last two changes utilising ultra-pure 100% ethanol).  The 
constructs were then soaked in 100µl of hexamethyldisilazane (HMDS, Sigma-
Aldrich) for 30 minutes.  A fresh change of HMDS was added and the scaffolds 
were then left to dry overnight in a desiccator.  Samples were then attached to 
aluminium stubs using carbon adhesive pads and sputter coated with a 6nm thick 
gold coating.  Cells were then imaged on a S3400N variable pressure SEM. 
5.2.3.7 Characterisation of MSC differentiation on the glass-ceramic scaffolds 
5.2.3.7.1 Cell culture 
Primary MSCs were cultured on the glass-ceramic scaffold compositions 0, 3.12 
6.24 and 12.47 Mol % strontium.  Cells were also seeded onto tissue culture plastic 
to observe if the cells were able to differentiate with the conditions used.  Cells were 
seeded according to the seeding method previously described.  Cells were cultured 
in 96-well plates.  Cells were seeded on the scaffolds at the optimum seeding 
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density, 1x10
5
 cells/scaffold and on tissue culture plastic at 6400 cells per well of a 
96-well plate.  Sample were cultured for up to 21 days in osteogenic media.  At time 
points 0, 7, 14 and 21 days samples were collected and the alkaline phosphatase 
activity and DNA content of the constructs was assessed using pNPP and PicoGreen 
assays, respectively.  6 scaffolds of each material were used for each time point.  
The experiment was repeated using 3 different donor cell lines. 
5.2.3.7.2 Cell Lysis 
At the desired time point, cells were washed twice with 0.2M carbonate buffer (2:1 
[vol:vol] of 0.2M Na2CO3 to 0.2M NaHCO3, pH 10.2).  150µl of the lysis buffer, 
(0.1% Triton-X in 0.2M carbonate buffer) was then added to each well and the 
samples were then treated with a freeze/thaw cycle (-80°C/37°C) three times.  The 
samples were then pipetted up and down to fully lyse the cells.  50µl of cell solution 
was then added to a new 96-well plate for the pNPP assay and a further 50 µl was 
added to a black bottomed 96-well plate for the PicoGreen assay. 
5.2.3.7.3 Alkaline Phosphatase via pNPP assay 
Alkaline phosphatase activity was measured using the p-nitrophenyl phosphate 
(pNPP, Sigma-Aldrich) assay.  This is a colourimetric assay that measures the 
conversion of colourless p-nitrophenyl phosphate (pNPP) to orange  p-nitrophenol 
(pNP) in the presence of a phosphatase catalyst.  The pNPP conversion is measured 
against a standard pNP curve.  The pNP standard was made by diluting a standard 
solution in carbonate buffer according to table 53.  100µl of each standard 
concentration was added to the pNPP 96-well plate in triplicate. 
Table 53: pNPP standard dilutions. 
Concentration pNP 
Volume Standard 
Solution (µl) 
Volume Carbonate 
Buffer (µl) 
0.5 20 380 
0.3 12 388 
0.2 8 392 
0.1 4 396 
0.05 2 398 
0.025 1 399 
0.0125 0.5 399.5 
0 0 400 
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The working pNPP substrate was made by diluting 1 part stock solution (10mg 
pNPP in 9ml 0.2M carbonate buffer + 1ml 100mM MgCl2) in 2 parts distilled H2O.  
50µl of the working substrate was added to each of the samples.  The samples were 
then incubated at 37°C for up to an hour.  The length of time that the substrates were 
incubated was noted before the absorbance of the wells was read at 405nm on a 
POLARstar OPTIMA microplate reader.  The absorbance values were then 
converted to pNP levels using the standard curves and normalised to the time spent 
in the incubator and DNA content. 
5.2.3.7.4 DNA Content via PicoGreen assay 
The DNA standards were prepared using a 10µg/ml stock salmon sperm solution 
(Sigma-Aldrich).  The solution was diluted to 100µg/ml in the lysis buffer (0.1% 
Triton-X in 0.2M carbonate buffer).  The standards were diluted as in table  54 and 
50µl of each was pipetted in triplicate into the black bottomed 96-well plate. 
Table 54: PicoGreen standard dilutions. 
DNA Conc. 
(µg/ml) 
Volume of DNA 
(µl) 
Volume of Lysis 
Buffer (µl) 
Total Volume (µl) 
8 
80 (µl of 
100µg/ml stock) 
950 1000 (A) 
4 500 of A 500 1000 (B) 
2 500 of B 500 1000 (C) 
1 500 of C 500 1000 (D) 
0.5 500 of D 500 1000 (E) 
0.25 500 of E 500 1000 
0 0 500 500 
 
A PicoGreen reagent was made up by diluting PicoGreen stock solution (Life 
Technologies) 1:50 in TE buffer (0.12g 10mM Tris + 0.029g 1mM EDTA made up 
in 100ml dH2O and the pH set to 7.5).  50µl of the PicoGreen/TE reagent was then 
added to each of the samples and standards.  The plate was gently shaken and then 
covered in foil.  The plate was read at 485nm excitation and 538nm emissions on a 
multipurpose plate reader system.  The absorbance values were then converted to 
DNA levels using the standard curves. 
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5.2.3.7.5 Statistical Analysis 
Statistical analysis was performed using SPSS software.  The normality of the 
results was first determined using a Shapiro-Wilk test.  Signifcant differences were 
then determined using an ANOVA test for normally distributed data and a Kruskall 
Wallis test for non-normal data.  A post-hoc Tukey test was used for multiple 
comparisons when a significant difference was observed. 
5.3 Results 
5.3.1 Simulated Body Fluid Analysis 
Cylindrical; scaffolds were soaked in SBF at 36.5°C for 1, 3 and 7 days.  At each 
time point the pH of the SBF solution after the scaffold was removed was measured 
using a calibrated electrode and compared to un-reacted SBF.  The scaffolds that 
were removed were then imaged via SEM and their composition analysed via EDX. 
5.3.1.1 pH 
The pH of the SBF solutions following soaking of the scaffolds for 0, 1, 3 and 7 
days are shown in figure 88 and table 55.  All pH measurements were made at 
36.5°C. 
 
Figure 88: The pH of the SBF solution following exposure to the scaffolds for 0, 1, 3 
and 7 days. 
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Table 55: pH of the SBF solution following soaking of glass ceramic samples. 
Soaking 
Time 
(Days) 
SBF 
Scaffold Strontium Content (Mol %) 
0 3.12 6.24 9.35 12.47 
pH pH pH pH pH pH 
0 7.39 7.39 7.39 7.39 7.39 7.39 
1 7.39 7.39 7.4 7.4 7.42 7.42 
3 7.39 7.43 7.48 7.5 7.51 7.52 
7 7.39 7.44 7.53 7.55 7.55 7.58 
 
The pH of the SBF stock solution remained constant at 7.39 for the 7 days that the 
experiment was run.  At day 1 there was no change in the pH of the 0 Mol% 
strontium sample.  An increase was observed in all strontium samples with a greater 
increase occurring in compositions 9.35-12.47 Mol % strontium.  In all samples, the 
largest increase in pH was observed between days 1 and 3.  The pH of the solution 
increased with increasing strontium content in the glass ceramic.  By day 7 the pH of 
composition 0 Mol % strontium had increased by 0.04 compared to SBF alone.  The 
pH of the strontium compositions had increased by 0.14-0.19, with a larger increase 
occurring with increasing strontium substitution. 
5.3.1.2 SEM 
SEM images of the scaffold surface following soaking in SBF for 0, 1, 3 and 7 days 
are shown in figures 89 to 93. 
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Figure 89: SEM images of the 0 Mol % strontium glass ceramic surfaces after 
soaking in SBF for different lengths of time.  (a-b) day 0 (c-d) day 1 (e-f) day 
3 and (g-h) day 7. 
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Figure 90: SEM images of the 3.12 Mol % strontium glass ceramic surfaces after 
soaking in SBF for different lengths of time.  (a-b) day 0 (c-d) day 1 (e-f) day 
3 and (g-h) day 7. 
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Figure 91: SEM images of the 6.24 Mol % strontium glass ceramic surfaces after 
soaking in SBF for different lengths of time.  (a-b) day 0 (c-d) day 1 (e-f) day 
3 and (g-h) day 7. 
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Figure 92: SEM images of the 9.35 Mol % strontium glass ceramic surfaces after 
soaking in SBF for different lengths of time.  (a-b) day 0 (c-d) day 1 (e-f) day 
3 and (g-h) day 7. 
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Figure 93: SEM images of the 12.47 Mol % strontium glass ceramic surfaces after 
soaking in SBF for different lengths of time.  (a-b) day 0 (c-d) day 1 (e-f) day 
3 and (g-h) day 7. 
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In both compositions 0 and 3.12 mol % strontium, crystals can be seen to form on 
the surface of the material by day 1.  The crystals increase in number up to day 7 at 
which point they form a confluent layer on the materials surface.  The crystals were 
not observed in compositions 6.24-12.47 Mol % strontium at any of the time points.  
Crystals were visible on composition 9.35 Mol % strontium at day 1 but they do not 
match the morphology previously observed and were not visible at any subsequent 
time points suggesting they are an artefact of the processing.  Composition 6.24 Mol 
% strontium showed no change in surface morphology up to day 7.  In compositions 
9.25 and 12.47 Mol % strontium, the morphology of the apatite containing domains 
changes between days 3 and 7.  The domains increase in size but no change in 
morphology is observed. 
5.3.1.3 EDX 
EDX was performed on the surface of the SBF soaked glass ceramics in order to 
determine any change in surface composition.  The elemental ratios of silicon, 
phosphorous, calcium and strontium were compared as these have been shown to 
vary following dissolution of the surface and formation of the surface apatite layer.  
The results are shown in figure 94. 
- 179 - 
 
Figure 94: EDX results of the glass ceramics soaked in SBF for 0, 1, 3 and 7 days. 
In all compositions except 6.24 Mol % strontium, the silicon levels decreased and 
the phosphorous levels increased with increasing time.  In composition 6.24 Mol % 
strontium a small overall drop was observed in the silicon levels.  A reduction in 
phosphorous was observed between days 0-1 followed by a gradual increase and by 
day 7 phosphorous levels were at the same point as day 0.  Changes in the silicon 
and phosphorous levels were detectable from day 1.  In composition 6.24 Mol % 
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strontium, no change was observed between the elemental ratios at different time 
points.The calcium and strontium levels remained relatively constant as time 
progressed.  The ratio of calcium to strontium got smaller with increasing strontium 
substitution.  An initial drop in the phosphorous levels was observed between days 0 
and 1 in composition 0 Mol % strontium.  An increase above the initial phosphorous 
levels was detected at days 3 and 7.  In composition 3.12 Mol % strontium, an 
increase was observed in silicon levels between days 1 and 3 before dropping down 
to at day 7 to levels well below those at day 1. 
5.3.2 Determination of MSC attachment and Differentiation on 
Strontium Containing Scaffolds 
The biocompatibility of the materials was determined via observing their 
interactions with primary mesenchymal stem cells.  To minimise the number of cells 
required, composition 9.35 Mol % strontium was not tested due to its low 
mechanical strength. 
5.3.2.1 Osteogenic Differentiation 
To determine the ability of the cells to undergo osteogenic differentiation, donor cell 
lines K28 and K17 were cultured in osteogenic media for 21 days in a static 
environment in 24 well tissue culture plates.  MSC cell lines were compared to cells 
cultured in basal media and Saos-2 osteosarcoma cell lines, the results are shown in 
figure 95. 
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Figure 95: Alkaline phosphates (red) and von Kossa (brown) staining of MSC K28 
and K17 donor lines cultured in basal and osteogenic media for21 days.  
Saos-2 cells are included as a positive control. 
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In both primary cell lines, K28 and K17, there was a small amount of red alkaline 
phosphatase staining following 21 days culture in basal media and very little dark 
von Kossa staining.  The cells retained a fibroblast like morphology when cultured 
in basal media.  In the SaOS-2 positive control there was strong alkaline 
phosphatase staining and very little evidence of Von Kossa staining following 21 
days culture in basal media.  The SaOS-2 cells had a rounded, osteoblast like 
morphology.  An increase in alkaline phosphatase activity was observed in both 
primary MSC cell lines following 21 days culture in osteogenic media compared to 
culture in basal media.  Higher alkaline phosphatase activity was detected cells K28 
than K17.  Small levels of von Kossa staining were observed following 21 days 
culture in osteogenic media. 
5.3.2.2 Flow Cytometry for MSC Surface Markers 
The donor cell lines that were used for subsequent biological assessment were 
assessed via flow cytometry for surface markers known to be present or absent on 
the surface of mesenchymal stem cells.  The red histogram represents the control, 
un-labelled, population and the green the labelled population.  A shift in the median 
to a higher value following labelling indicates the presence of the specific surface 
marker.  The results are shown in figures 96 to 98.  All cell lines were positive for 
CD44, CD90, CD105, CD29 and CD73 whilst being negative for CD45 and CD34.  
CD166 was positive in cell line K41 and 56 but negative in K28. 
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Figure 96: Flow cytometry results for donor K28.  RED = control median 
GREEN = sample median.  The surface marker and label used are also shown. 
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Figure 97: Flow cytometry results for donor K41.  RED = control median 
GREEN = sample median.  The surface marker and label used are also shown. 
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Figure 98: Flow cytometry results for donor K56.  RED = control median 
GREEN = sample median.  The surface marker and label used are also shown. 
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5.3.2.3 Scaffold Sterilisation   
The strontium containing scaffolds were sterilised by a high temperature and 
pressure autoclave process.  SEM imaging was used to determine if any change in 
surface morphology had occurred in the samples following sterilisation.  Figure 99 
shows that following autoclave sterilisation, all samples displayed the surface 
morphologies previously observed in samples that had not been treated, see 3 
chapter 3. 
 
Figure 99: SEM images of the post autoclave scaffold surface (a) 0 Mol % strontium 
(b) 3.12 Mol % strontium (c) 6.24 Mol % strontium and (d) 12.47 Mol % 
strontium. 
5.3.2.4 Optimum Seeding Density Determination 
MSCs were seeded onto the cylindrical scaffolds of composition 0 Mol % strontium 
and cultured for 24 hours in basal media.  Cells were seeded at 5x10
5
, 25.x10
5
, 
1x10
5
, 7.5x10
4
 and 5x10
4
 cells per scaffold, see figures 100 and 101.  The back 
scattered electron (BSE) images clearly show the dark cells contrasting the lighter 
scaffold.  Cells were observed on the scaffold following each of the seeding 
densities tested.  Individual cells are visible for seeding densities 5-7.5x10
4
 
cells/scaffold.  The individual cells are seen to bridge pores whilst making good 
contact with the material.  As the seeding density increases the cells increase their 
connectivity and also begin to form sheets on the surface of the scaffold.  Confluent 
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sheets are formed on the scaffolds for seeding densities 1-5x10
5
 cells/scaffold.  The 
sheets contain cracks induced by the dehydration process.  The particles of the 
scaffold are visible through the cell layer.  High magnification images reveal that in 
densities 2.5-5x10
5
 cells/scaffold the confluent layer is multiple cells thick.  
However cells on the bottom layer can still be seen to interact directly with the 
scaffold.  In concentration 1x10
5
 cells/scaffold the confluent layer is predominantly 
one cell thick. 
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Figure 100: Optimum seeding density determination. MSCs seeded at (a-b) 5x10
5
 
cells/scaffold (c-d) 2.5x10
5
 cells/scaffold (e-f) 1x10
5
 cells/scaffold 
(g-h) 7.5x10
4
 cells/scaffold and (i-j) 5x10
4
 cells/scaffold. 
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Figure 101: SE and BSE high magnification images of the optimum seeding density 
evaluation. (a) 5x10
5
 cells/scaffold (b) 2.5x10
5
 cells/scaffold 
(c) 1x10
5
 cells/scaffold (d) 7.5x10
4
 cells/scaffold and (e) 5x10
4
 cells/scaffold. 
5.3.2.5 Cell Expansion on the Glass-Ceramic Scaffolds 
Scaffolds were seeded at 5x10
4
 cells/scaffold (half the optimum seeding density) 
were cultured in basal media for up to 21 days and imaged at days 0, 7, 14 and 21 
using SEM SE and EDX, figures 102 to 105.  Green post analysis colouring was 
assigned to calcium and red to the carbon.  In all samples, the calcium rich scaffolds 
were marked as green regions and the carbon rich cells were labelled red.  The 
proliferation of cells across the scaffold was the same for all materials tested.  Cells 
were isolated at day 0, residing on both the particles and within pores.  At day 0 the 
cells can be seen to bridge pores.  By day 7 the number of cells had increased.  The 
increase in cell number also resulted in an increase in connectivity.  At day 14 the 
cells had begun to form sheets though were not confluent.  At day 21 the cells had 
formed near-confluent sheets.  The sheets bridged pores and formed across the 
surface of the scaffold.  Cells can be seen in the pores below the confluent sheets. 
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Figure 102: EDX (left) and SE (right) SEM images of the cell number expansion of 
MSCs seeded on composition 0 Mol % strontium at (a-b) day 0 (c-d) day 7 
(e-f) day 14 and (g-h) day 21. 
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Figure 103: EDX (left) and SE (right) SEM images of the cell number expansion of 
MSCs seeded on composition 3.12 Mol % strontium at (a-b) day 0 (c-d) day 7 
(e-f) day 14 and (g-h) day 21. 
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Figure 104: EDX (left) and SE (right) SEM images of the cell number expansion of 
MSCs seeded on composition 6.24 Mol % strontium at (a-b) day 0 (c-d) day 7 
(e-f) day 14 and (g-h) day 21. 
- 193 - 
 
Figure 105: EDX (left) and SE (right) SEM images of the proliferation assay of 
MSCs seeded on composition 12.47 Mol % strontium at (a-b) day 0 (c-d) day 
7 (e-f) day 14 and (g-h) day 21. 
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5.3.2.6 Alkaline Phosphatase Activity Via pNPP Assay 
MSC primary cell lines were seeded onto the scaffolds at a concentration of 1x10
5
 
cells/scaffold and cultured in osteogenic media for up to 21 days.  Cells K28 and 
K56 were at passage 4 when seeded and K41 was at passage 5.  Cell/scaffold 
constructs were collected at days 0, 7, 14 and 21 and the alkaline phosphatase 
activity of the local cells was calculated using a pNPP assay and the results 
normalised to DNA content using a PicoGreen assay.  The results are shown in 
figures 106 to 111 on pages 196 to 198. 
5.3.2.6.1 MSC Donor K28 
For donor K28, the DNA content at day 0 was 0.28±0.025 µg/ml and increased in all 
samples up to day 21.  Composition 0 Mol % strontium had the lowest DNA levels 
from day 0-14.  The rate of increase got larger for composition 0 Mol % strontium 
between days 14 and 21 and reduced for compositions 3.12, 6.24 and 12.47 Mol % 
strontium.  At day 21, composition 0 Mol % strontium had the highest DNA levels.  
The pNPP levels were highest in all compositions at day 0, though large error bars 
indicate a large distribution.  A drop was observed at day 7, followed by an increase 
at day 14 and a second reduction at day 21.  There was no significant difference 
between compositions at day 0 or day 7.  By day 14 there was a significant increase 
(p≤0.05) in the pNPP levels of composition 3.12 Mol % strontium compared to all 
the other groups, which were not significantly different from each other.  At day 21 
composition 3.12 Mol % strontium was significantly (p≤0.05) larger than the 3 other 
compositions.  The remaining compositions were not significantly different at 
p≤0.05 but at p≤0.10 composition 6.24 Mol % strontium was significantly larger 
than compositions 0 and 12.47 Mol % strontium, which were not significantly 
different. 
5.3.2.6.2 MSC Donor K41 
For cells K41, the initial DNA concentration was 0.35±0.015 µg/ml for all samples.  
In all samples an increase was observed between days 0-14.  Between days 14-21 
there was a small reduction for compositions 0 and 3.12 Mol % strontium, a large 
reduction in 6.24 Mol % strontium and an increase in composition 12.47 Mol 5 
strontium.  The pNPP levels increased between days 0-7 for compositions 0 and 
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3.12 Mol % strontium and reduced in the remaining compositions.  A reduction was 
observed between days 7-14 for composition 0 Mol % strontium while the 
remaining compositions increased.  Between days 14-21, a reduction was observed 
in composition 6.24 Mol % strontium while an increase was observed in 
compositions 0, 3.12 and 12.47 Mol % strontium.  There was no significant 
difference (p≤0.05) between all compositions at day 0.  At day 7 there was a 
significant (p≤0.05) reduction between composition 0 Mol % strontium and 
compositions 6.24 and 12.47 Mol % strontium.  Composition 3.12 Mol % strontium 
was significantly (p≤0.05) larger than composition 12.47 Mol % strontium.  
Compositions 0 and 3.12 Mol % strontium were significantly larger than 
compositions 6.24 and 12.47 Mol % strontium for p≤0.10.  At day 14, composition 
12.47 Mol % strontium was significantly (p≤0.05) lower than the remaining 
compositions.  Composition 3.12 Mol % strontium was significantly (p≤0.05) higher 
than composition 0 Mol % strontium.  At day 21, compositions 0 and 3.12 Mol % 
strontium were significantly higher than composition 12.47 Mol % strontium. 
5.3.2.6.3 MSC Donor K56 
For cell line K56, the DNA concentration was 0.45±0.055µg/ml at day 0.  There was 
a steady increase in DNA concentration between days 0-21 in all compositions 
tested.  Composition 12.47 Mol % strontium had a lower DNA concentration at time 
points 7-21 days.  Ther pNPP levels increased in all compositions between days 0-7.  
An increase was observed in compositions 0 and 3.12 Mol 5 strontium between 
days 7-14, compositions 6.24 Mol % strontium remained constant while 
composition 12.47 Mol % strontium reduced.  There was a reduction in all the pNPP 
levels of all compositions between days 14-21.  There was no significant (p≤0,05) 
difference between the compositions at day 0.  At day 7 composition 12.47 Mol 5 
strontium was significantly (p≤0,05) lower than compositions 0 and 3.12 Mol % 
strontium.  At day 14, compositions 0 and 3.12 Mol % strontium were significantly 
(p≤0,05) larger than compositions 6.24 and 12.47 Mol % strontium.  At day 21 
composition 12.47 Mol % strontium was significantly (p≤0,05)lower than the 
remaining compositions.  Composition 12.47 Mol % strontium was specifically 
higher than compositions 6.24 and 12.47 Mol % strontium. 
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Figure 106: DNA content of the cell/scaffold constructs at different time points for 
donor K28 seeded at passage 4.  Error bars represent the standard error. 
 
Figure 107: Alkaline phosphatase activity normalised to DNA at progressive time 
points for cell/scaffold constructs for donor K28 seeded at passage 4.  Error 
bars represent standard error.  Labels represent groups that were not 
significantly different for p<0.05 at a single time point, * indicates p<0.1. 
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Figure 108: DNA content of the cell/scaffold constructs at different time points for 
donor K41 seeded at passage 5.  Error bars represent the standard error. 
 
Figure 109: Alkaline phosphatase activity normalised to DNA at progressive time 
points for cell/scaffold constructs for donor K41 seeded at passage 5.  Error 
bars represent standard error.  Labels represent groups that were not 
significantly different for p<0.05 at a single time point, * indicates p<0.1. 
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Figure 110: DNA content of the cell/scaffold constructs at different time points for 
donor K56 seeded at passage 4.  Error bars represent the standard error. 
 
Figure 111: Alkaline phosphatase activity normalised to DNA at progressive time 
points for cell/scaffold constructs for donor K56 seeded at passage 4.  Error 
bars represent standard error.  Labels represent groups that were not 
significantly different for p<0.05 at a single time point. 
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5.3.2.6.4 Tissue Culture Plastic Control 
A fifth material, tissue culture plastic, was used to ensure the MSCs were able to 
differentiate under the conditions used.  6 replicates were performed for each time 
point and for each donor, the results are shown in figure 112.  DNA and normalised 
pNPP increased in all samples up to day 14.  In donors K41 and K56 DNA increased 
between days 14 and 21 where as a small reduction was observed in K28.  
Normalised pNPP levels reduced between days 14 and 21 in all samples, with donor 
K28 showing the least amount of reduction. 
 
Figure 112: The pNPP normalised to DNA (left) and DNA (right) results for MSCs 
cultured in osteogenic media on tissue culture plastic.  Donors from top to 
bottom are K28, K41 and K56. 
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5.4 Discussion 
The aim of this chapter was to assess the biological compatibility of the newly 
developed glass ceramics.  The method previously implemented for scaffold 
formation allowed for the rapid formation of porous glass-ceramic test specimens.  
The scaffolds that were used for biological testing represent an example of the 
application of the developed glass ceramics.  To aid comparison between samples an 
identical heat treatment was applied to all glass compositions.  The heat treatment 
that was chosen was that which had previously been shown to crystallise both 
apatite and calcium silicate phases in the glass while also forming well sintered 
materials that retained their porous structure.  The processing that was used was not 
optimised for the development of individual microstructures or porosities for 
individual compositions.  Individual scaffolds were utilised to ensure that 
subsequent analysis was done on the native scaffold surface as opposed to a cut 
surface.  The scaffold size was optimised to fit within 96-well plates during 
subsequent cell interaction testing. 
The first step that was taken in the biological assessment was the ability of the 
scaffolds to form a surface apatite layer when submerged in simulated body fluid.  
Simulated body fluid is a solution with ion concentrations nearly equal to those of 
blood plasma [116].  Some calcium phosphate materials will spontaneously form a 
surface layer of hydroxyapatite when submerged in simulated body fluid and this 
layer has been shown to enhance bonding of the materials to bone [161].  The 
formation of the surface apatite layer on the material surface varies depending on the 
material tested and the exact mechanism has been the subject of some debate.  In all 
calcium phosphates the mechanism first starts with the dissolution of elements from 
the material surface, altering the ionic concentration of the solution and providing 
nucleation points for subsequent nucleation.  Glass ceramic apatite-wollastonite has 
been shown to form a surface apatite layer following less than one day submersion 
in SBF [61].  The mechanism by which the layer forms has been described by 
Kokubo [116].  Briefly, dissolution of calcium and silica from the wollastonite and 
residual glass phases leads to an increase in the supersaturation of calcium in the 
SBF and the exposure of favourable apatite nucleation sites on the surface of the 
material.  The different phases in the glass-ceramic have different solubilities in 
SBF, from most to least soluble: glass > calcium silicate > apatite phase.  The 
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exchange of ions between the material and solution leads to variations in pH of the 
solution that influence subsequent dissolution of the material, formation of the 
surface apatite layer and also the behaviour of local cells [67].  The increase in pH 
of the SBF solution observed in all compositions is likely to be as result of an 
exchange of magnesium, calcium and strontium from the materials surface for H
+
 
ions in solution.  The H
+
 ions are produced from the dissociation of water and 
following their incorporation into the surface of the material leave an imbalance of 
OH
-
, resulting in an increase in pH (a more basic solution) [162].  The increase in 
pH with increasing strontium content in the parent glass may be a result of an 
increase in the release of calcium and strontium ions from the glass due to a 
reduction in the connectivity and expansion of the glass matrix due to the larger 
strontium ion leading to a less stable glass and increased ion release, as reported by 
Hesaraki in CaO-SrO-SiO2-P2O5 glasses [82].  O’Donnel [85] reported an increase 
in the pH following soaking in SBF of strontium substituted Bioglass compositions.  
This was also reported by Fredholm [81], who also identified an increase in 
strontium release with substitution into the glass but not an overall increase in 
strontium and calcium levels.  Silicon levels were also found not to vary with 
strontium substitution and only an increase in phosphorous was observed.  The pH 
change is therefore likely to be due either to the release of HPO4
2-
and PO4
3-
 ions or 
the increased reactivity of strontium with water compared to calcium.  The residual 
glass phase in the apatite-wollastonite system, as described here, is not thought to 
have high levels of phosphorous [135] and so will not be released to the solution and 
will therefore not influence the pH [89].  Lao [84] reported a reduction in dissolution 
with increasing strontium substitution in glasses in the CaO-SrO-SiO2 and 
CaO-SrO-SiO2-P2O5 systems when submerged in DMEM.  This was attributed to an 
increase in oxygen bonding strength for strontium, compared to calcium, that was 
thought to inhibit exchange with H
+
.  It was also suggested that strontium would 
stabilise the glass network more than calcium due to its lower electronegativity, 
resulting in better charge balancing with Si-O- bonds.  The inclusion of strontium 
into wollastonite was shown by Wu [73] to inhibit its dissolution in SBF and 
resulted in a lower pH following soaking.  The substitution of the larger strontium 
ion in place of calcium into the crystal lattice was thought to inhibit diffusion 
through the crystal and thus limit the dissolution of the crystal.  The reduction in the 
weight percentage of the wollastonite phase that was observed with increasing 
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strontium substitution into the glass-ceramics described here would limit the effect 
that wollastonite dissolution would have on the pH changes observed.  The apatite 
phase is thought to be stable in SBF due to the solution already being supersaturated 
with respect to apatite.  However, the substitution of strontium for calcium into the 
crystal has been shown increase its solubility [163, 164]. 
Analysis of the ionic composition of the SBF solution with time is required to 
determine the cause of the pH change.  The change in pH will however have an 
effect of the ability of the materials to form a surface apatite layer.  The dissolution 
of the material surface leads to an increase in calcium in the SBF, which is already 
supersaturated with respects to apatite.  This leads to the formation of a 
hydroxyapatite (HA) and/or hydroxyapatite/carbonate (HCA) surface layer.  The 
formation of the surface layer can be detected by looking at the composition and 
morphology of the material’s surface.  Crystals were detected on the surface of 
compositions 0 and 3.12 Mol % strontium from day 1 and its coverage of the surface 
increased up to day 7 when a complete covering was observed.  EDX analysis 
revealed that the surface composition changed over time with the silicon levels 
reducing and phosphorous levels increasing.  The phosphorous levels increased 
compared to calcium content suggesting that the change was due to a deposition of 
phosphorous and not just a reduction of silicon.  This would suggest that the surface 
layer that was deposited was a calcium phosphate, most likely HA or HCA.  The 
morphology of the surface layer was composed of crystals with a plate like 
morphology  and resembled that observed previously for apatite wollastonite glass-
ceramics [61, 89].  The plate like crystals were not observed on the surface of 
compositions 6.24-12.47 Mol % strontium.  The EDX results suggest that in 
compositions 9.35-12.47 Mol % strontium the composition of the surface was 
changing in accordance with that observed for compositions 0-3.12 Mol % 
strontium.  The morphology of the apatite phase changes between days 1-7, with the 
crystal domains becoming larger with less well defined boundaries.  The addition of 
strontium to wollastonite has been shown by Wu [73] to form an apatite layer 
consisting of ball like crystals instead of those that resemble plates.  The effect was 
also observed by Oliveira in strontium substituted apatite coatings.  The addition of 
strontium has also been shown to produce a thinner HA layer, a reason why the 
changes in morphology observed are not as prominent in the low strontium 
containing compositions.  The change in morphology could be due to dissolution of 
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the phase changing its appearance; however the EDX results indicate an increase in 
phosphorous, indicating deposition is taking place.  Dissolution of phases would not 
only change their appearance but has been shown to influence the morphology of the 
deposited HA surface layer [165].  The large silicate phase in the glass ceramics 
reported here does not appear to show any change in morphology following soaking, 
suggesting an inhibitory effect on the apatite layer formation.  It should be noted that 
the apatite rich domains may also contain residual glass and wollastonite levels that 
decrease with increasing strontium substitution, as previously reported.  The surface 
of composition 6.24 Mol % strontium showed little change in morphology up to 7 
days.  This could be due to a combination of the mechanisms described.  The 
reduction in solubility of the silicate phase that occurs with increasing strontium 
substitution would limit the material’s ability to form an apatite layer.  Composition 
6.24 Mol % strontium has a higher calcium silicate content than the higher strontium 
containing compositions and fewer exposed apatite domains, therefore the reduction 
in solubility of the silicate phase may not have been counteracted by the increased 
solubility of the apatite phase.  The increase in pH that was observed with increasing 
strontium substitution would favour apatite deposition.  The formation of HA 
proceeds as in equation 113 [166].  A lower pH favours the dissolution of HA due to 
there being an increase in H
+
 and a high pH at its formation [166].  This also 
suggests that the change in morphology of the apatite containing domains is due to 
deposition and not dissolution, as the higher pH would favour formation.  The 
reduction in the rate of pH increase may be due to the formation of an apatite layer 
which would prevent further dissolution and also release H
+
 ions into solution. 
            
       →                   
  
Equation 113 
Subsequent biological testing was only performed on compositions 0, 3.12, 6.24 and 
12.47 Mol % strontium.  This was done to minimise the number of cells required.  
Composition 9.35 Mol % strontium was not included due to its poor formability 
leading to low scaffold mechanical strength.  Sterilisation of the scaffold using an 
autoclave was shown to have no effect on the appearance of the surface features.  
This method of sterilisation has been reported previously for A-W glass 
ceramics [88, 117]. 
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MSCs were isolated from human knee explants, removed during knee arthroplasty.  
The arthroplasty involved the removal of the femoral condyle, which was collected, 
and its replacement with a prosthesis.  While the cells from different donors 
displayed the same fibroblast like morphology, variation was observed between their 
ability to differentiate down the osteogenic lineage when exposed to the osteogenic 
differentiation media.  Large inter donor variation in properties is a known problem 
with MSC populations [167].  One factor affecting the variation in osteogenic 
capacity is the age of the donor.  Cells from older donors have the same length 
telomeres as those from younger donors [168], maintaining their ability to divide.  
They do however show a reduction in their ability to differentiate, likely due to 
oxidative damage or senescence of supporting cells [33].  The disease state of the 
knee will also affect the capacity of the cells to differentiate .  All the knees were 
being operated on due to cartilage and eventual bone degradation due to 
osteoarthritis.  The severity of the disease state of the knees was not reported.  The 
use of cells from the diseased joint for the testing of the material reported here may 
better replicate the environment in which it will be used.  The number of population 
doublings that the cells undergo in culture affects their ability to proliferate and 
differentiate [169].  The differentiation ability of in vitro cultured bone MSCs drops 
from the 6
th
 passage on, due to a reduction in telomere length leading to senescence 
and cycle blocking [170].  Tissue derived and marrow derived MSCs have been 
shown to retain similar growth kinetics up to passage 8 [169].  Both cell lines that 
were used in the osteogenic assay were at passage 3.   
Flow cytometry results show that the populations were all positive for markers 
CD29, CD44, CD73, CD90 and CD105 while being negative for CD34 and CD45.  
The positive and negative cell markers reported are all in line with the most 
frequently reported MSC markers [171].  A small increase in the histogram median 
was observed for CD166.  The reduction in CD166 has previously been reported in 
cells that were extracted from the bone and cartilage as opposed to the bone marrow, 
which expressed CD166 at high levels [169].  Cells grown from trabecular bone and 
cartilage expressed CD29, CD90 and CD105 and were negative for CD45 and CD90 
but showed a large reduction in the expression of CD166 than populations of bone 
marrow derived mesenchymal cells.  The cells were still shown to proliferate and 
differentiate, but with a reduced capacity [169].  A systematic review by Mafi on the 
most commonly reported markers indicated some inconsistencies between the 
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reports of different research groups [171], highlighting the difficulties in assigning 
specific surface markers to this group of cells. 
The scaffold seeding protocol was modified from the method utilised by 
Dyson [117].  The optimum seeding density was chosen to provide a confluent 
monolayer in as short a time as possible.  Seeding of bone marrow derived cells at 
higher densities has been shown to enhance mineralisation [172].  Too high a 
seeding density resulted in the formation of layer which was multiple cells thick, 
reducing the contact which the cells had with the scaffold.  Too low a seeding 
density and the cells would not undergo osteogenic differentiation within the time 
frame of the experiment.  On A-W scaffolds with a similar structure, Dyson reported 
that when using scaffolds that were 3x3x3mm a seeding density of 5x10
5
 
cells/scaffold allowed cells to attach after 6 hours and form a confluent sheet by 24 
hours [117], a similar value to that reported here.  Dyson achieved a seeding density 
of 28.4±2.6% [117], the efficiency of static seeding has been shown to be around 
25% [172].  The seeding efficiency can be increased by using a dynamic seeding 
method, with the methods used reviewed by Yeatts [173].  The SEM/EDX 
proliferation study does however show that cells seeded at half the optimum seeding 
density are still capable of forming a confluent layer on the material.  Magallanes-
Perdomo [88] reported that individual cells were able to proliferate and migrate on 
A-W discs and formed a confluent sheet by day 14 with calcium phosphate 
depositions observed by day 21.  Bone derived MSCs have previously been shown 
to attach to and proliferate on A-W glass ceramics [88, 117] but the proliferation 
study shows that the novel strontium containing glass ceramics were also able to 
support cell attachment and proliferation to ultimately form a confluent cell layer by 
day 21.  No difference was observed between the ability of the different scaffolds to 
support cell attachment and expansion.  This was also verified using the pico green 
DNA assay where all compositions showed a similar rate of DNA increase.  
Strontium incorporated into Bioglass has previously been shown to not influence 
cell proliferation [85]. 
Three donors were used for the quantitative assay to help minimise the effect of inter 
donor variation.  the pNPP levels of day 0 for donor K28 were the highest reported 
but also had the largest error bars.  This was in part due to initially low DNA levels.  
An increase was observed in pNPP levels between days 7 and 14 in all samples but 
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donor K56 compositions 6.24 and 12.47 Mol % strontium.  The pNPP levels 
remained constant or decreased between days 14 and 21.  This was also observed in 
the cells cultured on tissue culture plastic, who’s normalised pNPP levels all peaked 
at day 14.  This behaviour has been observed previously in rat osteoblasts [174] and 
human MSCs [117] when cultured on A-W.  It was clear that by day 21 
compositions 0, 3.12 and 6.24 Mol % strontium were better able to support 
osteogenic differentiation than composition 12.47 Mol % strontium.  Composition 
3.12 Mol % strontium had the highest pNPP levels at day 21 in all donor groups but 
was only significantly larger than composition 0 Mol % strontium for donor K28.  A 
significant increase was observed for composition 3.12 Mol % strontium compared 
to composition 0 Mol % strontium at day 14 for donors K28 and K41.  It is clear 
from the results that strontium incorporation into the scaffolds is having an effect on 
the ability of the scaffolds to support osteogenic differentiation.  The lowest level of 
strontium substitution investigated was able to increase osteogenic differentiation 
while composition 6.24 Mol % strontium had no significant effect and composition 
12.47 Mol % inhibited osteogenic differentiation.  The mechanisms by which 
strontium has induced these effects will now be discussed. 
The release of strontium ions from the material’s surface may be responsible for the 
fluctuations in osteogenicity of the materials.  Orally administered strontium salt 
(strontium renate) has been shown to have a beneficial effect on bone mass in 
patients with osteoporosis [175, 176].  Part of the reason for this is that it has been 
shown to enhance osteoprogenitor differentiation into osteoblasts and enhance their 
proliferation [176].  Strontium substitution for calcium into Bioglass was shown to 
increase ALP levels with increasing substitution up to 100 % strontium [90].  
Strontium substitution into sol-gel derived CaO-SrO-SiO2-P2O5 glasses showed an 
increase in ALP with an optimum value at 5 Mol %.  Substitutions larger than this 
produced a reduction in ALP but also a reduction in proliferation resulting in a ALP 
normalised to DNA level not significantly different from 0 Mol % substitution.  The 
value of 5 Mol % strontium is close to the optimum (3.12 Mol %) composition 
developed here.  Substitution of strontium for calcium into hydroxyapatite, up to 
10% substitution, increased ALP levels in rat osteoblasts that were exposed to media 
conditioned with the apatites [71].  This was also shown in human osteoblast cell 
line MG-63 exposed to of strontium substituted hydroxyapatite conditioned media, 
substitutions greater than 10 % strontium produced no change in ALP [91].  The 
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same cell line increased ALP levels when exposed to strontium containing 
wollastonite, up to 20 % substitution [91].  It should be noted that optimum 
composition, 3.12 Mol % strontium, was a 12.5% strontium substitution for calcium, 
a close match to the optimum values reported in the literature.  These results from 
the literature clearly show that the dissolution products of strontium containing 
materials can influence the bone forming ability of osteoblasts and their progenitors. 
In the experiments reported here cells were put into direct contact with the scaffolds.  
The surface morphology of the material has been shown to influence the behaviour 
of cells [48, 177, 178].  The inclusion of strontium into the parent glass was shown 
to influence the morphology and ratio of phases that formed in the material, causing 
the surface topography of the material to change.  Changing in patterning of the 
surface has been shown to influence MSC differentiation and can be used to 
osteogenically differentiate human bone MSCs without the use of osteogenic factors 
in the media [178].  Though not investigated here, the change in materials stiffness 
and elasticity that would likely result with substitution of strontium will also 
influence the cells ability to differentiate into osteoblasts [48].  The surface of the 
materials will also spontaneously change upon immersion in the media.  
DMEM [179].  The change in morphology of the surface and the surface apatite 
layer will influence the surface that the cells are exposed to.  A-W preconditioned 
with a surface apatite layer was shown to enhance ALP expression compared to non-
conditioned A-W in rat osteoblasts following 23 days culture [174].  Unlike when 
standard SBF is used, the use of DMEM and also FCS will incorporate proteins into 
the surface, most likely fibronectin and vitronectin, which will enhance the 
osteoblast adhesion and interaction with the material [180].  The surface 
morphology and phase composition of 3.12 Mol % strontium was the most similar to 
composition 0 Mol % strontium (compared to the other strontium containing 
compositions).  This suggests that the changes in surface morphology and phase 
composition were having a negative effect on the osteogenic differentiation of the 
MSCs that were counteracting the enhancing effects of strontium ion release.  
Exposure of the cells to media conditioned with the materials would confirm if the 
observed effect was a result of the chemical dissolution products or the physical 
interactions with the material surface. 
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Chapter 6: General Discussion 
Replacement materials are required when spontaneous healing of a bone defect does 
not occur.  Healing of bone requires a combination of cells, extra cellular 
matrix (ECM) and environmental factors such as chemical signalling or mechanical 
stimulus.  A suitable replacement material should act as an ECM by mechanically 
supporting and protecting local cells while providing the correct environment to 
assist, accelerate or induce the formation of new bone.  Calcium phosphate bioactive 
glasses and glass-ceramics have found favour as bone replacement materials due to 
their ability to bond to native bone via a surface apatite layer and also to support and 
direct cell attachment, proliferation and differentiation [114].  This is done via 
modification of the material’s chemistry and processing to engineer a device that has 
the bulk and intrinsic mechanical strength, surface chemistry and topography and 
macro and micro structure that is optimised for bone formation.  One such 
modification is the substitution of strontium for calcium in glasses and ceramics to 
enhance their bone forming ability [68, 71, 73, 81, 85-87, 90, 136].  Strontium has 
the same charge as calcium (Sr
2+
/Ca
2+
) and so can be readily substituted in both 
crystalline and amorphous materials.  Strontium treatments have been shown to 
upregulate osteoblast activity and downregulate resorption by osteoclasts leading to 
an increase in bone mass [175, 176].  The substitution has been shown to have an 
effect on a material’s solubility and ion release [67, 68, 71, 73, 81, 84-86, 90], 
mechanical properties [181], formability [86, 125] and crystalline composition and 
morphology [71, 72, 86, 91, 125, 176, 182], all of which will influence how the 
material performs in bone replacement applications.  The aim of this work was to 
develop a new strontium containing glass-ceramic based on the apatite-
wollastonite (A-W) system for use as a bioactive bone replacement material.  
Apatite-wollastonite was chosen as the starting material as it has high mechanical 
strength compared to the bioactive glasses [139], such as Bioglass 45S, while 
remaining highly bioactive and capable of bonding to native bone [161].  A-W is a 
polycrystalline glass-ceramic formed primarily of apatite and wollastonite crystals 
that lie within a residual glass matrix.  It is the combination of ordered and 
disordered phases in the material that allow it to share both the high mechanical 
strength of a ceramic with the bioactivity of a glass [116].  A range of novel 
compositions were formed based on the molar substitution of strontium for calcium.  
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The effect of these substitutions on the amorphous, crystalline and bulk properties of 
the material were investigated along with what influence these changing parameters 
had on the processing of the material, its ability to be formed into a bone 
replacement device and ultimately its ability to promote bone healing. 
The synthesis and processing of the material will determine the properties of a 
device formed from it and so this will be discussed first.  The final material was 
required to consist of a glass that was capable of partial devitrifying to form 
biocompatible crystalline and residual amorphous phases following a post 
processing heat treatment.  Devitrification of the A-W parent glass has been shown 
to be highly sensitive to composition [111, 140], particle size [150] and heating 
rate [60].  The particle size and heating rate were thus maintained between 
compositions while the composition was varied to observe its effect on the final 
material.  Fibrous wollastonite forms in the A-W parent glass via a heterogeneous 
nucleation process and the growth of crystals from the periphery leads to cracking of 
large monolithic blocks [183].  As such A-W must be processed from a ground glass 
powder of smaller particle sizes that must both crystallise and sinter to form a bulk 
material.  The 45-90µm particle size fraction was chosen for devitrification studies 
as it could subsequently be used for the formation of porous materials without the 
use of a template, foaming or leaching agent or post processing machining.  A melt 
quench route was chosen as this has previously been shown to be a successful 
method to produce the A-W parent glass and allows for relatively large batch 
sizes (≈200g) [62].  Laser diffraction determined that the 45-90µm particle fractions 
all had the same size distribution and so were suitable for subsequent analysis.  The 
addition of strontium into the glass network was shown to produce x-ray amorphous 
materials with a network that expanded with increasing strontium substitution.  The 
successful substitution was also confirmed by an increasing density and x-ray 
attenuation with increasing strontium.  The substitution had a marked effect on the 
thermodynamic effects that occurred in the glasses following heating.  A reduction 
in the glass transition temperature was observed with increasing strontium 
substitution, possibly as a result of the expanded network.  There was also a 
reduction in the peak crystallisation of the first phase to form, the apatite phase, and 
an increase in that of the second phase, a calcium silicate.  The change in peak 
position was shown to influence the ratio of the crystalline phases in the bulk 
material, with increasing strontium producing a reduction in the weight percentage 
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of the calcium silicate phase.  The first phase to crystallise was identified as non- 
stoichiometric fluorapatite the unit cell of which expanded with strontium 
substitution, indicating its uptake into the phase.  The second phase was identified as 
monoclinic β-wollastonite, the unit cell of which also expanded with strontium 
addition and at higher substitutions partially transformed into pseudowollastonite.  
The inclusion of strontium into the crystalline phases and the weight ratios of the 
phases to each other plays a key role in the application of the final material as a bone 
replacement material [116].  The changes that occurred were shown to influence the 
materials mechanical strength, surface chemistry and topography and ability to form 
a surface apatite layer when exposed to biological conditions.  The premature 
crystallisation of the apatite phase counteracted the reduction of the glass 
temperature, reducing the size of the sintering window with increasing strontium 
substitution, this reduced the ability of the material to sinter.  Combined with the 
reduction in the wollastonite content of the glass, this produced scaffolds that had 
significantly lower flexural strengths than A-W.  This was not the case in the highest 
strontium containing composition, 12.47 Mol % strontium, where a lack of 
wollastonite and a reduction in glass connectivity allowed the material to melt at a 
lower temperature.  This induced liquid phase sintering upon heating, leading to 
increased densification and mechanical strength of the porous material, despite loss 
of the calcium silicate, which is known to reinforce the material [135].  Though the 
increase in strength is desirable, it was done so at the loss of porosity which should 
be avoided to ensure new bone growth within the material [160].  The wollastonite 
phase is also proven to be crucial in the ability of A-W to form a surface apatite 
layer and so its loss from the glass-ceramic should be avoided [116].  A balance 
between the materials sinterability, bulk mechanical strength and its retention of the 
wollastonite phase is therefore crucial to ensure a successful bone replacement 
material. 
Increasing strontium substitution caused the formation of different structures on the 
material’s surface compared to A-W.  A-W had a homogenous surface composed of 
small interlocking domains that have previously been identified as apatite and 
wollastonite crystals sitting within a residual glass matrix.  As the strontium content 
of the parent glass increased, separate regions formed that were identified as 
strontium containing apatite, a magnesium rich calcium silicate, a magnesium 
depleted calcium silicate and the residual glass phase.  The loss of wollastonite 
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exposed the apatite and glass domains and its partial transformation to 
pseudowollastonite resulted in the formation of distinct crystals.  All the phases 
were also present in the bulk of the material.  The change in ratio and morphology of 
the crystalline phases altered the surface chemistry and topography of the glass 
ceramics.  The result of this is modification of the environment that is presented to 
cells and body fluids when the material is placed in a biological setting.  This was 
highlighted via simulated body fluid testing and in vitro testing with mesenchymal 
stem cells (MSCs).  A coherent surface apatite layer of plate like crystals was 
formed on the surface of composition 0 Mol % strontium (A-W) following 7 days of 
immersion, this coincided with a reduction in silicon and calcium and an increase in 
phosphorous levels at the surface.  This behaviour was observed only in the lowest 
strontium composition tested, 3.12 Mol % strontium.  Very little change was 
observed in composition 6.24 Mol % strontium and although there was a change in 
the morphology and surface chemistry of 9.35 and 12.47 Mol % strontium, the 
change in the surface features did not resemble that which was observed in A-W.  
This suggests that these strontium substituted materials may be less able to bond to 
native bone but this could only be confirmed with in vivo tests.  A change in the pH 
of the SBF was observed between all samples suggesting a change in the dissolution 
of the samples and varied ion release.  SBF testing provides simplified insight into 
the ability of the scaffold to induce new bone formation.  One of the key 
components missing from the fluid is proteins.  Upon implantation in vivo the 
material surface will be coated with proteins, these proteins will direct any 
subsequent cell adhesion and also help to nucleate apatite on the materials 
surface [180].  The change in surface topography effects the material’s apparent 
surface area that is presented for protein attachment.  Immersion in a more 
biologically active medium such as cell culture medium containing serum will 
deposit proteins such as fibronectin and vitronectin on the material’s surface and, 
though this wasn’t directly investigated, cells were able to attach to all the 
compositions tested, suggesting protein incorporation onto the surface [180].  The 
effect of the change in the material’s surface following strontium incorporation had 
a significant effect on the ability of bone marrow derived mesenchymal stem cells to 
differentiate down an osteogenic lineage.  While MSCs were shown to attach and 
increase in number on all the compositions tested, their ability to undergo osteogenic 
differentiation was enhanced, compared to all other samples, on composition 
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3.12 Mol % strontium with the difference being significant (p≤0.05) for one of the 
donors.  In composition 12.47 Mol % strontium, osteogenic differentiation was 
significantly reduced (p≤0.05) compared to A-W in two of the three donors.  As 
discussed, the materials did not just vary in chemical composition but also in their 
crystalline makeup, surface features and also porosity.  While compositions 0-
6.24 Mol % strontium had comparable porosities, composition 12.47 Mol % 
strontium showed a reduction in pore size and interconnectivity.  This may have 
contributed to the cells lack of osteogenic differentiation but would be expected to 
play less of a role in vitro than in vivo [50, 157, 158] where an interconnected 
porosity is required for the formation of a vascular network [160].  The change in 
osteogenic capacity is thus down to the change in the surface presented to the cells 
which would influence signalling to the cells both directly through their attachment 
site [184] and also through local ion release and pH levels [185, 186].  The effect on 
the cells of ion release from the scaffolds could be tested using media conditioned 
with the material following a set soaking period, this was not however investigated 
in this work.  The enhanced osteogenic differentiation in osteogenic media induced 
by the scaffolds and their ability to form a surface apatite layer indicates that they 
have the capacity to be osteoconductive when implanted into the body [187].  This 
means that they are able to direct the growth and formation of new bone onto the 
material’s surface.  The ability of the scaffolds to direct osteogenic differentiation 
without the addition of osteogenic supplements is known as osteoinduction.  
Osteoinduction is thought to be strongly influenced by ion release but also the 
deposition of bone morphogenic proteins onto the material’s surface [187-189] and 
so can only truly be investigated in vivo [189]. 
The glass-ceramics that were tested represent only a single processing route.  The 
properties of the final material can not only be controlled by changing the 
composition of the parent glass but also by changing the particle size, heat treatment 
and post processing treatments. 
As was shown, the position of the wollastonite peak shifted to lower temperatures 
when smaller particle sizes were used, though this effect got smaller with increasing 
strontium substitution.  This does however mean that use of a smaller particle size 
would result in an increase in the wollastonite content of the glass-ceramic, 
potentially increasing the materials intrinsic strength and ability to form a surface 
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apatite layer.  The use of small, large or mixed particle sizes can also be used to 
modify the bulk materials porosity following sintering [108].  The green part 
packing, brown part density and neck formation decreases with increasing particle 
size, producing larger pores.  A range of particle sizes can be used to reduce the 
porosity and increase the networking of particles and number of necks formed 
following sintering, increasing the bulk mechanical strength of a material [114].  
However, in vivo bone formation favours more porous structures with large, 
interconnected porosities [158, 159] and so is often optimised at the expense of 
mechanical strength.  The sinterability and phase ratio will also be influenced by the 
heating rate used.  As the heating rate increased the temperature of both the apatite 
and wollastonite peaks increased while the glass transition temperature showed little 
variation.  This would delay the onset of crystallisation during heating, allowing 
viscous flow sintering of the glass phase to proceed further and enhance neck 
formation and mechanical strength of the porous material.  However, the 
wollastonite peak temperature increase with increasing temperature was greater than 
the apatite peak which would result in a reduced final weight percentage of 
wollastonite in the final glass ceramic.  A change in heating rate could be coupled 
with multiple dwells at different temperatures.  Temperature holds during heating 
can be used to optimise sintering and crystal nucleation and growth.  Viscous flow 
sintering can be enhanced by holding the material at a temperature between the glass 
transition region and the onset of crystallisation.  However in this work apatite was 
found to form in all materials 15°C bellow the DSC-determined onset of 
crystallisation.  The optimum nucleation and growth temperatures can be determined 
via DSC/DTA for the different phases and used to control crystal size and phase 
ratios [61] which in turn contribute to directing the cellular response to the scaffolds.  
Control of the crystalline content of the material will also influence its degradation 
rate.  Incorporation of strontium into both crystalline [73, 163, 164] and amorphous 
phases [84] will affect the rate at which it dissolves in the body.  Also, as the glass, 
wollastonite and apatite phases have different solubilities [116] so control of the 
ratio of the phases to each other can be used to control the resorption of the material.  
This would allow for the rate of resorption to be matched to the rate of new bone 
deposition, ensuring structural integrity of the defect site throughout healing [190].  
The increased radiodensity of the strontium containing materials would make their 
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degradation in the body easier to track using x-ray radiography and computed 
tomography [130]. 
Scaffolds were formed using a simple no-compression sintering route in a mould.  
This method was chosen as it provided a fast route through which a porous bulk 
material could be formed from the powders and was shown to produce consistent 
results.  The method also allowed for the formation of different size geometries to 
match the application which, in the case of this work, was the production of bars for 
flexural strength analysis and cylinders to fit within a 96-well plate.  Different 
mould sizes and dimensions could be utilised to produce scaffolds for different 
surgical interventions [191].  Applications where glass-ceramic bone replacement 
materials have previously been used include maxillofacial reconstruction, iliac crest 
prosthesis, vertebral prosthesis devices and dental implants [192].  Patient specific 
implants can be designed using accurate 3D models formed from computed 
tomography x-ray images of the defect gathered pre-operatively [193].  Bespoke 
implants reduce the time of the implantation surgery as the defect site and device are 
already matched with respect to geometry [194].  3D models can be used to form 
moulds or direct the milling of sintered blocks.  These methods are however limited 
in that they cannot control the internal geometry of a device and so cannot be used to 
introduce features such as channels to promote the in growth of vasculature.  
Additive manufacturing methods such as stereolithography, fused deposition 
moulding, selective laser sintering (SLS) and 3D printing [195] allow for the 
manufacture of bespoke geometries with controlled internal structures.   SLS has 
previously been used for the formation of porous A-W scaffolds [61, 117].  An 
indirect method was used whereby a binder is added to the glass powder which is 
subsequently melted via SLS, bonding the powders in the desired shape.  
Subsequent sintering and devitrification preserves the shape and forms the 
mechanically strong glass-ceramic.  The prefabricated scaffolds are useful for load 
bearing applications where immediate induction of structural integrity is required for 
bone healing.  In non-load bearing applications a loose powder may be used in 
combination an organic matrix.  Apatite-wollastonite glass-ceramic powders used in 
combination with fibrin glue or a bisphenol-a-glycidyl methacylate resin were 
shown to accelerate the healing of rabbit tibia defects [196, 197] and when 
processed properly can be injected to fill irregular voids or overly porous bone[198]. 
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The developed materials have shown promise as bone replacement materials and the 
knowledge gained through this work will allow for their optimisation to a range of 
bone replacement applications. 
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Chapter 7: Conclusions 
This work investigated the effects of strontium substitution for calcium into apatite-
wollastonite glass ceramic.  The work focussed on the substitution of strontium into 
the glass, the influence strontium has on the thermodynamic evolution of crystal 
phases and the morphology and composition of the phases formed.  The new 
materials were then formed into porous scaffolds and their biological properties 
investigated with respect to their ability to form a surface apatite layer in biological 
conditions and their effect on the growth and osteogenic differentiation of human 
mesenchymal stem cells.  To summarise the findings: 
 Strontium was successfully substituted for calcium on a molar ratio up to a 1 
SrCO:1 CaCO ratio.  All compositions formed via the melt quench route 
formed x-ray amorphous glasses with the intended final compositions. 
 The substitution of strontium for calcium produced an increase in the radio 
density of the material in line with theoretical models.  This would allow for 
a greater ease in post operative x-ray imaging of the materials if used in a 
bone replacement device. 
 When heated, all the parent glasses devitrified to form apatite and 
wollastonite phases and a residual glass phase.  Strontium was taken up into 
both the apatite and wollastonite phases with an increase in unit cell 
dimensions observed with subsequent substitutions.  At higher strontium 
levels, pseudowollastonite began to form alongside the monoclinc β-
wollastonite. 
 Electron microscopy of the glass-ceramics revealed the materials to be 
composed of interlocked phases sitting within a residual glass matrix.  The 
apatite crystals were found to form in small domains that also contained 
residual glass.  Two silicate phases were observed, definable by their 
morphology and varying magnesium content.  The surface phases were more 
pronounced at higher strontium contents. 
 The temperature at which the wollastonite phase formed increased with 
increasing strontium substitution and its relative phase contribution to the 
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glass ceramic decreased accordingly.  The temperature at which the apatite 
phase formed showed a small decrease with increasing strontium substitution 
while the glass transition temperature showed a small increase, reducing the 
working window of the materials. 
 The reduction in the size of the working windows led to a reduction in 
sintering and mechanical strength, apart from in composition 12.47 Mol % 
strontium where a shift from solid to liquid phase sintering produced an 
increase in densification and mechanical strength. 
 Scaffolds formed from the materials retained an interconnected porosity, 
apart from composition 12.47 Mol % strontium, where densification led to 
the occlusion of pores. 
 Compositions 0 and 3.12 Mol % strontium formed a surface apatite layer 
after 7 days immersion in simulated body fluid.  Composition 6.24 Mol % 
strontium showed no change following 7 days soaking.  The apatite surface 
domains increased in size in compositions 9.35-12.47 Mol % strontium 
between days 3 and 7 but no change on morphology was observed.  Energy 
dispersive x-ray analysis revealed that the calcium, phosphorous and silicon 
levels of the materials surfaces varied with soaking time, suggesting ion 
exchange with the solution.  Increasing strontium substitution produced an 
increase in the solution pH. 
 The interaction of compositions 0, 3.12, 6.24 and 12.47 Mol % strontium 
with human bone marrow mesenchymal stem cells was investigated.  All 
compositions were able to support cell attachment and expansion up to 
day 21.  Composition 12.47 Mol % strontium inhibited osteogenic 
differentiation compared to apatite-wollastonite (composition 0 Mol % 
strontium) where-as composition 3.12 mol % strontium enhanced osteogenic 
differentiation; this was significant for one donor. 
In conclusion, glass-ceramics were successfully formed following the substitution of 
strontium into the apatite-wollastonite parent glass.  The materials were shown to 
support mesenchymal stem cell growth and differentiation and thus show promise as 
bone replacement materials. 
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Chapter 8: Future Work 
The complex nature of the glass-ceramics produced in this piece of work provides a 
large scope for future work.  Though it was shown that strontium could be 
substituted for calcium into the apatite-wollastonite glass-ceramic, the processing 
was not fully optimised for the ultimate goal of producing a bone replacement 
device from the materials.  While the devitrification of the material was 
characterised in terms of the thermodynamics and phase formation in the glass, the 
effect of different heat treatments on the final glass-ceramics was not determined.  
This would involve characterisation of the material’s physical properties and also its 
biological interactions with simulated body fluid, bone forming cells and also in vivo 
animal and human studies. 
To aid comparison between samples, all materials were exposed to the same heat 
treatment.  The materials were found to crystallise at different temperatures and so 
heating regimes specific to each material could be used to control the phase content 
of the glass-ceramics.  Subsequent testing with mesenchymal stem cells (MSCs) 
would allow for a better understanding of how each phase contributes to the effects 
that were observed in this work.  For example, a heat treatment that does not 
nucleate the calcium silicate phase would allow for a better understanding of how 
the apatite phase influences both the ability of the material to form a surface apatite 
layer in simulated body fluid (SBF) and also how it directs the fate of MSCs.  
Testing could be performed using a matrix setup, comparing the biological response 
to different heat treatments and thus different phase compositions.  The heating rate 
and particle size used influenced the temperature at which the phases formed in the 
material, and so a varied heating rate would also allow for the control of the glass-
ceramic’s final crystal composition.  This would not only influence the environment 
exposed to the body if implanted but also the mechanical properties of the material 
including mechanical strength, porosity and solubility. 
Only one method of forming a porous material was investigated in this work.  
Further work should focus on the formation of more biologically relevant 
architectures.  This would focus on both the pore structure of the material, matching 
it to the application eg. cancellous or cortical bone, and also the bulk architecture, 
matching the size and shape of the scaffold to the defect site.  The application of the 
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material for a range of free form fabrication methods, such as selective laser 
sintering and 3D-printing, should be investigated to achieve the goal of producing a 
controlled architecture. 
The dissolution of the material within a biologically relevant environment should be 
examined.  Analysis of the ion levels of simulated body fluid following specimen 
soaking would help to understand the degradation of the materials, this could be 
done using inductively coupled plasma atomic absorption or optical emission 
spectroscopy.  The rate of degradation and its effect on the mechanical properties of 
the material should also be investigated to allow for the formation of a device which 
degrades at the same rate as new tissue formation, thus maintaining structural 
integrity of the implant site during healing. 
Biological testing should be furthered through in vivo testing in animal models and 
subsequent human testing.  Though the in vitro tests reported provide an insight into 
the potential of the materials as bone replacement devices, they fail to simulate the 
complex environment found in the body.  Subcutaneous implantation of the 
materials would allow for the osteoinductive nature of the materials to be properly 
assessed as in vitro testing lacks the local proteins, fluctuations in serum 
compositions and variety of cell types that are found in the body.  Implantation into 
a defect in an animal model would allow for investigation of the ability of the 
material to bond to bone and also the time taken for resorption.  In vivo animal 
studies would first have to be performed before human clinical tries could be 
conducted in order to assess the efficacy of the material as the basis of a bone 
replacement device. 
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Appendix A 
License Numbers for Re-Print Permissions 
Figure 1: National Cancer Institute, free to use or share 
Figure 2: 3198880286380 
Figure 3: 3199450772357 
Figure 4: 3198880106136 
Figure 5: 3198880106136 
Figure 6: 3198880106136 
Figure 7: 3198880106136 
Figure 8: 3205951030101 
Figure 9: 3205951276294 
Figure 10: 3198871443484 
Figure 11: 3205941243679 
Figure 12: 3205950043817 
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Appendix B 
Silicon Standard Rietveld Refinement 
The Rietveld refinement of the silicon standard matched to PDF 04-016-4861. 
B.I Rietveld refinement of the silicon standard 
 
Figure B.I.a: The Si standard experimental and refined x-ray diffraction patterns. 
Table B.I.a: The results of the Si standard Rietveld refinement. 
Phase Refinement Factors 
U σ W σ 
Si 0.0091 0.0023 0.0065 0.0004 
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Appendix C 
SPSS Statistical Output of the 3-Point Flexural Test 
The SPSS statistical output of the 3-point flexural test, figure 75 and tables 48 and 
49. 
C.I SPSS statistical output for 3-point flexural test 
Table C.I.a: Test of normality. 
Tests of Normality 
 1 Kolmogorov-Smirnov
a
 Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
flexural 
strength 
0 .176 11 .200
*
 .900 11 .183 
3.12 .133 11 .200
*
 .968 11 .861 
6.24 .223 11 .133 .895 11 .160 
9.35 .195 11 .200
*
 .928 11 .394 
12.47 .132 11 .200
*
 .985 11 .987 
 
Table C.I.b: ANOVA test of normally distributed samples. 
ANOVA 
flexural strength   
 Sum of 
Squares 
df Mean Square F Sig. 
Between Groups 4217.411 4 1054.353 214.622 .000 
Within Groups 245.631 50 4.913   
Total 4463.041 54    
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Table C.I.c: Post hok Tukey test for normally distributed samples. 
Multiple Comparisons 
Dependent Variable:   flexural strength   
Tukey HSD   
(I) 1 (J) 1 Mean 
Difference (I-
J) 
Std. Error Sig. 95% Confidence Interval 
Lower Bound Upper Bound 
0 
3.12 13.06628
*
 .94509 .000 10.3918 15.7407 
6.24 11.21400
*
 .94509 .000 8.5396 13.8884 
9.35 15.86014
*
 .94509 .000 13.1857 18.5346 
12.47 -7.21992
*
 .94509 .000 -9.8944 -4.5455 
3.12 
0 -13.06628
*
 .94509 .000 -15.7407 -10.3918 
6.24 -1.85227 .94509 .300 -4.5267 .8222 
9.35 2.79387
*
 .94509 .037 .1194 5.4683 
12.47 -20.28620
*
 .94509 .000 -22.9606 -17.6118 
6.24 
0 -11.21400
*
 .94509 .000 -13.8884 -8.5396 
3.12 1.85227 .94509 .300 -.8222 4.5267 
9.35 4.64614
*
 .94509 .000 1.9717 7.3206 
12.47 -18.43392
*
 .94509 .000 -21.1084 -15.7595 
9.35 
0 -15.86014
*
 .94509 .000 -18.5346 -13.1857 
3.12 -2.79387
*
 .94509 .037 -5.4683 -.1194 
6.24 -4.64614
*
 .94509 .000 -7.3206 -1.9717 
12.47 -23.08006
*
 .94509 .000 -25.7545 -20.4056 
12.47 
0 7.21992
*
 .94509 .000 4.5455 9.8944 
3.12 20.28620
*
 .94509 .000 17.6118 22.9606 
6.24 18.43392
*
 .94509 .000 15.7595 21.1084 
9.35 23.08006
*
 .94509 .000 20.4056 25.7545 
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Appendix D 
SPSS Statistical Output for pNPP Results 
SPSS statistical output for pNPP results, figures 107 to 111. 
D.I Donor K21 
D.I.1 Day 0 
Table D.I.1.a: Test of normality. 
Tests of Normality 
VAR00002 Kolmogorov-Smirnov
a
 Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
.00 .192 6 .200
*
 .972 6 .903 
1.00 .256 6 .200
*
 .931 6 .584 
2.00 .287 6 .133 .728 6 .012 
3.00 .244 6 .200
*
 .930 6 .583 
*. This is a lower bound of the true significance. 
a. Lilliefors Significance Correction 
Table D.I.1.b: Kruskal-Wallis test of not normally distributed data. 
Test Statistics
a,b
 
 VAR00001 
Chi-Square 1.767 
df 3 
Asymp. Sig. .622 
a. Kruskal Wallis Test 
b. Grouping Variable: 
VAR00002 
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D.I.2 Day 7 
Table D.I.2.a: Test of normality. 
Tests of Normality 
 VAR0000
2 
Kolmogorov-Smirnov
a
 Shapiro-Wilk 
 Statistic df Sig. Statistic df Sig. 
VAR0000
1 
10.00 .284 6 .141 .862 6 .196 
11.00 .193 6 .200
*
 .924 6 .533 
12.00 .223 6 .200
*
 .941 6 .668 
13.00 .206 6 .200
*
 .893 6 .333 
*. This is a lower bound of the true significance. 
a. Lilliefors Significance Correction 
 
Table D.I.2.b: ANOVA analysis of normally distributed data. 
ANOVA 
VAR00001   
 Sum of 
Squares 
df Mean Square F Sig. 
Between Groups .018 3 .006 3.559 .033 
Within Groups .034 20 .002   
Total .053 23    
 
D.I.3 Day 14 
Table D.I.3.a: Test of normality. 
Tests of Normality 
 VAR0000
2 
Kolmogorov-Smirnov
a
 Shapiro-Wilk 
 Statistic df Sig. Statistic df Sig. 
VAR0000
1 
20.00 .227 6 .200
*
 .917 6 .481 
21.00 .154 6 .200
*
 .952 6 .760 
22.00 .131 6 .200
*
 .994 6 .997 
23.00 .184 6 .200
*
 .913 6 .455 
*. This is a lower bound of the true significance. 
a. Lilliefors Significance Correction 
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Table D.I.3.b: ANOVA analysis of normally distributed data. 
ANOVA 
VAR00001   
 Sum of 
Squares 
df Mean Square F Sig. 
Between Groups .145 3 .048 13.902 .000 
Within Groups .069 20 .003   
Total .214 23    
 
Table D.I.3.c: Tukey post hoc analysis. 
Multiple Comparisons 
Dependent Variable:   VAR00001   
Tukey HSD   
(I) 
VAR00002 
(J) 
VAR00002 
Mean 
Difference 
(I-J) 
Std. 
Error 
Sig. 95% Confidence Interval 
Lower 
Bound 
Upper 
Bound 
20.00 
21.00 -.137
*
 .034 .003 -.232 -.042 
22.00 .007 .034 .997 -.088 .102 
23.00 .077 .034 .138 -.018 .172 
21.00 
20.00 .137
*
 .034 .003 .042 .232 
22.00 .144
*
 .034 .002 .049 .239 
23.00 .214
*
 .034 .000 .119 .309 
22.00 
20.00 -.007 .034 .997 -.102 .088 
21.00 -.144
*
 .034 .002 -.239 -.049 
23.00 .070 .034 .198 -.025 .165 
23.00 
20.00 -.077 .034 .138 -.172 .018 
21.00 -.214
*
 .034 .000 -.309 -.119 
22.00 -.070 .034 .198 -.165 .025 
*. The mean difference is significant at the 0.05 level. 
 
D.I.4 Day 21 
Table D.I.4.a: Test of normality. 
Tests of Normality 
 VAR0000
2 
Kolmogorov-Smirnov
a
 Shapiro-Wilk 
 Statistic df Sig. Statistic df Sig. 
VAR0000
1 
30.00 .194 6 .200
*
 .918 6 .491 
31.00 .159 6 .200
*
 .973 6 .914 
32.00 .167 6 .200
*
 .984 6 .968 
33.00 .232 6 .200
*
 .935 6 .619 
*. This is a lower bound of the true significance. 
a. Lilliefors Significance Correction 
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Table D.I.4.b: ANOVA analysis of normally distributed data. 
ANOVA 
VAR00001   
 Sum of 
Squares 
df Mean Square F Sig. 
Between Groups .160 3 .053 20.183 .000 
Within Groups .053 20 .003   
Total .213 23    
 
Table D.I.4.c: Tukey post hoc analysis. 
Multiple Comparisons 
Dependent Variable:   VAR00001   
Tukey HSD   
(I) 
VAR00002 
(J) 
VAR00002 
Mean 
Difference 
(I-J) 
Std. 
Error 
Sig. 95% Confidence Interval 
Lower 
Bound 
Upper 
Bound 
30.00 
31.00 -.197
*
 .030 .000 -.280 -.114 
32.00 -.073 .030 .096 -.156 .010 
33.00 .005 .030 .998 -.078 .088 
31.00 
30.00 .197
*
 .030 .000 .114 .280 
32.00 .124
*
 .030 .002 .041 .207 
33.00 .202
*
 .030 .000 .119 .285 
32.00 
30.00 .073 .030 .096 -.010 .156 
31.00 -.124
*
 .030 .002 -.207 -.041 
33.00 .078 .030 .068 -.005 .161 
33.00 
30.00 -.005 .030 .998 -.088 .078 
31.00 -.202
*
 .030 .000 -.285 -.119 
32.00 -.078 .030 .068 -.161 .005 
*. The mean difference is significant at the 0.05 level. 
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D.II. Donor K41 
D.II.1 Day 0 
Table D.II.1.a: Test of normality. 
Tests of Normality 
 VAR0000
2 
Kolmogorov-Smirnov
a
 Shapiro-Wilk 
 Statistic df Sig. Statistic df Sig. 
VAR00001 
.00 .208 6 .200
*
 .913 6 .455 
1.00 .187 6 .200
*
 .911 6 .444 
2.00 .285 6 .140 .840 6 .130 
3.00 .276 6 .173 .795 6 .053 
*. This is a lower bound of the true significance. 
a. Lilliefors Significance Correction 
 
Table D.II.1.b: ANOVA analysis of normal data. 
ANOVA 
VAR00001   
 Sum of 
Squares 
df Mean Square F Sig. 
Between Groups .017 3 .006 1.517 .241 
Within Groups .076 20 .004   
Total .094 23    
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D.II.2 Day 7 
Table D.II.2.a: Test of normality. 
Tests of Normality 
 VAR0000
2 
Kolmogorov-Smirnov
a
 Shapiro-Wilk 
 Statistic df Sig. Statistic df Sig. 
VAR00001 
10.00 .288 6 .131 .823 6 .094 
11.00 .197 6 .200
*
 .965 6 .855 
12.00 .221 6 .200
*
 .930 6 .580 
13.00 .195 6 .200
*
 .956 6 .790 
*. This is a lower bound of the true significance. 
a. Lilliefors Significance Correction 
Table D.II.2.b: ANOVA analysis of normally distributed data. 
ANOVA 
VAR00001   
 Sum of 
Squares 
df Mean Square F Sig. 
Between Groups .145 3 .048 7.799 .001 
Within Groups .124 20 .006   
Total .269 23    
 
Table D.II.2.c: Tukey post hoc analysis. 
Multiple Comparisons 
Dependent Variable:   VAR00001   
Tukey HSD   
(I) 
VAR00002 
(J) 
VAR00002 
Mean 
Difference 
(I-J) 
Std. 
Error 
Sig. 95% Confidence Interval 
Lower 
Bound 
Upper 
Bound 
10.00 
11.00 .048 .045 .719 -.079 .175 
12.00 .159
*
 .045 .011 .032 .287 
13.00 .189
*
 .045 .003 .062 .316 
11.00 
10.00 -.048 .045 .719 -.175 .079 
12.00 .111 .045 .100 -.016 .239 
13.00 .141
*
 .045 .026 .014 .268 
12.00 
10.00 -.159
*
 .045 .011 -.287 -.032 
11.00 -.111 .045 .100 -.239 .016 
13.00 .030 .045 .912 -.097 .157 
13.00 
10.00 -.189
*
 .045 .003 -.316 -.062 
11.00 -.141
*
 .045 .026 -.268 -.014 
12.00 -.030 .045 .912 -.157 .097 
*. The mean difference is significant at the 0.05 level. 
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D.II.3 Day 14 
Table D.II.3.a: Test of normality. 
Tests of Normality 
 VAR0000
2 
Kolmogorov-Smirnov
a
 Shapiro-Wilk 
 Statistic df Sig. Statistic df Sig. 
VAR00001 
20.00 .184 6 .200
*
 .943 6 .687 
21.00 .200 6 .200
*
 .926 6 .550 
22.00 .203 6 .200
*
 .911 6 .441 
23.00 .175 6 .200
*
 .918 6 .491 
*. This is a lower bound of the true significance. 
a. Lilliefors Significance Correction 
 
Table D.II.3.b: ANOV analysis of normally distributed data. 
ANOVA 
VAR00001   
 Sum of 
Squares 
df Mean Square F Sig. 
Between Groups .246 3 .082 13.577 .000 
Within Groups .121 20 .006   
Total .366 23    
 
Table D.II.3.c: Tukey post hoc analysis. 
Multiple Comparisons 
Dependent Variable:   VAR00001   
Tukey HSD   
(I) 
VAR00002 
(J) 
VAR00002 
Mean 
Difference 
(I-J) 
Std. 
Error 
Sig. 95% Confidence Interval 
Lower 
Bound 
Upper 
Bound 
20.00 
21.00 -.128
*
 .045 .044 -.254 -.003 
22.00 -.084 .045 .268 -.210 .041 
23.00 .137
*
 .045 .029 .012 .263 
21.00 
20.00 .128
*
 .045 .044 .003 .254 
22.00 .044 .045 .762 -.082 .169 
23.00 .265
*
 .045 .000 .140 .391 
22.00 
20.00 .084 .045 .268 -.041 .210 
21.00 -.044 .045 .762 -.169 .082 
23.00 .221
*
 .045 .000 .096 .347 
23.00 
20.00 -.137
*
 .045 .029 -.263 -.012 
21.00 -.265
*
 .045 .000 -.391 -.140 
22.00 -.221
*
 .045 .000 -.347 -.096 
*. The mean difference is significant at the 0.05 level. 
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D.II.4 Day 21 
Table D.II.4.a: Test of normality. 
Tests of Normality 
 VAR0000
2 
Kolmogorov-Smirnov
a
 Shapiro-Wilk 
 Statistic df Sig. Statistic df Sig. 
VAR00001 
30.00 .296 6 .108 .804 6 .064 
31.00 .273 6 .185 .799 6 .057 
32.00 .235 6 .200
*
 .906 6 .408 
33.00 .311 6 .071 .723 6 .011 
*. This is a lower bound of the true significance. 
a. Lilliefors Significance Correction 
 
Table D.II.4.b: Kruskal-Wallis analysis of not normally distributed data. 
Test Statistics
a,b
 
 VAR00001 
Chi-Square 10.607 
df 3 
Asymp. Sig. .014 
a. Kruskal Wallis Test 
b. Grouping Variable: 
VAR00002 
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Table D.II.4.c: Bonferroni post hoc analysis. 
Multiple Comparisons 
Dependent Variable:   VAR00001   
Bonferroni   
(I) 
VAR00002 
(J) 
VAR00002 
Mean 
Difference 
(I-J) 
Std. 
Error 
Sig. 95% Confidence Interval 
Lower 
Bound 
Upper 
Bound 
30.00 
31.00 -.031 .066 1.000 -.224 .163 
32.00 .108 .066 .712 -.086 .301 
33.00 .236
*
 .066 .011 .043 .429 
31.00 
30.00 .031 .066 1.000 -.163 .224 
32.00 .138 .066 .296 -.055 .332 
33.00 .267
*
 .066 .004 .073 .460 
32.00 
30.00 -.108 .066 .712 -.301 .086 
31.00 -.138 .066 .296 -.332 .055 
33.00 .128 .066 .398 -.065 .322 
33.00 
30.00 -.236
*
 .066 .011 -.429 -.043 
31.00 -.267
*
 .066 .004 -.460 -.073 
32.00 -.128 .066 .398 -.322 .065 
*. The mean difference is significant at the 0.05 level. 
 
D.III Donor K56 
D.III.1 Day 0 
Table D.III.1.a: Test of normality. 
Tests of Normality 
 VAR0000
2 
Kolmogorov-Smirnov
a
 Shapiro-Wilk 
 Statistic df Sig. Statistic df Sig. 
VAR00001 
.00 .169 6 .200
*
 .933 6 .604 
1.00 .303 6 .090 .858 6 .181 
2.00 .255 6 .200
*
 .874 6 .244 
3.00 .221 6 .200
*
 .935 6 .617 
*. This is a lower bound of the true significance. 
a. Lilliefors Significance Correction 
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Table D.III.1.b: ANOVA analysis of normally distributed data. 
ANOVA 
VAR00001   
 Sum of 
Squares 
df Mean Square F Sig. 
Between Groups .060 3 .020 2.144 .127 
Within Groups .186 20 .009   
Total .246 23    
 
D.III.2 Day 7 
Table D.III.2.a: Test of normality. 
Tests of Normality 
 VAR0000
2 
Kolmogorov-Smirnov
a
 Shapiro-Wilk 
 Statistic df Sig. Statistic df Sig. 
VAR00001 
10.00 .321 6 .052 .820 6 .088 
11.00 .259 6 .200
*
 .883 6 .284 
12.00 .230 6 .200
*
 .874 6 .241 
13.00 .367 6 .011 .736 6 .014 
*. This is a lower bound of the true significance. 
a. Lilliefors Significance Correction 
 
Table D.III.2.b: Kruskal-Wallis analysis of not normally distributed data. 
Test Statistics
a,b
 
 VAR00001 
Chi-Square 14.287 
df 3 
Asymp. Sig. .003 
a. Kruskal Wallis Test 
b. Grouping Variable: 
VAR00002 
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Table D.III.2.c: Bonferroni post hoc analysis. 
Multiple Comparisons 
Dependent Variable:   VAR00001   
Bonferroni   
(I) 
VAR00002 
(J) 
VAR00002 
Mean 
Difference 
(I-J) 
Std. 
Error 
Sig. 95% Confidence Interval 
Lower 
Bound 
Upper 
Bound 
10.00 
11.00 .047 .155 1.000 -.407 .501 
12.00 .377 .155 .148 -.077 .832 
13.00 .625
*
 .155 .004 .170 1.079 
11.00 
10.00 -.047 .155 1.000 -.501 .407 
12.00 .330 .155 .276 -.124 .785 
13.00 .578
*
 .155 .008 .123 1.032 
12.00 
10.00 -.377 .155 .148 -.832 .077 
11.00 -.330 .155 .276 -.785 .124 
13.00 .247 .155 .759 -.207 .702 
13.00 
10.00 -.625
*
 .155 .004 -1.079 -.170 
11.00 -.578
*
 .155 .008 -1.032 -.123 
12.00 -.247 .155 .759 -.702 .207 
*. The mean difference is significant at the 0.05 level. 
 
D.III.3 Day 14 
Table D.III.3.a: Test of normality. 
Tests of Normality 
 VAR0000
2 
Kolmogorov-Smirnov
a
 Shapiro-Wilk 
 Statistic df Sig. Statistic df Sig. 
VAR0000
1 
20.00 .206 6 .200
*
 .900 6 .374 
21.00 .242 6 .200
*
 .904 6 .397 
22.00 .230 6 .200
*
 .874 6 .241 
23.00 .367 6 .011 .736 6 .014 
*. This is a lower bound of the true significance. 
a. Lilliefors Significance Correction 
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Table D.III.3.b: Kruskal-Wallis analysis of not normally distributed data. 
Test Statistics
a,b
 
 VAR00001 
Chi-Square 19.227 
df 3 
Asymp. Sig. .000 
a. Kruskal Wallis Test 
b. Grouping Variable: 
VAR00002 
 
Table D.III.3.c: Bonferroni post hoc analysis. 
Multiple Comparisons 
Dependent Variable:   VAR00001   
Bonferroni   
(I) 
VAR00002 
(J) 
VAR00002 
Mean 
Difference 
(I-J) 
Std. 
Error 
Sig. 95% Confidence Interval 
Lower 
Bound 
Upper 
Bound 
20.00 
21.00 .104 .106 1.000 -.205 .414 
22.00 .602
*
 .106 .000 .292 .912 
23.00 .850
*
 .106 .000 .540 1.160 
21.00 
20.00 -.104 .106 1.000 -.414 .205 
22.00 .498
*
 .106 .001 .188 .808 
23.00 .745
*
 .106 .000 .435 1.055 
22.00 
20.00 -.602
*
 .106 .000 -.912 -.292 
21.00 -.498
*
 .106 .001 -.808 -.188 
23.00 .247 .106 .179 -.062 .557 
23.00 
20.00 -.850
*
 .106 .000 -1.160 -.540 
21.00 -.745
*
 .106 .000 -1.055 -.435 
22.00 -.247 .106 .179 -.557 .062 
*. The mean difference is significant at the 0.05 level. 
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D.III.4 Day 21 
Table D.III.4.a: Test of normality. 
Tests of Normality 
 VAR0000
2 
Kolmogorov-Smirnov
a
 Shapiro-Wilk 
 Statistic df Sig. Statistic df Sig. 
VAR00001 
30.00 .161 6 .200
*
 .962 6 .835 
31.00 .217 6 .200
*
 .892 6 .329 
32.00 .350 6 .020 .788 6 .045 
33.00 .288 6 .130 .884 6 .288 
*. This is a lower bound of the true significance. 
a. Lilliefors Significance Correction 
 
Table D.III.4.b: Kruskal-Wallis analysis of not normally distributed data. 
Test Statistics
a,b
 
 VAR00001 
Chi-Square 16.333 
df 3 
Asymp. Sig. .001 
a. Kruskal Wallis Test 
b. Grouping Variable: 
VAR00002 
Table D.III.4.c: Bonferroni post hoc analysis. 
Multiple Comparisons 
Dependent Variable:   VAR00001   
Bonferroni   
(I) 
VAR00002 
(J) 
VAR00002 
Mean 
Difference 
(I-J) 
Std. 
Error 
Sig. 95% Confidence Interval 
Lower 
Bound 
Upper 
Bound 
30.00 
31.00 -.138 .090 .844 -.402 .125 
32.00 .151 .090 .648 -.112 .415 
33.00 .436
*
 .090 .001 .173 .700 
31.00 
30.00 .138 .090 .844 -.125 .402 
32.00 .290
*
 .090 .026 .026 .553 
33.00 .574
*
 .090 .000 .311 .838 
32.00 
30.00 -.151 .090 .648 -.415 .112 
31.00 -.290
*
 .090 .026 -.553 -.026 
33.00 .285
*
 .090 .029 .021 .548 
33.00 
30.00 -.436
*
 .090 .001 -.700 -.173 
31.00 -.574
*
 .090 .000 -.838 -.311 
32.00 -.285
*
 .090 .029 -.548 -.021 
*. The mean difference is significant at the 0.05 level. 
 
